Difference between revisions of "Msigdb mapping v2.5 to v3"
(created page using 2.5 data; must add 3.0 mapping data!) |
(correct data, still needs formatting) |
||
Line 4: | Line 4: | ||
<p><span style="font-size: 12pt;">Gene set names are case insensitive. In MSigDB v2, all gene set names are uppercase.</span></p> | <p><span style="font-size: 12pt;">Gene set names are case insensitive. In MSigDB v2, all gene set names are uppercase.</span></p> | ||
<br /> | <br /> | ||
− | <table cellspacing="0" cellpadding="0" border=" | + | <meta content="text/html; charset=utf-8" http-equiv="Content-Type" /> |
+ | <meta content="Excel.Sheet" name="ProgId" /> | ||
+ | <meta content="Microsoft Excel 2008" name="Generator" /> | ||
+ | <link href="file://localhost/Users/judymcla/Library/Caches/TemporaryItems/msoclip/0/clip.htm" rel="Main-File" id="Main-File" /> <style type="text/css"> | ||
+ | <!--table | ||
+ | {mso-displayed-decimal-separator:"\."; | ||
+ | mso-displayed-thousand-separator:"\,";} | ||
+ | .font5 | ||
+ | {color:windowtext; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Verdana; | ||
+ | mso-generic-font-family:auto; | ||
+ | mso-font-charset:0;} | ||
+ | .font6 | ||
+ | {color:windowtext; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Arial; | ||
+ | mso-generic-font-family:auto; | ||
+ | mso-font-charset:0;} | ||
+ | td | ||
+ | {padding-top:1px; | ||
+ | padding-right:1px; | ||
+ | padding-left:1px; | ||
+ | mso-ignore:padding; | ||
+ | color:windowtext; | ||
+ | font-size:12.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Verdana; | ||
+ | mso-generic-font-family:auto; | ||
+ | mso-font-charset:0; | ||
+ | mso-number-format:General; | ||
+ | text-align:general; | ||
+ | vertical-align:bottom; | ||
+ | border:none; | ||
+ | mso-background-source:auto; | ||
+ | mso-pattern:auto; | ||
+ | mso-protection:locked visible; | ||
+ | white-space:nowrap; | ||
+ | mso-rotate:0;} | ||
+ | .xl24 | ||
+ | {font-family:Arial; | ||
+ | mso-generic-font-family:auto; | ||
+ | mso-font-charset:0;} | ||
+ | .xl25 | ||
+ | {font-family:Cambria; | ||
+ | mso-generic-font-family:auto; | ||
+ | mso-font-charset:0;} | ||
+ | ruby | ||
+ | {ruby-align:left;} | ||
+ | rt | ||
+ | {color:windowtext; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Verdana; | ||
+ | mso-generic-font-family:auto; | ||
+ | mso-font-charset:0; | ||
+ | mso-char-type:none; | ||
+ | display:none;} | ||
+ | --> | ||
+ | </style> | ||
+ | <table width="500" height="94477" cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse;" summary=""> | ||
+ | <!--StartFragment--> <col width="294" style=""></col> <col width="421" style=""></col> | ||
<tbody> | <tbody> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td width="294" height="16"> |
− | + | <p><strong><font size="3"><a name="RANGE!A1:B12">v2.5_name or status</a></font></strong></p> | |
− | |||
− | |||
− | |||
− | |||
</td> | </td> | ||
− | <td | + | <td width="421"> |
− | + | <p><strong><font size="3">v3.0_name or status</font></strong></p> | |
</td> | </td> | ||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_ALL_UP</font></td> |
− | < | + | <td><font size="2">ZHU_CMV_ALL_UP</font></td> |
− | + | </tr> | |
− | <td | + | <tr height="16"> |
− | < | + | <td height="16"><font size="2">CMV_8HRS_DN</font></td> |
− | + | <td><font size="2">ZHU_CMV_8_HR_DN</font></td> | |
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_24HRS_DN</font></td> |
− | + | <td><font size="2">ZHU_CMV_24_HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_ALL_DN</font></td> |
− | + | <td><font size="2">ZHU_CMV_ALL_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_24HRS_UP</font></td> |
− | + | <td><font size="2">ZHU_CMV_24_HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_8HRS_UP</font></td> |
− | + | <td><font size="2">ZHU_CMV_8_HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">DER_IFN_ALPHA_RESPONSE_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DER_IFNB_DN</font></td> |
− | + | <td><font size="2">DER_IFN_BETA_RESPONSE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DER_IFNB_UP</font></td> |
− | + | <td><font size="2">DER_IFN_BETA_RESPONSE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DER_IFNG_DN</font></td> |
− | + | <td><font size="2">DER_IFN_GAMMA_RESPONSE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DER_IFNG_UP</font></td> |
− | + | <td><font size="2">DER_IFN_GAMMA_RESPONSE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFN_ALL_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFN_BETA_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFN_ANY_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFN_GAMMA_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFN_ALPHA_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DER_IFNA_UP</font></td> |
− | + | <td><font size="2">DER_IFN_ALPHA_RESPONSE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CALRES_MOUSE_UP</font></td> |
− | + | <td><font size="2">LEE_CALORIE_RESTRICTION_MUSCLE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_MUSCLE_DN</font></td> |
− | + | <td><font size="2">LEE_AGING_MUSCLE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CALRES_MOUSE_DN</font></td> |
− | + | <td><font size="2">LEE_CALORIE_RESTRICTION_MUSCLE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_MUSCLE_UP</font></td> |
− | + | <td><font size="2">LEE_AGING_MUSCLE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">GOLUB_ALL_VS_AML_UP</font></td> |
− | + | <td><font size="2">GOLUB_ALL_VS_AML_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">GOLUB_ALL_VS_AML_DN</font></td> |
− | + | <td><font size="2">GOLUB_ALL_VS_AML_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA1_SW480_DN</font></td> |
− | + | <td><font size="2">MACLACHLAN_BRCA1_TARGETS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA1_SW480_UP</font></td> |
− | + | <td><font size="2">MACLACHLAN_BRCA1_TARGETS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">COLLER_MYC_UP</font></td> |
− | + | <td><font size="2">COLLER_MYC_TARGETS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">COLLER_MYC_DN</font></td> |
− | + | <td><font size="2">COLLER_MYC_TARGETS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HG_PROGERIA_DN</font></td> |
− | + | <td><font size="2">LY_AGING_PREMATURE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">MIDDLEAGE_UP</font></td> |
− | + | <td><font size="2">LY_AGING_MIDDLE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">OLDAGE_DN</font></td> |
− | + | <td><font size="2">LY_AGING_OLD_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">MIDDLEAGE_DN</font></td> |
− | + | <td><font size="2">LY_AGING_MIDDLE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">LY_AGING_OLD_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">LY_AGING_PREMATURE_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HPV31_DN</font></td> |
− | + | <td><font size="2">CHANG_IMMORTALIZED_BY_HPV31_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HPV31_UP</font></td> |
− | + | <td><font size="2">CHANG_IMMORTALIZED_BY_HPV31_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_NEOCORTEX_DN</font></td> |
− | + | <td><font size="2">LEE_AGING_NEOCORTEX_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CALRES_MOUSE_NEOCORTEX_UP</font></td> |
− | + | <td><font size="2">LEE_CALORIE_RESTRICTION_NEOCORTEX_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_CEREBELLUM_DN</font></td> |
− | + | <td><font size="2">LEE_AGING_CEREBELLUM_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_NEOCORTEX_UP</font></td> |
− | + | <td><font size="2">LEE_AGING_NEOCORTEX_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_CEREBELLUM_UP</font></td> |
− | + | <td><font size="2">LEE_AGING_CEREBELLUM_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CALRES_MOUSE_NEOCORTEX_DN</font></td> |
− | + | <td><font size="2">LEE_CALORIE_RESTRICTION_NEOCORTEX_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CURSUL_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL48HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA48HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSABUT_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER7</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL12HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER8</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CURSUL_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL30MIN_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR48HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT30MIN_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA2HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR12HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT2HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER10</font></td> |
− | + | <td><font size="2">MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR24HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL16HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL24HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER9</font></td> |
− | + | <td><font size="2">MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL12HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA24HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT48HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT16HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT24HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER4</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR16HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT16HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA12HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL16HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL2HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER5</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR2HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL2HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT12HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT12HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT2HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CUR24HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT48HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_CLUSTER6</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL24HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA2HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_SUL48HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSABUT_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA30MIN_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_BUT24HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HDACI_COLON_TSA48HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_3</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARP_KO_DN</font></td> |
− | + | <td><font size="2">SIMBULAN_PARP1_TARGETS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARP_KO_UP</font></td> |
− | + | <td><font size="2">SIMBULAN_PARP1_TARGETS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">NADLER_OBESITY_UP</font></td> |
− | + | <td><font size="2">NADLER_OBESITY_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">NADLER_OBESITY_DN</font></td> |
− | + | <td><font size="2">NADLER_OBESITY_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">NADLER_OBESITY_HYPERGLYCEMIA</font></td> |
− | + | <td><font size="2">NADLER_HYPERGLYCEMIA_AT_OBESITY</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CORTEX_ENRICHMENT_EARLY_UP</font></td> |
− | + | <td><font size="2">RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CORTEX_ENRICHMENT_LATE_UP</font></td> |
− | + | <td><font size="2">RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_DN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DNMT1_KO_UP</font></td> |
− | + | <td><font size="2">JACKSON_DNMT1_TARGETS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DNMT1_KO_DN</font></td> |
− | + | <td><font size="2">JACKSON_DNMT1_TARGETS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">SCHUMACHER_MYC_DN</font></td> |
− | + | <td><font size="2">SCHUHMACHER_MYC_TARGETS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">SCHUMACHER_MYC_UP</font></td> |
− | + | <td><font size="2">SCHUHMACHER_MYC_TARGETS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_CORTEX_UP</font></td> |
− | + | <td><font size="2">JIANG_AGING_CEREBRAL_CORTEX_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_HYPOTH_DN</font></td> |
− | + | <td><font size="2">JIANG_AGING_HYPOTHALAMUS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_CORTEX_DN</font></td> |
− | + | <td><font size="2">JIANG_AGING_CEREBRAL_CORTEX_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_MOUSE_HYPOTH_UP</font></td> |
− | + | <td><font size="2">JIANG_AGING_HYPOTHALAMUS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BREASTCA_THREE_CLASSES</font></td> |
− | + | <td><font size="2">HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BREASTCA_TWO_CLASSES</font></td> |
− | + | <td><font size="2">HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOHENKIRK_MONOCYTE_DEND_UP</font></td> |
− | + | <td><font size="2">LENAOUR_DENDRITIC_CELL_MATURATION_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOHENKIRK_MONOCYTE_DEND_DN</font></td> |
− | + | <td><font size="2">LENAOUR_DENDRITIC_CELL_MATURATION_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_ALL_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_C2_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_RESPONSE_TO_TGFB1_C2</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_C1_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_RESPONSE_TO_TGFB1_C1</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_C5_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_RESPONSE_TO_TGFB1_C5</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_EARLY_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_EARLY_RESPONSE_TO_TGFB1</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_LATE_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_C4_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_RESPONSE_TO_TGFB1_C4</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">TGFBETA_C3_UP</font></td> |
− | + | <td><font size="2">VERRECCHIA_RESPONSE_TO_TGFB1_C3</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">VERRECCHIA_RESPONSE_TO_TGFB1_C6</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CALRES_RHESUS_DN</font></td> |
− | + | <td><font size="2">KAYO_CALORIE_RESTRICTION_MUSCLE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_RHESUS_UP</font></td> |
− | + | <td><font size="2">KAYO_AGING_MUSCLE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">AGED_RHESUS_DN</font></td> |
− | + | <td><font size="2">KAYO_AGING_MUSCLE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CALRES_RHESUS_UP</font></td> |
− | + | <td><font size="2">KAYO_CALORIE_RESTRICTION_MUSCLE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">E2F1_DNA_UP</font></td> |
− | + | <td><font size="2">KALMA_E2F1_TARGETS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA1_MES_UP</font></td> |
− | + | <td><font size="2">APRELIKOVA_BRCA1_TARGETS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">KANNAN_P53_UP</font></td> |
− | + | <td><font size="2">KANNAN_TP53_TARGETS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">KANNAN_P53_DN</font></td> |
− | + | <td><font size="2">KANNAN_TP53_TARGETS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">GH_IGF_CHONDROCYTES_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HYPOPHYSECTOMY_RAT_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HYPOPHYSECTOMY_RAT_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">GH_HYPOPHYSECTOMY_RAT_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">GH_HYPOPHYSECTOMY_RAT_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ISHIDA_E2F_TARGETS</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BUT_TSA_UP</font></td> |
− | + | <td><font size="2">DELLA_RESPONSE_TO_TSA_AND_BUTYRATE</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HIPPOCAMPUS_DEVELOPMENT_POSTNATAL</font></td> |
− | + | <td><font size="2">MODY_HIPPOCAMPUS_POSTNATAL</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HIPPOCAMPUS_DEVELOPMENT_NEONATAL</font></td> |
− | + | <td><font size="2">MODY_HIPPOCAMPUS_NEONATAL</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HIPPOCAMPUS_DEVELOPMENT_PRENATAL</font></td> |
− | + | <td><font size="2">MODY_HIPPOCAMPUS_PRENATAL</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HBX_NL_DN</font></td> |
− | + | <td><font size="2">WU_HBX_TARGETS_2_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HBX_HCC_DN</font></td> |
− | + | <td><font size="2">WU_HBX_TARGETS_1_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HBX_HEP_UP</font></td> |
− | + | <td><font size="2">WU_HBX_TARGETS_3_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HBX_HEP_DN</font></td> |
− | + | <td><font size="2">WU_HBX_TARGETS_3_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HBX_HCC_UP</font></td> |
− | + | <td><font size="2">WU_HBX_TARGETS_1_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HBX_NL_UP</font></td> |
− | + | <td><font size="2">WU_HBX_TARGETS_2_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">LIAN_MYELOID_DIFF_RECEPTORS</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">LIAN_MYELOID_DIFF_TF</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">LIAN_MYELOID_DIFF_GRANULE</font></td> |
− | + | <td><font size="2">LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOFMANN_MANTEL_LYMPHOMA_VS_LYMPH_NODES_DN</font></td> |
− | + | <td><font size="2">HOFMANN_CELL_LYMPHOMA_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOFMANN_MANTEL_LYMPHOMA_VS_LYMPH_NODES_UP</font></td> |
− | + | <td><font size="2">HOFMANN_CELL_LYMPHOMA_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DSRNA_DN</font></td> |
− | + | <td><font size="2">GEISS_RESPONSE_TO_DSRNA_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DSRNA_UP</font></td> |
− | + | <td><font size="2">GEISS_RESPONSE_TO_DSRNA_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">NAKAJIMA_MCSMBP_EOS</font></td> |
− | + | <td><font size="2">NAKAJIMA_EOSINOPHIL</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">NAKAJIMA_MCSMBP_MAST</font></td> |
− | + | <td><font size="2">NAKAJIMA_MAST_CELL</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRG1_SW13_UP</font></td> |
− | + | <td><font size="2">LIU_SMARCA4_TARGETS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HIF1_TARGETS</font></td> |
− | + | <td><font size="2">SEMENZA_HIF1_TARGETS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24"><font size="2">LIN_WNT_UP</font></td> |
− | + | <td><font size="2">LIN_APC_TARGETS</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK4_6HRS_DN</font></td> |
− | + | <td><font size="2">MURAKAMI_UV_RESPONSE_6HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK4_6HRS_UP</font></td> |
− | + | <td><font size="2">MURAKAMI_UV_RESPONSE_6HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK4_24HRS_DN</font></td> |
− | + | <td><font size="2">MURAKAMI_UV_RESPONSE_24HR</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">MURAKAMI_UV_RESPONSE_1HR_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">MURAKAMI_UV_RESPONSE_1HR_DN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IGF1_NIH3T3_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">INSULIN_NIH3T3_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">GRAEBER_BETA2_INTEGRINS</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_20HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_20HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_16HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_16HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_1HR_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UV-CMV_UNIQUE_HCMV_6HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_UV-CMV_COMMON_HCMV_6HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_16HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_16HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_10HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_10HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_ALL_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_24HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_24HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_14HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_14HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFNA_HCMV_6HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_INTERFERON_RESPONSIVE_GENES</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_8HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_8HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_20HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_20HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV-CHX_HCMV_6HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_48HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_48HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_48HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_48HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_8HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_8HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_14HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_14HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_UV-CMV_COMMON_HCMV_6HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV-UV_HCMV_6HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_18HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_18HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">IFNA_UV-CMV_COMMON_HCMV_6HRS_UP</font></td> |
− | + | <td><font size="2">IFNA_UV-CMV_COMMON_HCMV_6HRS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_18HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_18HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UV-CMV_UNIQUE_HCMV_6HRS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_10HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_10HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_12HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_12HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_6HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_6HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_6HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_24HRS_UP</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_24HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_4HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_6HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_6HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV-UV_HCMV_6HRS_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_12HRS_DN</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_12HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">CMV_HCMV_TIMECOURSE_ALL_DN</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_30MIN_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_30MIN_DN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_1HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_1HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_2HR_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_2HR_DN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_4HR_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">BROWNE_HCMV_INFECTION_4HR_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">ICF_UP</font></td> |
− | + | <td><font size="2">EHRLICH_ICF_SYNDROM_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">ICF_DN</font></td> |
− | + | <td><font size="2">EHRLICH_ICF_SYNDROM_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">ET743PT650_COLONCA_DN</font></td> |
− | + | <td><font size="2">MARTINEZ_RESPONSE_TO_TRABECTEDIN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HSIAO_LIVER_SPECIFIC_GENES</font></td> |
− | + | <td><font size="2">HSIAO_LIVER_SPECIFIC_GENES</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">HSIAO_HOUSEKEEPING_GENES</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOFFMANN_BIVSBII_LGBII</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOFFMANN_BIVSBII_BI</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOFFMANN_BIVSBII_IMVM</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">HOFFMANN_BIVSBII_BI_TABLE2</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARK_HSC_VS_MPP_DN</font></td> |
− | + | <td><font size="2">PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARK_HSC_VS_MPP_UP</font></td> |
− | + | <td><font size="2">PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARK_MSCS_BOTH</font></td> |
− | + | <td><font size="2">PARK_HSC_MARKERS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARK_MSCS_DIFF</font></td> |
− | + | <td><font size="2">PARK_HSC_AND_MULTIPOTENT_PROGENITORS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">PARK_MSCS_LIN2</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">SHIPP_DLBCL_CURED_DN</font></td> |
− | + | <td><font size="2">SHIPP_DLBCL_CURED_VS_FATAL_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">SHIPP_DLBCL_CURED_UP</font></td> |
− | + | <td><font size="2">SHIPP_DLBCL_CURED_VS_FATAL_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">SHIPP_FL_VS_DLBCL_DN</font></td> |
− | + | <td><font size="2">SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">SHIPP_FL_VS_DLBCL_UP</font></td> |
− | + | <td><font size="2">SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">REN_E2F1_TARGETS</font></td> |
− | + | <td><font size="2">REN_BOUND_BY_E2F</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">POMEROY_DESMOPLASIC_VS_CLASSIC_MD_UP</font></td> |
− | + | <td><font size="2">POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">POMEROY_DESMOPLASIC_VS_CLASSIC_MD_DN</font></td> |
− | + | <td><font size="2">POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">POMEROY_MD_TREATMENT_GOOD_VS_POOR_UP</font></td> |
− | + | <td><font size="2">POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">POMEROY_MD_TREATMENT_GOOD_VS_POOR_DN</font></td> |
− | + | <td><font size="2">POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">MMC_RES_XENOGRAFTS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">RESISTANCE_XENOGRAFTS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">VLB_RES_XENOGRAFTS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">MTX_RES_XENOGRAFTS_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_CISPLATIN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_DN</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_METASTASIS_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_UP</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_METASTASIS_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA_PROGNOSIS_POS</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA_BRCA1_NEG</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA_PROGNOSIS_NEG</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA_BRCA1_POS</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA_ER_NEG</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">BRCA_ER_POS</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_ESR1_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_ESR1_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_BRCA1_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_BRCA1_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">—</font></td> |
− | + | <td><font size="2">VANTVEER_BREAST_CANCER_POOR_PROGNOSIS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DORSEY_DOXYCYCLINE_UP</font></td> |
− | + | <td><font size="2">DORSEY_GAB2_TARGETS</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24"><font size="2">ZHAN_MULTIPLE_MYELOMA_SUBCLASSES_DIFF</font></td> |
− | + | <td><font size="2">ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24"><font size="2">ZHAN_PCS_MULTIPLE_MYELOMA_SPKD</font></td> |
− | + | <td><font size="2">ZHAN_MULTIPLE_MYELOMA_SPIKED</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24"><font size="2">ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_UP</font></td> |
− | + | <td><font size="2">ZHAN_MULTIPLE_MYELOMA_UP</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24"><font size="2">ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_DN</font></td> |
− | + | <td><font size="2">ZHAN_MULTIPLE_MYELOMA_DN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DAC_BLADDER_UP</font></td> |
− | + | <td><font size="2">LIANG_SILENCED_BY_METHYLATION_2</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DAC_CGI_BLADDER_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DAC_IFN_BLADDER_UP</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DAC_FIBRO_UP</font></td> |
− | + | <td><font size="2">LIANG_SILENCED_BY_METHYLATION_UP</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">DAC_FIBRO_DN</font></td> |
− | + | <td><font size="2">LIANG_SILENCED_BY_METHYLATION_DN</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24"><font size="2">CMV_IE86_UP</font></td> |
− | + | <td><font size="2">SONG_TARGETS_OF_IE86_CMV_PROTEIN</font></td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C8</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C8</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C4</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C4</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C6</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C6</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C2</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C2</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_ALL</font></td> |
− | + | <td><font size="2">Deprecated</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C0</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C0</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C1</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C1</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C7</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C7</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C5</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C5</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16"><font size="2">UVB_NHEK3_C3</font></td> |
− | + | <td><font size="2">SESTO_RESPONSE_TO_UV_C3</font></td> | |
− | < | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">INNEREAR_UP</td> |
− | + | <td>ABE_INNER_EAR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HYPOXIA_REVIEW</td> |
− | + | <td>HARRIS_HYPOXIA</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_PANCREAS</td> |
− | + | <td>SU_PANCREAS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_SALIVARY</td> |
− | + | <td>SU_SALIVARY_GLAND</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_TESTIS</td> |
− | + | <td>SU_TESTIS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_THYMUS</td> |
− | + | <td>SU_THYMUS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_KIDNEY</td> |
− | + | <td>SU_KIDNEY</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">MOUSE_TISSUE_TESTIS</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">MOUSE_TISSUE_KIDNEY</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_LIVER</td> |
− | + | <td>SU_LIVER</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HUMAN_TISSUE_PLACENTA</td> |
− | + | <td>SU_PLACENTA</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">RADAEVA_IFNA_DN</td> |
− | + | <td>RADAEVA_IFN_ALPHA_RESPONSE_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">RADAEVA_IFNA_UP</td> |
− | + | <td>RADAEVA_IFN_ALPHA_RESPONSE_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IFNALPHA_NL_HCC_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IFNALPHA_HCC_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IFNALPHA_NL_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">STANELLE_E2F1_UP</td> |
− | + | <td>STANELLE_E2F1_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_HISTIOCYTOMA_UP</td> |
− | + | <td>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_SYNOVIAL_DN</td> |
− | + | <td>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_GISTROMAL_UP</td> |
− | + | <td>NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_LIPOSARCOMA_DN</td> |
− | + | <td>NIELSEN_LIPOSARCOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_LIPOSARCOMA_UP</td> |
− | + | <td>NIELSEN_LIPOSARCOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_SYNOVIAL_UP</td> |
− | + | <td>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_SCHWANNOMA_UP</td> |
− | + | <td>NIELSEN_SCHWANNOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_LEIOMYOSARCOMA_CALP_UP</td> |
− | + | <td>NIELSEN_LEIOMYOSARCOMA_CNN1_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SARCOMAS_LEIOMYOSARCOMA_UP</td> |
− | + | <td>NIELSEN_LEIOMYOSARCOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_GIST</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_LEIOMYOSARCOMA_CNN1_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_LEIOMYOSARCOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_SYNOVIAL_SARCOMA_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_SYNOVIAL_SARCOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>NIELSEN_SCHWANNOMA_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIPOCYTE_PPARG_UP</td> |
− | + | <td>LI_ADIPOGENESIS_BY_ACTIVATED_PPARG</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">UVB_NHEK2_UP</td> |
− | + | <td>TAKAO_RESPONSE_TO_UVB_RADIATION_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">UVB_NHEK2_DN</td> |
− | + | <td>TAKAO_RESPONSE_TO_UVB_RADIATION_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">MENSSEN_MYC_UP</td> |
− | + | <td>MENSSEN_MYC_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">GRANDVAUX_IFN_NOT_IRF3_UP</td> |
− | + | <td>GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">GRANDVAUX_IRF3_DN</td> |
− | + | <td>GRANDVAUX_IRF3_TARGETS_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">GRANDVAUX_IRF3_UP</td> |
− | + | <td>GRANDVAUX_IRF3_TARGETS_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TSADAC_RKOSILENT_UP</td> |
− | + | <td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TSADAC_RKOEXP_UP</td> |
− | + | <td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TSA_RKO_UP</td> |
− | + | <td>SUZUKI_RESPONSE_TO_TSA</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">AS3_FIBRO_C2</td> |
− | + | <td>YIH_RESPONSE_TO_ARSENITE_C2</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">AS3_FIBRO_C4</td> |
− | + | <td>YIH_RESPONSE_TO_ARSENITE_C4</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">AS3_FIBRO_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">AS3_FIBRO_C3</td> |
− | + | <td>YIH_RESPONSE_TO_ARSENITE_C3</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">AS3_FIBRO_C1</td> |
− | + | <td>YIH_RESPONSE_TO_ARSENITE_C1</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">AS3_FIBRO_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>YIH_RESPONSE_TO_ARSENITE_C5</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">ADIP_VS_PREADIP_DN</td> |
− | + | <td>ADIP_VS_PREADIP_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">ADIP_VS_FIBRO_DN</td> |
− | + | <td>GERHOLD_ADIPOGENESIS_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PREADIP_VS_FIBRO_UP</td> |
− | + | <td>PREADIP_VS_FIBRO_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIP_VS_PREADIP_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TZD_ADIP_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">ADIP_VS_FIBRO_UP</td> |
− | + | <td>GERHOLD_ADIPOGENESIS_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>GERHOLD_RESPONSE_TO_TZD_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>GERHOLD_RESPONSE_TO_TZD_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">WELCSH_BRCA_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">WELCSH_BRCA_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">BRCA1_OVEREXP_UP</td> |
− | + | <td>WELCSH_BRCA1_TARGETS_1_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">BRCA1_OVEREXP_DN</td> |
− | + | <td>WELCSH_BRCA1_TARGETS_1_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">NF90_UP</td> |
− | + | <td>KRASNOSELSKAYA_ILF3_TARGETS_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">NF90_DN</td> |
− | + | <td>KRASNOSELSKAYA_ILF3_TARGETS_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">LI_FETAL_VS_WT_KIDNEY_DN</td> |
− | + | <td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">LI_FETAL_VS_WT_KIDNEY_UP</td> |
− | + | <td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>LI_WILMS_TUMOR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">FERRANDO_T_CELL_DIFFERENTIATION_PATHWAY</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">FERRANDO_TAL1_NEIGHBORS</td> |
− | + | <td>FERRANDO_TAL1_NEIGHBORS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">FERRANDO_LYL1_NEIGHBORS</td> |
− | + | <td>FERRANDO_LYL1_NEIGHBORS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">FERRANDO_CHEMO_RESPONSE_PATHWAY</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>FERRANDO_HOX11_NEIGHBORS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IL1_CORNEA_DN</td> |
− | + | <td>MAHAJAN_RESPONSE_TO_IL1A_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IL1_CORNEA_UP</td> |
− | + | <td>MAHAJAN_RESPONSE_TO_IL1A_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">WILLERT_WNT_NCCIT_ALL_UP</td> |
− | + | <td>WILLERT_WNT_SIGNALING</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">BRCA2_BRCA1_DN</td> |
− | + | <td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">BRCA2_BRCA1_UP</td> |
− | + | <td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_LEUCINE_UP</td> |
− | + | <td>PENG_LEUCINE_DEPRIVATION_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_GLUCOSE_UP</td> |
− | + | <td>PENG_GLUCOSE_DEPRIVATION_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_GLUTAMINE_UP</td> |
− | + | <td>PENG_GLUTAMINE_DEPRIVATION_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_LEUCINE_DN</td> |
− | + | <td>PENG_LEUCINE_DEPRIVATION_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_GLUCOSE_DN</td> |
− | + | <td>PENG_GLUCOSE_DEPRIVATION_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_RAPAMYCIN_DN</td> |
− | + | <td>PENG_RAPAMYCIN_RESPONSE_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_RAPAMYCIN_UP</td> |
− | + | <td>PENG_RAPAMYCIN_RESPONSE_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PENG_GLUTAMINE_DN</td> |
− | + | <td>PENG_GLUTAMINE_DEPRIVATION_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">MA_ATRA_EMP_DN</td> |
− | + | <td>MA_MYELOID_DIFFERENTIATION_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">MA_ATRA_EMP_UP</td> |
− | + | <td>MA_MYELOID_DIFFERENTIATION_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIP_DIFF_CLUSTER5</td> |
− | + | <td>BURTON_ADIPOGENESIS_PEAK_AT_24HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIP_DIFF_CLUSTER2</td> |
− | + | <td>BURTON_ADIPOGENESIS_PEAK_AT_2HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIP_DIFF_CLUSTER1</td> |
− | + | <td>BURTON_ADIPOGENESIS_PEAK_AT_0HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIP_DIFF_CLUSTER3</td> |
− | + | <td>BURTON_ADIPOGENESIS_PEAK_AT_8HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ADIP_DIFF_CLUSTER4</td> |
− | + | <td>BURTON_ADIPOGENESIS_PEAK_AT_16HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_ANY_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_EARLY_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_P53_LATE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_P53_EARLY_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_ANY_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_MIDDLE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_P53_MIDDLE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P21_P53_ANY_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>WU_APOPTOSIS_BY_CDKN1A_VIA_TP53</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">NELSON_ANDROGEN_DN</td> |
− | + | <td>NELSON_RESPONSE_TO_ANDROGEN_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">NELSON_ANDROGEN_UP</td> |
− | + | <td>NELSON_RESPONSE_TO_ANDROGEN_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_HUVEC_2HRS_UP</td> |
− | + | <td>ABE_VEGFA_TARGETS_2HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_HUVEC_UP</td> |
− | + | <td>ABE_VEGFA_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_HUVEC_30MIN_UP</td> |
− | + | <td>ABE_VEGFA_TARGETS_30MIN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ET743_HELA_DN</td> |
− | + | <td>GAJATE_RESPONSE_TO_TRABECTEDIN_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ET743_HELA_UP</td> |
− | + | <td>GAJATE_RESPONSE_TO_TRABECTEDIN_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TIS7_OVEREXP_DN</td> |
− | + | <td>VIETOR_IFRD1_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_MMMEC_6HRS_UP</td> |
− | + | <td>WESTON_VEGFA_TARGETS_6HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_MMMEC_12HRS_UP</td> |
− | + | <td>WESTON_VEGFA_TARGETS_12HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_MMMEC_ALL_UP</td> |
− | + | <td>WESTON_VEGFA_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">VEGF_MMMEC_3HRS_UP</td> |
− | + | <td>WESTON_VEGFA_TARGETS_3HR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">MKK6EE_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IGFR_IR_UP</td> |
− | + | <td>MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IGFR_IR_DN</td> |
− | + | <td>MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">STEMCELL_COMMON_DN</td> |
− | + | <td>RAMALHO_STEMNESS_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">STEMCELL_COMMON_UP</td> |
− | + | <td>RAMALHO_STEMNESS_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">STEMCELL_NEURAL_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">STEMCELL_EMBRYONIC_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">STEMCELL_HEMATOPOIETIC_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_EARLYPROGENITORS_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_HSC_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_MATURE_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_MATURE_CELL</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_LATEPROGENITORS_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_LTHSC_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_HSCANDPROGENITORS_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_HSC_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_STEM_CELL</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_MATURE_FETAL</td> |
− | + | <td>HSC_MATURE_FETAL</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_LTHSC_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_STHSC_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_LTHSC_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_LATEPROGENITORS_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_EARLYPROGENITORS_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_INTERMEDIATEPROGENITORS_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_HSCANDPROGENITORS_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_MATURE_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_HSCANDPROGENITORS_SHARED</td> |
− | + | <td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_INTERMEDIATEPROGENITORS_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_LATEPROGENITORS_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_STHSC_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_EARLYPROGENITORS_ADULT</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_HSC_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_STHSC_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HSC_INTERMEDIATEPROGENITORS_FETAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IRITANI_ADPROX_VASC</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IRITANI_ADPROX_LYMPH</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IRITANI_ADPROX_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IRITANI_ADPROX_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>IRITANI_MAD1_TARGETS_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>IRITANI_MAD1_TARGETS_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">JNK_DN</td> |
− | + | <td>HAN_JNK_SINGALING_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">JNK_UP</td> |
− | + | <td>HAN_JNK_SINGALING_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">LINDSTEDT_DEND_8H_VS_48H_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">LINDSTEDT_DEND_8H_VS_48H_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">LINDSTEDT_DEND_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">LINDSTEDT_DEND_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>LINDSTEDT_DENDRITIC_CELL_MATURATION_B</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>LINDSTEDT_DENDRITIC_CELL_MATURATION_C</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>LINDSTEDT_DENDRITIC_CELL_MATURATION_D</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl25">—</td> |
− | + | <td>CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">INOS_ALL_UP</td> |
− | + | <td>ZAMORA_NOS2_TARGETS_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">INOS_ALL_DN</td> |
− | + | <td>ZAMORA_NOS2_TARGETS_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_SENS_MIDDLE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_RESIST_LATE_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_SENS_LATE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_RESIST_EARLY_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_RESIST_MIDDLE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_RESIST_EARLY_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_RESIST_MIDDLE_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_SENS_MIDDLE_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_SENS_EARLY_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_RESIST_LATE_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_SENS_LATE_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">TPA_SENS_EARLY_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ASTIER_BCELL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ASTIER_FN_DIFF</td> |
− | + | <td>ASTIER_INTEGRIN_SIGNALING</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_TONSIL_PCBC</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_TONSIL_BONEMARROW</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_MMPC_PC</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_MMPC_EARLYVS</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_MMPC_SIMAL</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_MMPC_SIM_BC_AND_MM</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_MMPC_SIM</td> |
− | + | <td>ZHAN_V2_LATE_DIFFERENTIATION_GENES</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">ZHAN_MMPC_LATEVS</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_EARLY_DIFFERENTIATION_GENES_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_EARLY_DIFFERENTIATION_GENES_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_LATE_DIFFERENTIATION_GENES_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_LATE_DIFFERENTIATION_GENES_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">NAKAJIMA_MCS_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOGERKORP_ANTI_CD44_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOGERKORP_ANTI_CD44_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOGERKORP_CD44_DN</td> |
− | + | <td>HOEGERKORP_CD44_TARGETS_DIRECT_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOGERKORP_CD44_TEMPORALLY_DN</td> |
− | + | <td>HOEGERKORP_CD44_TARGETS_TEMPORAL_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOGERKORP_CD44_TEMPORALLY_UP</td> |
− | + | <td>HOEGERKORP_CD44_TARGETS_TEMPORAL_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOGERKORP_CD44_UP</td> |
− | + | <td>HOEGERKORP_CD44_TARGETS_DIRECT_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOFMANN_MDS_CD34_LOW_RISK</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOFMANN_MDS_CD34_HIGH_RISK</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">HOFMANN_MDS_CD34_LOW_AND_HIGH_RISK</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">—</td> |
− | + | <td>HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">IFNALPHA_RESIST_DN</td> |
− | < | + | <td>TRACEY_RESISTANCE_TO_IFNA2_DN</td> |
− | + | </tr> | |
− | <td | + | <tr height="16"> |
− | + | <td height="16" class="xl25">—</td> | |
− | </td> | + | <td>TRACEY_RESISTANCE_TO_IFNA2_UP</td> |
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">OXSTRESS_BREASTCA_DN</td> |
− | + | <td>CHUANG_OXIDATIVE_STRESS_RESPONSE_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">OXSTRESS_BREASTCA_UP</td> |
− | + | <td>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">RETT_DN</td> |
− | + | <td>TRAYNOR_RETT_SYNDROM_UP</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16" class="xl24">RETT_UP</td> |
− | + | <td>TRAYNOR_RETT_SYNDROM_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">OXSTRESS_RPE_H2O2TBH_DN</td> |
− | + | <td>WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">OXSTRESS_RPETHREE_DN</td> |
− | + | <td>WEIGEL_OXIDATIVE_STRESS_RESPONSE</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">OXSTRESS_RPE_H2O2HNE_DN</td> |
− | + | <td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">OXSTRESS_RPETWO_DN</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">OXSTRESS_RPE_HNETBH_DN</td> |
− | + | <td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">GNATENKO_PLATELET</td> |
− | + | <td>GNATENKO_PLATELET_SIGNATURE</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">GNATENKO_PLATELET_UP</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">PLATELET_EXPRESSED</td> |
− | + | <td>Deprecated</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">GILDEA_BLADDER_UP</td> |
− | + | <td>GILDEA_METASTASIS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">SHH_UP</td> |
− | + | <td>INGRAM_SHH_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">P53GENES_ALL</td> |
− | + | <td>INGA_TP53_TARGETS</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">METHOTREXATE_PROBCELL_DN</td> |
− | + | <td>BRACHAT_RESPONSE_TO_METHOTREXATE_DN</td> | |
− | |||
− | <td | ||
− | |||
− | |||
</tr> | </tr> | ||
− | <tr> | + | <tr height="16"> |
− | <td | + | <td height="16">CISPLATIN_PROBCELL_UP</td> |
− | < | + | <td>BRACHAT_RESPONSE_TO_CISPLATIN</td> |
− | </td> | + | </tr> |
− | <td | + | <tr height="16"> |
− | < | + | <td height="16">CANCERDRUGS_PROBCELL_DN</td> |
− | </td> | + | <td>BRACHAT_RESPONSE_TO_CANCER_DRUGS_DN</td> |
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">METHOTREXATE_PROBCELL_UP</td> | ||
+ | <td>BRACHAT_RESPONSE_TO_METHOTREXATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CAMPTOTHECIN_PROBCELL_UP</td> | ||
+ | <td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CANCERDRUGS_PROBCELL_UP</td> | ||
+ | <td>BRACHAT_RESPONSE_TO_CANCER_DRUGS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CAMPTOTHECIN_PROBCELL_DN</td> | ||
+ | <td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">METASTASIS_ADENOCARC_DN</td> | ||
+ | <td>RAMASWAMY_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">METASTASIS_ADENOCARC_UP</td> | ||
+ | <td>RAMASWAMY_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">O6BG_RESIST_MEDULLOBLASTOMA_DN</td> | ||
+ | <td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">O6BG_RESIST_MEDULLOBLASTOMA_UP</td> | ||
+ | <td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CHAUHAN_2ME2</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">KLEIN_PEL_DN</td> | ||
+ | <td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">KLEIN_PEL_UP</td> | ||
+ | <td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NI2_MOUSE_UP</td> | ||
+ | <td>MCDOWELL_ACUTE_LUNG_INJURY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NI2_MOUSE_DN</td> | ||
+ | <td>MCDOWELL_ACUTE_LUNG_INJURY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">UNDERHILL_PROLIFERATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">YAO_P4_KO_VS_WT_DN</td> | ||
+ | <td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">YAO_P4_KO_VS_WT_UP</td> | ||
+ | <td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">SMITH_HCV_INDUCED_HCC_UP</td> | ||
+ | <td>SMITH_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ELONGINA_KO_UP</td> | ||
+ | <td>YAMAZAKI_TCEB3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ELONGINA_KO_DN</td> | ||
+ | <td>YAMAZAKI_TCEB3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">H2O2_CSBDIFF_C1</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">H2O2_CSBRESCUED_C2_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">H2O2_CSBCOMBINED</td> | ||
+ | <td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">H2O2_CSBRESCUED_UP</td> | ||
+ | <td>KYNG_RESPONSE_TO_H2O2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">H2O2_CSBDIFF_C2</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">H2O2_CSBRESCUED_C1_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRACX_UP</td> | ||
+ | <td>HEDENFALK_BREAST_CANCER_BRACX_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRACX_DN</td> | ||
+ | <td>HEDENFALK_BREAST_CANCER_BRACX_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HEATSHOCK_OLD_UP</td> | ||
+ | <td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGEING_LYMPH_DN</td> | ||
+ | <td>VISALA_AGING_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HEATSHOCK_YOUNG_UP</td> | ||
+ | <td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VISALA_AGING_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ROME_INSULIN_2F_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ROME_INSULIN_2F_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ROME_INSULIN_TARGETS_IN_MUSCLE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN</td> | ||
+ | <td>MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP</td> | ||
+ | <td>MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MAGRANGEAS_MULTIPLE_MYELOMA_IGL_VS_IGK_DN</td> | ||
+ | <td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MAGRANGEAS_MULTIPLE_MYELOMA_IGL_VS_IGK_UP</td> | ||
+ | <td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">FERRANDO_MLL_T_ALL_UP</td> | ||
+ | <td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">FERRANDO_MLL_T_ALL_DN</td> | ||
+ | <td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">YE_INTRAMETASTATIC_HCC_UP</td> | ||
+ | <td>YE_METASTATIC_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TPA_SKIN_UP</td> | ||
+ | <td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TPA_SKIN_DN</td> | ||
+ | <td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BENNETT_SLE_UP</td> | ||
+ | <td>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIPOGENESIS_HMSC_CLASS1_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIPOGENESIS_HMSC_CLASS2_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIPOGENESIS_HMSC_CLASS3_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIPOGENESIS_HMSC_CLASS5_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIPOGENESIS_HMSC_CLASS8_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>NAKAMURA_ADIPOGENESIS_EARLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>NAKAMURA_ADIPOGENESIS_EARLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>NAKAMURA_ADIPOGENESIS_LATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>NAKAMURA_ADIPOGENESIS_LATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">YAMA_RECURRENT_HCC_UP</td> | ||
+ | <td>IIZUKA_RECURRENT_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ICHIBA_GVHD</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ICHIBA_D7_GRAFT_VERSUS_HOST_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ICHIBA_D7_GRAFT_VERSUS_HOST_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ICHIBA_D35_GRAFT_VERSUS_HOST_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ICHIBA_D35_GRAFT_VERSUS_HOST_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TARTE_BCELL</td> | ||
+ | <td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TARTE_PC</td> | ||
+ | <td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TARTE_PLASMA_BLASTIC</td> | ||
+ | <td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TARTE_MATURE_PC</td> | ||
+ | <td>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NUTT_GBN_VS_AO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NUTT_GBN_VS_AO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUTT_GBM_VS_AO_GLIOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUTT_GBM_VS_AO_GLIOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HINATA_NFKB_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HINATA_NFKB_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HINATA_NFKB_TARGETS_KERATINOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HINATA_NFKB_TARGETS_FIBROBLAST_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HINATA_NFKB_TARGETS_FIBROBLAST_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_4HRS_UP</td> | ||
+ | <td>ZHOU_TNF_SIGNALING_4HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_ALL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_30MIN_UP</td> | ||
+ | <td>ZHOU_TNF_SIGNALING_30MIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AS3_HEK293_DN</td> | ||
+ | <td>ZHENG_RESPONSE_TO_ARSENITE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AS3_HEK293_UP</td> | ||
+ | <td>ZHENG_RESPONSE_TO_ARSENITE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">OSAWA_TNFA_HEPATOCYTE_UP</td> | ||
+ | <td>OSAWA_TNF_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">VHL_NORMAL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">VHL_RCC_UP</td> | ||
+ | <td>JIANG_VHL_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">RCC_NL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HYPOXIA_NORMAL_UP</td> | ||
+ | <td>JIANG_HYPOXIA_NORMAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HYPOXIA_RCC_NOVHL_UP</td> | ||
+ | <td>JIANG_HYPOXIA_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HYPOXIA_RCC_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JIANG_HYPOXIA_VIA_VHL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FERNANDEZ_MYC_TARGETS</td> | ||
+ | <td>FERNANDEZ_BOUND_BY_MYC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HTERT_DN</td> | ||
+ | <td>LINDVALL_IMMORTALIZED_BY_TERT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HTERT_UP</td> | ||
+ | <td>LINDVALL_IMMORTALIZED_BY_TERT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEOK_MP_DN</td> | ||
+ | <td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEOK_LDMTX_MP_UP</td> | ||
+ | <td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEOK_MP_UP</td> | ||
+ | <td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEOK_HDMTX_DN</td> | ||
+ | <td>CHEOK_RESPONSE_TO_HD_MTX_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEOK_HDMTX_UP</td> | ||
+ | <td>CHEOK_RESPONSE_TO_HD_MTX_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEOK_LDMTX_MP_DN</td> | ||
+ | <td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SMITH_HTERT_DN</td> | ||
+ | <td>SMITH_TERT_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SMITH_HTERT_UP</td> | ||
+ | <td>SMITH_TERT_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">RIBAVIRIN_RSV_DN</td> | ||
+ | <td>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">RIBAVIRIN_RSV_UP</td> | ||
+ | <td>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSADAC_HYPERMETH_OVCA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSADAC_HYPOMETH_HYPERAC_OVCA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSADAC_HYPERMETH_HYPERAC_OVCA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSADAC_HYPOMETH_OVCA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TGZ_ADIP_UP</td> | ||
+ | <td>RUAN_RESPONSE_TO_TROGLITAZONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_ADIP_UP</td> | ||
+ | <td>RUAN_RESPONSE_TO_TNF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_TGZ_ADIP_DN</td> | ||
+ | <td>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_ADIP_DN</td> | ||
+ | <td>RUAN_RESPONSE_TO_TNF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TNFALPHA_TGZ_ADIP_UP</td> | ||
+ | <td>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIP_DIFF_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUAN_RESPONSE_TO_TROGLITAZONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YAGI_AML_PROGNOSIS</td> | ||
+ | <td>YAGI_AML_RELAPSE_PROGNOSIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YAGI_AML_PROG_ASSOC</td> | ||
+ | <td>YAGI_AML_SURVIVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YAGI_AML_PROG_FAB</td> | ||
+ | <td>YAGI_AML_FAB_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAGI_AML_WITH_T_8_21_TRANSLOCATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAGI_AML_WITH_INV_16_TRANSLOCATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAGI_AML_WITH_T_9_11_TRANSLOCATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAGI_AML_WITH_11Q23_REARRANGED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NEMETH_TNF_UP</td> | ||
+ | <td>NEMETH_INFLAMMATORY_RESPONSE_LPS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NEMETH_TNF_DN</td> | ||
+ | <td>NEMETH_INFLAMMATORY_RESPONSE_LPS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_C3</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_SCC_DN</td> | ||
+ | <td>DAZARD_RESPONSE_TO_UV_SCC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_UP</td> | ||
+ | <td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_C4</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_DN</td> | ||
+ | <td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_SCC_UP</td> | ||
+ | <td>DAZARD_RESPONSE_TO_UV_SCC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_C1</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_C6</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVB_NHEK1_C2</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G24</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAZARD_UV_RESPONSE_CLUSTER_G28</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">SCHRAETS_MLL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>SCHRAETS_MLL_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>SCHRAETS_MLL_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROONQUIST_RAS_STROMA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROONQUIST_RAS_STROMA_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROONQUIST_IL6_STARVE_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROONQUIST_IL6_RAS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROONQUIST_IL6_STROMA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROONQUIST_IL6_RAS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CROONQUIST_IL6_DEPRIVATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CROONQUIST_IL6_DEPRIVATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CROONQUIST_STROMAL_STIMULATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CROONQUIST_STROMAL_STIMULATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CROONQUIST_NRAS_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CROONQUIST_NRAS_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GUO_HEX_UP</td> | ||
+ | <td>GUO_HEX_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GUO_HEX_DN</td> | ||
+ | <td>GUO_HEX_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">P53_BRCA1_UP</td> | ||
+ | <td>ONGUSAHA_TP53_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONGUSAHA_BRCA1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONGUSAHA_BRCA1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MOOTHA_VOXPHOS</td> | ||
+ | <td>MOOTHA_VOXPHOS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HUMAN_MITODB_6_2002</td> | ||
+ | <td>MOOTHA_HUMAN_MITODB_6_2002</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PGC</td> | ||
+ | <td>MOOTHA_PGC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TCA</td> | ||
+ | <td>MOOTHA_TCA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MITOCHONDRIA</td> | ||
+ | <td>MOOTHA_MITOCHONDRIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ROS</td> | ||
+ | <td>MOOTHA_ROS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOTHA_PYR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOTHA_FFA_OXYDATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOTHA_GLUCONEOGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOTHA_GLYCOGEN_METABOLISM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOTHA_GLYCOLYSIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GALINDO_ACT_UP</td> | ||
+ | <td>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LVAD_HEARTFAILURE_DN</td> | ||
+ | <td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LVAD_HEARTFAILURE_UP</td> | ||
+ | <td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">FSH_HUMAN_GRANULOSA_UP</td> | ||
+ | <td>SASSON_FSH_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">DAC_PANC50_UP</td> | ||
+ | <td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSADAC_PANC50_UP</td> | ||
+ | <td>SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSA_PANC50_UP</td> | ||
+ | <td>SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">DAC_PANC_UP</td> | ||
+ | <td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OKUMURA_MC_LPS</td> | ||
+ | <td>OKUMURA_INFLAMMATORY_RESPONSE_LPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HYPOXIA_REG_UP</td> | ||
+ | <td>LEONARD_HYPOXIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">REOVIRUS_HEK293_UP</td> | ||
+ | <td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">REOVIRUS_HEK293_DN</td> | ||
+ | <td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PARK_RARALPHA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PARK_RARALPHA_MOD</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>PARK_APL_PATHOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>PARK_APL_PATHOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>PARK_TRETINOIN_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">DISTECHE_XINACTIVATED_GENES</td> | ||
+ | <td>DISTECHE_ESCAPED_FROM_X_INACTIVATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D9_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D9</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_LOW_ALL_UP</td> | ||
+ | <td>GENTILE_UV_LOW_DOSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D4_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_LOW_C2_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D5_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D2_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D7_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D6_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_LOW_A2_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_ALL_DN</td> | ||
+ | <td>GENTILE_UV_HIGH_DOSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_ALL_UP</td> | ||
+ | <td>GENTILE_UV_HIGH_DOSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D1_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_LOW_C1_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_LOW_C3_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_LOW_ALL_DN</td> | ||
+ | <td>GENTILE_UV_LOW_DOSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D8_DN</td> | ||
+ | <td>GENTILE_UV_RESPONSE_CLUSTER_D8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UVC_HIGH_D3_DN</td> | ||
+ | <td>GENTILE_RESPONSE_CLUSTER_D3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LAMB_CYCLIN_D1_UP</td> | ||
+ | <td>LAMB_CCND1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LAMB_CYCLIN_D3_GLOCUS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NI2_LUNG_DN</td> | ||
+ | <td>CHENG_RESPONSE_TO_NICKEL_ACETATE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">VERNELL_PRB_CLSTR2</td> | ||
+ | <td>VERNELL_RETINOBLASTOMA_PATHWAY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">VERNELL_PRB_CLSTR1</td> | ||
+ | <td>VERNELL_RETINOBLASTOMA_PATHWAY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DAVIES_MGUS_MM</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DAVIES_N</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MUNSHI_MM_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MUNSHI_MM_VS_PCS_DN</td> | ||
+ | <td>MUNSHI_MULTIPLE_MYELOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MUNSHI_MM_VS_PCS_UP</td> | ||
+ | <td>MUNSHI_MULTIPLE_MYELOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BROCKE_IL6</td> | ||
+ | <td>BROCKE_APOPTOSIS_REVERSED_BY_IL6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KRETZSCHMAR_IL6_DIFF</td> | ||
+ | <td>KRETZSCHMAR_IL6_DIFF</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HYPOXIA_FIBRO_UP</td> | ||
+ | <td>KIM_HYPOXIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ADIPOCYTE_BRCA_UP</td> | ||
+ | <td>IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TAVOR_CEBP_DN</td> | ||
+ | <td>TAVOR_CEBPA_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TAVOR_CEBP_UP</td> | ||
+ | <td>TAVOR_CEBPA_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">EGF_HDMEC_UP</td> | ||
+ | <td>ZHANG_PROLIFERATING_VS_QUIESCENT</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZELLER_MYC_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZELLER_MYC_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MYC_TARGETS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DANG_REGULATED_BY_MYC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DANG_REGULATED_BY_MYC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DANG_MYC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DANG_MYC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DANG_BOUND_BY_MYC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YEN_MYC_WT</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YEN_MYC_MUT</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ELLWOOD_MYC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>ELLWOOD_MYC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BYSTROM_IL5_DN</td> | ||
+ | <td>BYSTROEM_CORRELATED_WITH_IL5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BYSTROM_IL5_UP</td> | ||
+ | <td>BYSTROEM_CORRELATED_WITH_IL5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">WERNER_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">WERNERONLY_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">WERNER_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OLDWERNER_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">WERNERONLY_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OLD_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OLDWERNER_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OLDONLY_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OLD_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">OLDONLY_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_NORMAL_AGING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_NORMAL_AGING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_WERNER_SYNDROM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_WERNER_SYNDROM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">INSULIN_ADIP_INSENS_UP</td> | ||
+ | <td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">INSULIN_ADIP_SENS_DN</td> | ||
+ | <td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">INSULIN_ADIP_SENS_UP</td> | ||
+ | <td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">INSULIN_ADIP_INSENS_DN</td> | ||
+ | <td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">EMT_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">EMT_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">DFOSB_BRAIN_8WKS_UP</td> | ||
+ | <td>MCCLUNG_DELTA_FOSB_TARGETS_8WK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CREB_BRAIN_2WKS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CREB_BRAIN_8WKS_DN</td> | ||
+ | <td>MCCLUNG_CREB1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">COCAINE_BRAIN_5D_UP</td> | ||
+ | <td>MCCLUNG_COCAINE_REWARD_5D</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">DFOSB_BRAIN_2WKS_UP</td> | ||
+ | <td>MCCLUNG_DELTA_FOSB_TARGETS_2WK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CREB_BRAIN_8WKS_UP</td> | ||
+ | <td>MCCLUNG_CREB1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">COCAINE_BRAIN_4WKS_UP</td> | ||
+ | <td>MCCLUNG_COCAIN_REWARD_4WK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEN_LUNG_SURVIVAL</td> | ||
+ | <td>CHEN_LUNG_CANCER_SURVIVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ABBUD_LIF_DN</td> | ||
+ | <td>ABBUD_LIF_SIGNALING_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ABBUD_LIF_GH3_UP</td> | ||
+ | <td>ABBUD_LIF_SIGNALING_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ABBUD_LIF_UP</td> | ||
+ | <td>ABBUD_LIF_SIGNALING_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ABBUD_LIF_GH3_DN</td> | ||
+ | <td>ABBUD_LIF_SIGNALING_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_IMMUNE_FUNCTION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_CYTOSKELETON</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_SIGNALING</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_REPAIR</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_TRANSPORT</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_CELL_CYCLE</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_ANGIOGENESIS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_DEATH</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_CELL_ADHESION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_TRANSPORT_OF_VESICLES</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_CANCER_TESTIS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_DNA_METHYLATION_AND_MODIFICATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_TRANSCRIPTION_FACTORS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_PROTEIN_MODIFICATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRENTANI_HORMONAL_FUNCTION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DORSAM_HOXA9_UP</td> | ||
+ | <td>DORSAM_HOXA9_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DORSAM_HOXA9_DN</td> | ||
+ | <td>DORSAM_HOXA9_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSA_CD4_UP</td> | ||
+ | <td>MOREIRA_RESPONSE_TO_TSA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSA_CD4_DN</td> | ||
+ | <td>MOREIRA_RESPONSE_TO_TSA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KUMAR_HOXA_DIFF</td> | ||
+ | <td>KUMAR_TARGETS_OF_MLL_AF9_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HEDVAT_ELF_UP</td> | ||
+ | <td>HEDVAT_ELF4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HEDVAT_ELF_DN</td> | ||
+ | <td>HEDVAT_ELF4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CANTHARIDIN_UP</td> | ||
+ | <td>ZHANG_RESPONSE_TO_CANTHARIDIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CANTHARIDIN_DN</td> | ||
+ | <td>ZHANG_RESPONSE_TO_CANTHARIDIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRG1_ALAB_UP</td> | ||
+ | <td>HENDRICKS_SMARCA4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRG1_ALAB_DN</td> | ||
+ | <td>HENDRICKS_SMARCA4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROMER_HYPOPHARYNGEAL_MET_VS_NON_UP</td> | ||
+ | <td>CROMER_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CROMER_HYPOPHARYNGEAL_MET_VS_NON_DN</td> | ||
+ | <td>CROMER_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>CROMER_TUMORIGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CROMER_TUMORIGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHIARETTI_T_ALL</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHIARETTI_T_ALL_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARETTI_T_ALL_RELAPSE_PROGNOSIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BRUNO_IL3_DN</td> | ||
+ | <td>BRUNO_HEMATOPOIESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BASSO_HCL_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>BASSO_HAIRY_CELL_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>BASSO_HAIRY_CELL_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CIS_RESIST_GASTRIC_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">5FU_RESIST_GASTRIC_DN</td> | ||
+ | <td>KANG_FLUOROURACIL_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">5FU_RESIST_GASTRIC_UP</td> | ||
+ | <td>KANG_FLUOROURACIL_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DOX_RESIST_GASTRIC_UP</td> | ||
+ | <td>KANG_DOXORUBICIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DOX_RESIST_GASTRIC_DN</td> | ||
+ | <td>KANG_DOXORUBICIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KANG_CISPLATIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KANG_CISPLATIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CIS_RESIST_LUNG_UP</td> | ||
+ | <td>WHITESIDE_CISPLATIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CIS_RESIST_LUNG_DN</td> | ||
+ | <td>WHITESIDE_CISPLATIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHANG_SERUM_RESPONSE_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHANG_SERUM_RESPONSE_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SERUM_FIBROBLAST_CORE_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SERUM_FIBROBLAST_CELLCYCLE</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SERUM_FIBROBLAST_CORE_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CHANG_CORE_SERUM_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CHANG_CORE_SERUM_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>CHANG_CYCLING_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ALZHEIMERS_INCIPIENT_UP</td> | ||
+ | <td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ALZHEIMERS_DISEASE_DN</td> | ||
+ | <td>BLALOCK_ALZHEIMERS_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ALZHEIMERS_DISEASE_UP</td> | ||
+ | <td>BLALOCK_ALZHEIMERS_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ALZHEIMERS_INCIPIENT_DN</td> | ||
+ | <td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RORIE_ES_PNET_UP</td> | ||
+ | <td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RORIE_ES_PNET_DN</td> | ||
+ | <td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FRASOR_ER_UP</td> | ||
+ | <td>FRASOR_RESPONSE_TO_ESTRADIOL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FRASOR_ER_DN</td> | ||
+ | <td>FRASOR_RESPONSE_TO_ESTRADIOL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRASOR_RESPONSE_TO_SERM_OR_ICI_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRASOR_RESPONSE_TO_SERM_OR_ICI_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PDGF_ES_UP</td> | ||
+ | <td>CHEN_PDGF_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_APOPTOSIS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_TRANSCRIPTION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_EM</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_ADHESION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_INFLAMMATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_SIGNAL</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_OXIDATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_IMMUNE</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_PROLIFERATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_GROWTH</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">PASSERINI_COMPLEMENT</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">STEFFEN_AML_PML_PLZF_TRGT</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LH_GRANULOSA_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">FSH_GRANULOSA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GN_CAMP_GRANULOSA_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GN_CAMP_GRANULOSA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">FSH_GRANULOSA_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LH_GRANULOSA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>SASSON_RESPONSE_TO_GONADOTROPHINS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>SASSON_RESPONSE_TO_GONADOTROPHINS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>SASSON_RESPONSE_TO_FORSKOLIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>SASSON_RESPONSE_TO_FORSKOLIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">JISON_SICKLE_CELL</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">JISON_SICKLECELL_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>JISON_SICKLE_CELL_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>JISON_SICKLE_CELL_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">REFRACTORY_GASTRIC_UP</td> | ||
+ | <td>KIM_GASTRIC_CANCER_CHEMOSENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_DN_CLUSTER4</td> | ||
+ | <td>BURTON_ADIPOGENESIS_10</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_DN_CLUSTER6</td> | ||
+ | <td>BURTON_ADIPOGENESIS_12</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_UP_CLUSTER5</td> | ||
+ | <td>BURTON_ADIPOGENESIS_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_UP_CLUSTER3</td> | ||
+ | <td>BURTON_ADIPOGENESIS_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_DN_CLUSTER2</td> | ||
+ | <td>BURTON_ADIPOGENESIS_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_UP_CLUSTER2</td> | ||
+ | <td>BURTON_ADIPOGENESIS_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_UP_CLUSTER4</td> | ||
+ | <td>BURTON_ADIPOGENESIS_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_UP_CLUSTER1</td> | ||
+ | <td>BURTON_ADIPOGENESIS_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_DN_CLUSTER1</td> | ||
+ | <td>BURTON_ADIPOGENESIS_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_DN_CLUSTER5</td> | ||
+ | <td>BURTON_ADIPOGENESIS_11</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_DN_CLUSTER3</td> | ||
+ | <td>BURTON_ADIPOGENESIS_9</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IDX_TSA_UP_CLUSTER6</td> | ||
+ | <td>BURTON_ADIPOGENESIS_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">STOSSI_ER_UP</td> | ||
+ | <td>STOSSI_ESTRADIOL_SIGNALING_VIA_ESTROGEN_RECEPTORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DIAB_NEPH_UP</td> | ||
+ | <td>BAELDE_DIABETIC_NEPHROPATHY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">DIAB_NEPH_DN</td> | ||
+ | <td>BAELDE_DIABETIC_NEPHROPATHY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ADIP_HUMAN_UP</td> | ||
+ | <td>URS_ADIPOCYTE_DIFFERENTIATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ADIP_HUMAN_DN</td> | ||
+ | <td>URS_ADIPOCYTE_DIFFERENTIATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROS_MOUSE_AORTA_UP</td> | ||
+ | <td>KEEN_RESPONSE_TO_ROSIGLITAZONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROS_MOUSE_AORTA_DN</td> | ||
+ | <td>KEEN_RESPONSE_TO_ROSIGLITAZONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BHATTACHARYA_ESC_UP</td> | ||
+ | <td>BHATTACHARYA_EMBRYONIC_STEM_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_9</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_10</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_11</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_12</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_13</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_15</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_CLUSTER_16</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_WITH_T_8_21_TRANSLOCATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_WITH_11Q23_REARRANGED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_WITH_EVI1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_WITH_CEBPA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VALK_AML_WITH_FLT3_ITD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IL6_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IL6_SCAR_FIBRO_UP</td> | ||
+ | <td>DASU_IL6_SIGNALING_SCAR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IL6_SCAR_FIBRO_DN</td> | ||
+ | <td>DASU_IL6_SIGNALING_SCAR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DASU_IL6_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DASU_IL6_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WIELAND_HEPATITIS_B_INDUCED</td> | ||
+ | <td>WIELAND_UP_BY_HBV_INFECTION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HEARTFAILURE_ATRIA_DN</td> | ||
+ | <td>KAAB_FAILED_HEART_ATRIUM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ATRIA_UP</td> | ||
+ | <td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HEARTFAILURE_ATRIA_UP</td> | ||
+ | <td>KAAB_FAILED_HEART_ATRIUM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">VENTRICLES_UP</td> | ||
+ | <td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HEARTFAILURE_VENTRICLE_DN</td> | ||
+ | <td>KAAB_FAILED_HEART_VENTRICLE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAAB_FAILED_HEART_VENTRICLE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEI_MYB_REGULATED_GENES</td> | ||
+ | <td>LEI_MYB_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CIS_XPC_DN</td> | ||
+ | <td>WANG_CISPLATIN_RESPONSE_AND_XPC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CIS_XPC_UP</td> | ||
+ | <td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CHAUVIN_ANDROGEN_REGULATED_GENES</td> | ||
+ | <td>On Hold</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GENOTOXINS_4HRS_DISCR</td> | ||
+ | <td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GENOTOXINS_ALL_24HRS_REG</td> | ||
+ | <td>HU_GENOTOXIC_DAMAGE_24HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GENOTOXINS_24HRS_DISCR</td> | ||
+ | <td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GENOTOXINS_ALL_4HRS_REG</td> | ||
+ | <td>HU_GENOTOXIC_DAMAGE_4HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">IGLESIAS_E2FMINUS_DN</td> | ||
+ | <td>IGLESIAS_E2F_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">IGLESIAS_E2FMINUS_UP</td> | ||
+ | <td>IGLESIAS_E2F_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RAY_P210_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BCRABL_HL60_CDNA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BCRABL_HL60_AFFY_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BCRABL_HL60_AFFY_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BCRABL_HL60_CDNA_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CANCER_NEOPLASTIC_META_UP</td> | ||
+ | <td>RHODES_CANCER_META_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CANCER_UNDIFFERENTIATED_META_UP</td> | ||
+ | <td>RHODES_UNDIFFERENTIATED_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KNUDSEN_PMNS_UP</td> | ||
+ | <td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KNUDSEN_PMNS_DN</td> | ||
+ | <td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WALLACE_JAK2_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>WALLACE_JAK2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>WALLACE_JAK2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AGEING_BRAIN_DN</td> | ||
+ | <td>LU_AGING_BRAIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AGEING_BRAIN_UP</td> | ||
+ | <td>LU_AGING_BRAIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANSOM_APC_LOSS4_UP</td> | ||
+ | <td>SANSOM_APC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANSOM_APC_5_DN</td> | ||
+ | <td>SANSOM_APC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANSOM_APC_4_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANSOM_APC_LOSS5_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AGUIRRE_PANCREAS_CHR12</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR9</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR1</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR19</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR18</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR7</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR8</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR17</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR22</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGUIRRE_PANCREAS_CHR6</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HALMOS_CEBP_DN</td> | ||
+ | <td>HALMOS_CEBPA_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HALMOS_CEBP_UP</td> | ||
+ | <td>HALMOS_CEBPA_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS10_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS8_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS9_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS3_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS4_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS5_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS1_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS6_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS7_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">LEE_TCELLS2_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_EARLY_T_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_EARLY_T_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_INTRATHYMIC_T_PROGENITOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_DOUBLE_POLAR_THYMOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_SP4_THYMOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_RECENT_THYMIC_EMIGRANT</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_NAIVE_T_LYMPHOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>LEE_DIFFERENTIATING_T_LYMPHOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KIM_TH_CELLS_UP</td> | ||
+ | <td>KIM_GERMINAL_CENTER_T_HELPER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KIM_TH_CELLS_DN</td> | ||
+ | <td>KIM_GERMINAL_CENTER_T_HELPER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_CBF</td> | ||
+ | <td>ROSS_AML_OF_CBF_TYPE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_PML_RAR</td> | ||
+ | <td>ROSS_AML_WITH_PML_RARA_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_CBF_MYH</td> | ||
+ | <td>ROSS_AML_WITH_CBFB_MYH11_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_MLL_FUSION</td> | ||
+ | <td>ROSS_AML_WITH_MLL_FUSIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_CBF_LEUKEMIA</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_FAB_M7</td> | ||
+ | <td>ROSS_AML_OF_FAB_M7_TYPE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROSS_AML1_ETO</td> | ||
+ | <td>ROSS_AML_WITH_AML1_ETO_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSS_LEUKEMIA_WITH_MLL_FUSIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HEMATOP_STEM_ALL_UP</td> | ||
+ | <td>GEORGANTAS_HSC_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ADDYA_K562_HEMIN_TREATMENT</td> | ||
+ | <td>ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TENEDINI_MEGAKARYOCYTIC_GENES</td> | ||
+ | <td>TENEDINI_MEGAKARYOCYTE_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">UEDA_MOUSE_SCN</td> | ||
+ | <td>UEDA_CENTRAL_CLOCK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">UEDA_MOUSE_LIVER</td> | ||
+ | <td>UEDA_PERIFERAL_CLOCK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WELCH_GATA1</td> | ||
+ | <td>On Hold</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MARTINELLI_IFNS_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>MARTINELLI_IMMATURE_NEUTROPHIL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>MARTINELLI_IMMATURE_NEUTROPHIL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NOUZOVA_CPG_METHLTD</td> | ||
+ | <td>NOUZOVA_METHYLATED_IN_APL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NOUZOVA_CPG_H4_UP</td> | ||
+ | <td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ASTON_DEPRESSION_DN</td> | ||
+ | <td>ASTON_MAJOR_DEPRESSIVE_DISORDER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ASTON_OLIGODENDROGLIA_MYELINATION_SUBSET</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ASTON_DEPRESSION_UP</td> | ||
+ | <td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_WELL_PBL_DN</td> | ||
+ | <td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_REJECTION_UP</td> | ||
+ | <td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_WELL_PBL_UP</td> | ||
+ | <td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_REJECTION_PBL_DN</td> | ||
+ | <td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_REJECTION_DN</td> | ||
+ | <td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_WELL_DN</td> | ||
+ | <td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_REJECTION_PBL_UP</td> | ||
+ | <td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLECHNER_KIDNEY_TRANSPLANT_WELL_UP</td> | ||
+ | <td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GREENBAUM_E2A_DN</td> | ||
+ | <td>GREENBAUM_E2A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GREENBAUM_E2A_UP</td> | ||
+ | <td>GREENBAUM_E2A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NAB_LUNG_DN</td> | ||
+ | <td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NAB_LUNG_UP</td> | ||
+ | <td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HADDAD_HSC_CD7_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HADDAD_HSC_CD10_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HADDAD_HSC_CD7_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HADDAD_CD45CD7_PLUS_VS_MINUS_UP</td> | ||
+ | <td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HADDAD_HPCLYMPHO_ENRICHED</td> | ||
+ | <td>HADDAD_B_LYMPHOCYTE_PROGENITOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HADDAD_CD45CD7_PLUS_VS_MINUS_DN</td> | ||
+ | <td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BASSO_GERMINAL_CENTER_CD40_DN</td> | ||
+ | <td>BASSO_CD40_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BASSO_GERMINAL_CENTER_CD40_UP</td> | ||
+ | <td>BASSO_CD40_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">TSA_HEPATOMA_UP</td> | ||
+ | <td>CHIBA_RESPONSE_TO_TSA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">NICK_RHAPC_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>NICK_RESPONSE_TO_PROC_TREATMENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>NICK_RESPONSE_TO_PROC_TREATMENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_LIVER_CANCER_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_LIVER_CANCER_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SCHURINGA_STAT5A_UP</td> | ||
+ | <td>SCHURINGA_STAT5A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SCHURINGA_STAT5A_DN</td> | ||
+ | <td>SCHURINGA_STAT5A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MANALO_HYPOXIA_DN</td> | ||
+ | <td>MANALO_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MANALO_HYPOXIA_UP</td> | ||
+ | <td>MANALO_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FSH_OVARY_MCV152_DN</td> | ||
+ | <td>JI_RESPONSE_TO_FSH_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FSH_OVARY_MCV152_UP</td> | ||
+ | <td>JI_RESPONSE_TO_FSH_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ABRAHAM_MM_VS_AL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ABRAHAM_MM_VS_AL_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ABRAHAM_AL_VS_MM_UP</td> | ||
+ | <td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ABRAHAM_AL_VS_MM_DN</td> | ||
+ | <td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_DN</td> | ||
+ | <td>KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_UP</td> | ||
+ | <td>KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TSA_HEPATOMA_CANCER_UP</td> | ||
+ | <td>CHIBA_RESPONSE_TO_TSA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TSA_HEPATOMA_CANCER_DN</td> | ||
+ | <td>CHIBA_RESPONSE_TO_TSA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HASLINGER_B_CLL_17P13</td> | ||
+ | <td>HASLINGER_B_CLL_WITH_17P13_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HASLINGER_B_CLL_MUTATED</td> | ||
+ | <td>HASLINGER_B_CLL_WITH_MUTATED_VH_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HASLINGER_B_CLL_13Q14</td> | ||
+ | <td>HASLINGER_B_CLL_WITH_13Q14_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HASLINGER_B_CLL_11Q23</td> | ||
+ | <td>HASLINGER_B_CLL_WITH_11Q23_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HASLINGER_B_CLL_12</td> | ||
+ | <td>HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HASLINGER_B_CLL_6Q21</td> | ||
+ | <td>HASLINGER_B_CLL_WITH_6Q21_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NING_COPD_DN</td> | ||
+ | <td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NING_COPD_UP</td> | ||
+ | <td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SASAKI_TCELL_LYMPHOMA_VS_CD4_UP</td> | ||
+ | <td>SASAKI_ADULT_T_CELL_LEUKEMIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SASAKI_ATL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IGF_VS_PDGF_DN</td> | ||
+ | <td>KUNINGER_IGF1_VS_PDGFB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IGF_VS_PDGF_UP</td> | ||
+ | <td>KUNINGER_IGF1_VS_PDGFB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PRMT5_KD_UP</td> | ||
+ | <td>PAL_PRMT5_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PRMT5_KD_DN</td> | ||
+ | <td>PAL_PRMT5_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HANSON_NFKAPPB_IND</td> | ||
+ | <td>HANSON_HRAS_SIGNALING_VIA_NFKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RUIZ_TENASCIN_TARGETS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUIZ_TNC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUIZ_TNC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LOTEM_LEUKEMIA_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MMS_HUMAN_LYMPH_LOW_4HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BLEO_HUMAN_LYMPH_HIGH_24HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MMS_HUMAN_LYMPH_HIGH_24HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BLEO_MOUSE_LYMPH_HIGH_24HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BLEO_HUMAN_LYMPH_HIGH_4HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MMS_MOUSE_LYMPH_HIGH_24HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MMS_MOUSE_LYMPH_HIGH_4HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BLEO_MOUSE_LYMPH_LOW_24HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">MMS_HUMAN_LYMPH_HIGH_24HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BLEO_MOUSE_LYMPH_HIGH_4HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_OPN_TARGETS_CLUSTER_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_FIG_7C_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TERAMOTO_FIG_7C_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_SERUM_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLOSSER_SERUM_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRCA1_OVEREXP_PROSTATE_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRCA1KO_MEF_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BRCA1_OVEREXP_PROSTATE_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAE_BRCA1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAE_BRCA1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_WILMS_TUMOR_ANAPLASTIC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_WILMS_TUMOR_ANAPLASTIC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GOLDRATH_HP</td> | ||
+ | <td>GOLDRATH_HOMEOSTATIC_PROLIFERATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GOLDRATH_CYTOLYTIC</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GOLDRATH_CELLCYCLE</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GOLDRATH_MEMORY</td> | ||
+ | <td>GOLDRATH_IMMUNE_MEMORY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOLDRATH_ANTIGEN_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">STAEGE_EFTS_UP</td> | ||
+ | <td>STAEGE_EWING_FAMILY_TUMOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEINHOLD_FIG_3S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ODONNELL_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ODONNELL_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">VANASSE_BCL2_TARGETS</td> | ||
+ | <td>VANASSE_BCL2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANASSE_BCL2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANASSE_BCL2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGEING_KIDNEY_SPECIFIC_DN</td> | ||
+ | <td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGEING_KIDNEY_DN</td> | ||
+ | <td>RODWELL_AGING_KIDNEY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGEING_KIDNEY_SPECIFIC_UP</td> | ||
+ | <td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGEING_KIDNEY_UP</td> | ||
+ | <td>RODWELL_AGING_KIDNEY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_ACOX1_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_ACOX1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_ACOX1_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_ACOX1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_CIP_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_CIPROFIBRATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_CIP_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_CIPROFIBRATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_DENA_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_DENA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_DENA_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_DENA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_E2F1_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_E2F1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_E2F1_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_E2F1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_MYC_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_MYC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_MYC_E2F1_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_MYC_E2F1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_MYC_E2F1_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_MYC_E2F1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_MYC_TGFA_DN</td> | ||
+ | <td>LEE_LIVER_CANCER_MYC_TGFA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_MYC_TGFA_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_MYC_TGFA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEE_MYC_UP</td> | ||
+ | <td>LEE_LIVER_CANCER_MYC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">JAIN_NEMO_DIFF</td> | ||
+ | <td>JAIN_NFKB_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KANG_TERT_UP</td> | ||
+ | <td>KANG_IMMORTALIZED_BY_TERT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KANG_TERT_DN</td> | ||
+ | <td>KANG_IMMORTALIZED_BY_TERT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ANDRECHEK_ERBB2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ANDRECHEK_ERBB2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHRAMM_INHBA_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHRAMM_INHBA_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LU_IL4BCELL</td> | ||
+ | <td>LU_IL4_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRASNOSELSKY_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLLIS_PRKDC_SUBSTRATES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLLIS_PRKDC_REGULATORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AGARWAL_AKT_PATHWAY_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HU_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HU_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HU_ANGIOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HU_ANGIOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAZAG_TGFB1_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAZAG_TGFB1_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MARCINIAK_CHOP_DIFF</td> | ||
+ | <td>MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZUCCHI_EPITHELIAL_DN</td> | ||
+ | <td>ZUCCHI_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZUCCHI_EPITHELIAL_UP</td> | ||
+ | <td>ZUCCHI_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CORDERO_KRAS_KD_VS_CONTROL_DN</td> | ||
+ | <td>SWEET_KRAS_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CORDERO_KRAS_KD_VS_CONTROL_UP</td> | ||
+ | <td>SWEET_KRAS_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SWEET_LUNG_CANCER_KRAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SWEET_LUNG_CANCER_KRAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SWEET_KRAS_ONCOGENIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSUNODA_CISPLATIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSUNODA_CISPLATIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSUNODA_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSUNODA_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANG_MYB_FAMILY_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_TABLE_1S_XPCS_4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_TABLE_1S_XPCS_4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_TABLE_1S_TTD_8_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_TABLE_1S_TTD_8_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_PAX8_PPARG_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_PAX8_PPARG_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_CLUSTER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_CLUSTER_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_CLUSTER_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_THYROID_CANCER_CLUSTER_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUI_TARGETS_OF_PAX8_PPARG_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_INTERFERON_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BOQUEST_CD31PLUS_VS_CD31MINUS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BOQUEST_CD31PLUS_VS_CD31MINUS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>BOQUEST_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>BOQUEST_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WANG_MLL_CBP_VS_GMP_UP</td> | ||
+ | <td>WANG_TARGETS_OF_MLL_CBP_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WANG_MLL_CBP_VS_GMP_DN</td> | ||
+ | <td>WANG_TARGETS_OF_MLL_CBP_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAESCH_ANAPHASE_PROMOTING_COMPLEX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAESCH_APC_YEAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKB_0.5H VS TRKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKB_1H VS TRKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKB_6H VS TRKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKB_24H VS TRKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKA_0.5H VS TRKA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKA_1H VS TRKA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKA_6H VS TRKA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_TRKA_24H VS TRKA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_VEC_0.5H VS VEC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_VEC_1H VS VEC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_VEC_6H VS VEC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHULTE_VEC_24H VS VEC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KENNY_WNT_UP</td> | ||
+ | <td>KENNY_CTNNB1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">KENNY_WNT_DN</td> | ||
+ | <td>KENNY_CTNNB1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_PROSTATE_CANCER_EPIGENETIC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BECKER_ESTROGEN_RESPONSIVE_SUBSET_2</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BECKER_TAMOXIFEN_RESISTANT_UP</td> | ||
+ | <td>BECKER_TAMOXIFEN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BECKER_IFN_INDUCIBLE_SUBSET_1</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BECKER_CANCER_ASSOCIATED_SUBSET_1</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BECKER_CANCER_ASSOCIATED_SUBSET_2</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BECKER_TAMOXIFEN_RESISTANT_DN</td> | ||
+ | <td>BECKER_TAMOXIFEN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ET743_RESIST_UP</td> | ||
+ | <td>MARCHINI_TRABECTEDIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ET743_RESIST_DN</td> | ||
+ | <td>MARCHINI_TRABECTEDIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NUMATA_G_CSF_DIFF</td> | ||
+ | <td>NUMATA_CSF3_SIGNALING_VIA_STAT3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>URBICH_MRNA_EXPRESSION_IN_EPC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>URBICH_MRNA_EXPRESSION_IN_EPC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>URBICH_MRNA_EXPRESSION_IN_HUVEC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>URBICH_MRNA_EXPRESSION_IN_HUVEC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>URBICH_RNA_EXPRESSION_IN_CD14+_MONOCYTES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>URBICH_RNA_EXPRESSION_IN_CD14+_MONOCYTES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIRMEIER_LMP1_RESPONSE_EARLY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIRMEIER_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIRMEIER_LMP1_RESPONSE_LATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIRMEIER_LMP1_RESPONSE_LATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_FIG_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_FIG_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_AML_WITH_MUTATED_FLT3_OR_NRAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_AML_WITH_MUTATED_FLT3_OR_NRAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_TABLE_2_FLT3-TKD_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_TABLE_2_FLT3-TKD_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_TABLE_2_NRAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEBEN_TABLE_2_NRAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BORLAK_LIVER_CANCER_EGF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BORLAK_LIVER_CANCER_EGF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTRO_APC IN YEAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTRO_S_POMBE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTRO_ANAPHASE_PROMOTING_COMPLEX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AD12_ANY_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AD12_24HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AD12_32HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">AD12_48HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_12HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_12HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_32HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_32HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>DORN_ADENOVIRUS_INFECTION_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLICON_8Q24_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLICON_8Q24_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLICON_12P11_12_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLICON_12P11_12_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEGUM_FIG_5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEGUM_FIG_5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KANG_GIST_WITH_PDGFRA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KANG_GIST_WITH_PDGFRA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LE_MYELIN_DN</td> | ||
+ | <td>LE_EGR2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LE_MYELIN_UP</td> | ||
+ | <td>LE_EGR2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEI_HOXC8_DN</td> | ||
+ | <td>LEI_HOXC8_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LEI_HOXC8_UP</td> | ||
+ | <td>LEI_HOXC8_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_UP</td> | ||
+ | <td>WONG_IFNA2_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_DN</td> | ||
+ | <td>WONG_IFNA2_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_G1_SM_G2</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_G1_GR_G2</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_G2_SM_G3</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_G2_GR_G3</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_L0_SM_L1</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_L0_GR_L1</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_L1_SM_G1</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LIZUKA_L1_GR_G1</td> | ||
+ | <td>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_D6MIT150_TRANSCRIPTION_FACTORS_GLOCUS</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_D6MIT150_CIS_GLOCUS</td> | ||
+ | <td>CHESLER_BRAIN_D6MIT150_QTL_CIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_BRAIN_CIS_GENES</td> | ||
+ | <td>CHESLER_BRAIN_QTL_CIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_BRAIN_ONLY_SUBSET</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_BRAIN_TRANS_GENES</td> | ||
+ | <td>CHESLER_BRAIN_QTL_TRANS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_BRAIN_HIGHEST_VARIANCE_GENES</td> | ||
+ | <td>CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_HIGHEST_FOLD_RANGE_GENES</td> | ||
+ | <td>CHESLER_BRAIN_HIGHEST_EXPRESSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_D6MIT150_NEURAL_TARGETS_GLOCUS</td> | ||
+ | <td>CHESLER_BRAIN_D6MIT150_QTL_TRANS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHESLER_BRAIN_NEURAL_HIGH_GENES</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_SCP2_QTL</td> | ||
+ | <td>BYSTRYKH_SCP2_QTL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_FGF3_TARGETS</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_HSC_CIS_REGULATED_QTL</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_HSC_AND_BRAIN_TRANS_REGULATED_QTL</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_HSC_AND_BRAIN_CIS_REGULATED_QTL</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_RUNX1_TARGETS</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_HSC_TRANS_REGULATED_QTL</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_FLI1_TARGETS</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_IL3RA_TARGETS</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BYSTRYKH_HSC_TRANS_REGULATED_BY_QTL_SCP2</td> | ||
+ | <td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TNFA_NFKB_DEP_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>TIAN_TNF_SIGNALING_VIA_NFKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIAN_TNF_SIGNALING_NOT_VIA_NFKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BRG1_H1299_UP</td> | ||
+ | <td>MEDINA_SMARCA4_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUNG_IL2_SIGNALING_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUNG_IL2_SIGNALING_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PATIL_TABLE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PATIL_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAUER_STAT3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAUER_STAT3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_METHYLATED_IN_BREAST_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOERNER_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SILIGAN_BOUND_BY_EWS_FLT1_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTIOLI_MGUS_VS_PCL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_PML_TARGETS_BOUND_BY_MYC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_PML_TARGETS_BOUND_BY_MYC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PEART_HISTONE_UP</td> | ||
+ | <td>PEART_HDAC_PROLIFERATION_CLUSTER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PEART_HISTONE_DN</td> | ||
+ | <td>PEART_HDAC_PROLIFERATION_CLUSTER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROTH_HTERT_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROTH_HTERT_DN</td> | ||
+ | <td>ROETH_TERT_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ROTH_HTERT_UP</td> | ||
+ | <td>ROETH_TERT_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANA_TNFA_ENDOTHELIAL_DN</td> | ||
+ | <td>SANA_RESPONSE_TO_TNF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANA_IFNG_ENDOTHELIAL_UP</td> | ||
+ | <td>SANA_RESPONSE_TO_IFNG_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANA_TNFA_ENDOTHELIAL_UP</td> | ||
+ | <td>SANA_RESPONSE_TO_TNF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SANA_IFNG_ENDOTHELIAL_DN</td> | ||
+ | <td>SANA_RESPONSE_TO_IFNG_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MANN_RESPONSE_TO_AMIFOSTINE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MANN_RESPONSE_TO_AMIFOSTINE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_TABLE_2_PDGFRX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_TABLE_2_TUMOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_TABLE_2_BTL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_TABLE_2_OTHER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_TABLE_2_DIFF</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WANG_HOXA9_VS_MEIS1_DN</td> | ||
+ | <td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WANG_HOXA9_VS_MEIS1_UP</td> | ||
+ | <td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">APPEL_IMATINIB_UP</td> | ||
+ | <td>APPEL_IMATINIB_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEN_HOXA5_TARGETS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHEN_HOXA5_TARGETS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>CHEN_HOXA5_TARGETS_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>CHEN_HOXA5_TARGETS_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>CHEN_HOXA5_TARGETS_9HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>CHEN_HOXA5_TARGETS_9HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KARLSSON_TABLE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BASSO_REGULATORY_HUBS</td> | ||
+ | <td>BASSO_B_LYMPHOCYTE_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARIS_THYROID_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARIS_THYROID_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FALT_BCLL_IG_MUTATED_VS_WT_UP</td> | ||
+ | <td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FALT_BCLL_IG_MUTATED_VS_WT_DN</td> | ||
+ | <td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FALT_BCLL_DN</td> | ||
+ | <td>FAELT_B_CLL_WITH_VH3_21_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FALT_BCLL_UP</td> | ||
+ | <td>FAELT_B_CLL_WITH_VH3_21_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_DNA_DAMAGE_RESPONSE_TP53</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_SUPPL_DATA_SET_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_GENOTOXIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_RESPONSE_TO_ARSENITE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAINA_HYPOXIA_VHL_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAINA_HYPOXIA_VHL_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAINA_VHL_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAINA_VHL_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SNIJDERS_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_XG_13_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_HI_IN_PPC_UP</td> | ||
+ | <td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_BAFF_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_XG_13_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_BAFF_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_HI_VS_LOW_UP</td> | ||
+ | <td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_HI_VS_LOW_DN</td> | ||
+ | <td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MOREAUX_TACI_HI_IN_BMPC</td> | ||
+ | <td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MARSHALL_SPLEEN_BAL</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>MARSHALL_VIRAL_INFECTION_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>MARSHALL_VIRAL_INFECTION_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ALCALAY_AML_NPMC_UP</td> | ||
+ | <td>ALCALAY_AML_BY_NPM1_LOCALIZATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ALCALAY_AML_NPMC_DN</td> | ||
+ | <td>ALCALAY_AML_BY_NPM1_LOCALIZATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TCELL_ANERGIC_UP</td> | ||
+ | <td>SAFFORD_T_LYMPHOCYTE_ANERGY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VAN_VUGT_MITOTIC_EXIT_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_EARLY_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_LATE_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_ANY_UP</td> | ||
+ | <td>XU_GH1_EXOGENOUS_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_EARLY_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_AUTOCRINE_UP</td> | ||
+ | <td>XU_GH1_AUTOCRINE_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_ANY_DN</td> | ||
+ | <td>XU_GH1_EXOGENOUS_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_AUTOCRINE_DN</td> | ||
+ | <td>XU_GH1_AUTOCRINE_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_ALL_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_MIDDLE_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GH_EXOGENOUS_LATE_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SASAKI_TARGETS_OF_TP73_AND_TP63</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_ENVIRONMENTAL_STRESS_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_ENVIRONMENTAL_STRESS_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_RESPONSE_TO_4NQO</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_RESPONSE_TO_GAMMA_RADIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_UV_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_STRESS_RESPONSE_SUBSET_F</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_STRESS_RESPONSE_SUBSET_H</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_STRESS_RESPONSE_SUBSET_G</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_TABLE_2S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUGO_TABLE_2S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANAGIDA_CIS_AT_26</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANAGIDA_RIS_AT_20</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANAGIDA_RIS_AT_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POOLA_INVASIVE_BREAST_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POOLA_INVASIVE_BREAST_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CARIES_PULP_HIGH_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CARIES_PULP_DN</td> | ||
+ | <td>MCLACHLAN_DENTAL_CARIES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CARIES_PULP_UP</td> | ||
+ | <td>MCLACHLAN_DENTAL_CARIES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MYOD_NIH3T3_DN</td> | ||
+ | <td>DELASERNA_MYOD_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MYOD_NIH3T3_UP</td> | ||
+ | <td>DELASERNA_MYOD_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MYOD_BRG1_UP</td> | ||
+ | <td>DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_EMBRYONAL_CARCINOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_TERATOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_YOLK_SAC_TUMOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_CHORIOCARCINOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PITUITARY_FETAL_DN</td> | ||
+ | <td>MA_PITUITARY_FETAL_VS_ADULT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">PITUITARY_FETAL_UP</td> | ||
+ | <td>MA_PITUITARY_FETAL_VS_ADULT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">IRS1_KO_ADIP_DN</td> | ||
+ | <td>TSENG_IRS1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">IRS1_KO_ADIP_UP</td> | ||
+ | <td>TSENG_IRS1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IRS_KO_ADIP_DN</td> | ||
+ | <td>TSENG_ADIPOGENIC_POTENTIAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">IRS_KO_ADIP_UP</td> | ||
+ | <td>TSENG_ADIPOGENIC_POTENTIAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_24HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_UP</td> | ||
+ | <td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_72HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_72HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_24HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_6HRS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_DN</td> | ||
+ | <td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ET743_SARCOMA_48HRS_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEINMANN_ADAPTATION_TO_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEINMANN_ADAPTATION_TO_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANAGIHARA_ESX1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZIRN_TRETINOIN_RESPONSE_WT1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZIRN_TRETINOIN_RESPONSE_WT1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZIRN_TRETINOIN_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZIRN_TRETINOIN_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_ERBB2_BREAST_TUMORS_65_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_ERBB2_BREAST_TUMORS_324_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_ERBB2_BREAST_TUMORS_324_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRUETZMANN_PANCREATIC_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRUETZMANN_PANCREATIC_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GAMMA_UNIQUE_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UV_ESR_OLD_UNREG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UV_ESR_WS_UNREG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GAMMA-UV_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">4NQO_UNIQUE_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">4NQO_UNIQUE_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UV-4NQO_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ESR_FIBROBLAST_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UV_UNIQUE_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">4NQO_ESR_OLD_UNREG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UV_UNIQUE_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GAMMA_ESR_WS_UNREG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GAMMA-UV_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">UV-4NQO_FIBRO_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">4NQO_ESR_WS_UNREG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GAMMA_ESR_OLD_UNREG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">GAMMA_UNIQUE_FIBRO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ESR_FIBROBLAST_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_BY_4NQO</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_BY_UV</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_BY_4NQO_OR_UV</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_DNA_DAMAGE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_APOCRINE VS LUMINAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_BASAL_VS_LULMINAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FARMER_BREAST_CANCER_CLUSTER_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHANG_EFT_EWSFLI1_UP</td> | ||
+ | <td>ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GLINSKY_CANCER_DEATH_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GLINSKY_CANCER_DEATH_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANHARANTA_UTERINE_FIBROID_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANHARANTA_UTERINE_FIBROID_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VANHARANTA_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KERLEY_RESPONSE_TO_CISPLATIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KERLEY_RESPONSE_TO_CISPLATIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_11S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_11S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_12S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_12S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUELLET_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FERRARI_4HPR_UP</td> | ||
+ | <td>FERRARI_4HPR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>FERRARI_RESPONSE_TO_FENRETINIDE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">—</td> | ||
+ | <td>FERRARI_RESPONSE_TO_FENRETINIDE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGED_MOUSE_HIPPOCAMPUS_MULTI_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGED_MOUSE_HIPPOCAMPUS_ANY_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGED_MOUSE_RETINA_ANY_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGED_MOUSE_HIPPOCAMPUS_ANY_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">AGED_MOUSE_RETINA_ANY_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BCNU_GLIOMA_NOMGMT_24HRS_UP</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BCNU_GLIOMA_MGMT_24HRS_DN</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BCNU_GLIOMA_NOMGMT_48HRS_UP</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BCNU_GLIOMA_NOMGMT_48HRS_DN</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BCNU_GLIOMA_MGMT_48HRS_DN</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">BCNU_GLIOMA_MGMT_48HRS_UP</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GERY_CEBP_TARGETS</td> | ||
+ | <td>GERY_CEBP_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CPR_LOW_LIVER_UP</td> | ||
+ | <td>WENG_POR_TARGETS_GLOBAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CPR_LOW_LIVER_DN</td> | ||
+ | <td>WENG_POR_TARGETS_GLOBAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CPR_NULL-LOW_LIVER_UP</td> | ||
+ | <td>WENG_POR_DOSAGE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CPR_NULL_LIVER_UP</td> | ||
+ | <td>WENG_POR_TARGETS_LIVER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">CPR_NULL_LIVER_DN</td> | ||
+ | <td>WENG_POR_TARGETS_LIVER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">HYPERME_COLONCA_SW48</td> | ||
+ | <td>WEBER_METHYLATED_IN_COLON_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>INAMURA_LUNG_CANCER_SCC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>INAMURA_LUNG_CANCER_SCC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_4S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_4S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_5S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_5S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_2S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROSTY_TABLE_6S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAN_ESCAPE_FROM_ANOIKIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EINAV_INTERFERON_SIGNATURE_IN_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUCAS_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUCAS_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUCAS_HNF4A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUCAS_HNF4A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SIMBULAN_UV_RESPONSE_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SIMBULAN_UV_RESPONSE_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SIMBULAN_UV_RESPONSE_IMMORTALIZED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATTEL_FIG_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATTEL_FIG_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NOVA2_KO_SPLICING</td> | ||
+ | <td>ULE_SPLICING_VIA_NOVA2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_TABLE_2_AGAIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_TABLE_2_AGAIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_FIG_2A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_FIG_2A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_FIG_2B_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_FIG_2B_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_DOXORUBICIN_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GYORFFY_MITOXANTRONE_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UROSEVIC_RESPONSE_TO_IMIQUIMOD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ZMPSTE24_KO_DN</td> | ||
+ | <td>VARELA_ZMPSTE24_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">ZMPSTE24_KO_UP</td> | ||
+ | <td>VARELA_ZMPSTE24_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALE_APL_WITH_FLT3_MUTATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALE_APL_WITH_FLT3_MUTATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ERM_KO_SERTOLI_DN</td> | ||
+ | <td>CHEN_ETV5_TARGETS_SERTOLI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ERM_KO_TESTES_DN</td> | ||
+ | <td>CHEN_ETV5_TARGETS_TESTIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">VERHAAK_AML_NPM1_MUT_VS_WT_UP</td> | ||
+ | <td>VERHAAK_AML_WITH_NPM1_MUTATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">VERHAAK_AML_NPM1_MUT_VS_WT_DN</td> | ||
+ | <td>VERHAAK_AML_WITH_NPM1_MUTATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WU_ALZHEIMER_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WU_ALZHEIMER_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHOW_RASSF1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHOW_RASSF1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_MYC_AMPLIFICATION_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_MYC_AMPLIFICATION_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_MYCN_AMPLIFICATION_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_MYCN_AMPLIFICATION_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_MYCL1_AMPLIFICATION_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_MYCL1_AMPLIFICATION_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SYED_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SYED_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SYED_ESTRADIOL_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">TFF2_KO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>BAUS_TFF2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>BAUS_TFF2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LAL_KO_6MO_UP</td> | ||
+ | <td>LIAN_LIPA_TARGETS_6M</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">LAL_KO_3MO_UP</td> | ||
+ | <td>LIAN_LIPA_TARGETS_3M</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIZUKAMI_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIZUKAMI_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BAF57_BT549_DN</td> | ||
+ | <td>WANG_SMARCE1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BAF57_BT549_UP</td> | ||
+ | <td>WANG_SMARCE1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">IFN_BETA_GLIOMA_UP</td> | ||
+ | <td>NATSUME_RESPONSE_TO_INTERFERON_BETA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">IFN_BETA_GLIOMA_DN</td> | ||
+ | <td>NATSUME_RESPONSE_TO_INTERFERON_BETA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">XU_ATRA_PLUSNSC_UP</td> | ||
+ | <td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">XU_ATRA_UP</td> | ||
+ | <td>XU_RESPONSE_TO_TRETINOIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">XU_ATRA_DN</td> | ||
+ | <td>XU_RESPONSE_TO_TRETINOIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">XU_ATRA_PLUSNSC_DN</td> | ||
+ | <td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_CRASH_AND_BURN_MUT_VS_WT_UP</td> | ||
+ | <td>SHEPARD_CRUSH_AND_BURN_MUTANT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_BMYB_MORPHOLINO_DN</td> | ||
+ | <td>SHEPARD_BMYB_MORPHOLINO_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_GENES_COMMON_BW_CB_MO</td> | ||
+ | <td>SHEPARD_BMYB_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_CRASH_AND_BURN_MUT_VS_WT_DN</td> | ||
+ | <td>SHEPARD_CRUSH_AND_BURN_MUTANT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_BMYB_MORPHOLINO_UP</td> | ||
+ | <td>SHEPARD_BMYB_MORPHOLINO_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_NEG_REG_OF_CELL_PROLIFERATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_CELL_PROLIFERATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SHEPARD_POS_REG_OF_CELL_PROLIFERATION</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEIDEN_MET_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEIDEN_ONCOGENESIS_BY_MET</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEIDEN-LONG_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CHIARETTI_ZAP70_DIFF</td> | ||
+ | <td>CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OSWALD_HEMATOPOIETIC_STEM_CELLS_IN_COLLAGEN_GEL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OSWALD_HEMATOPOIETIC_STEM_CELLS_IN_COLLAGEN_GEL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOBAYASHI_RESPONSE_TO_ROMIDEPSIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KLEIN_TARGETS_OF_BCR_ABL1_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_CMYB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_CMYB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_VMYB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_VMYB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TABLE_1S_CMYB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TABLE_1S_CMYB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TABLE_4S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TABLE_4S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TARGETS_OF_VMYB_VS_CMYB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TARGETS_OF_VMYB_VS_CMYB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HASINA_NOL7_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HASINA_NOL7_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">POD1_KO_DN</td> | ||
+ | <td>CUI_TCF21_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">POD1_KO_MOST_DN</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">POD1_KO_MOST_UP</td> | ||
+ | <td>CUI_TCF21_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">POD1_KO_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAATINEN_HEMATOPOIETIC_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAATINEN_HEMATOPOIETIC_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_BEXAROTENE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_BEXAROTENE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROVERSI_GLIOMA_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROVERSI_GLIOMA_LOH_REGIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROVERSI_GLIOMA_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_HYPOXIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSAI_RESPONSE_TO_IONIZING_RADIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS TPA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS TPA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_BENIGN_SKIN_TUMOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_BENIGN_SKIN_TUMOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS SCC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS SCC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_MALIGNANT_SKIN_TUMOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_MALIGNANT_SKIN_TUMOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS PAP_MALIGNANT TUMOURS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS PAP_MALIGNANT TUMOURS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS TPA_MALIGNANT TUMOURS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_CO. VS TPA_MALIGNANT TUMOURS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_SKIN_CANCER_PROGRESSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMERICH_SKIN_CANCER_PROGRESSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOINUMA_COLON_CANCER_MSI_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOINUMA_COLON_CANCER_MSI_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_BREAST_CANCER_ESR1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_BREAST_CANCER_ESR1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_BREAST_CANCER_ESR1_LASER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_BREAST_CANCER_ESR1_LASER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_BREAST_CANCER_ESR1_BULK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_BREAST_CANCER_ESR1_BULK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MYC_ONCOGENIC_SIGNATURE</td> | ||
+ | <td>BILD_MYC_ONCOGENIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">E2F3_ONCOGENIC_SIGNATURE</td> | ||
+ | <td>BILD_E2F3_ONCOGENIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RAS_ONCOGENIC_SIGNATURE</td> | ||
+ | <td>BILD_HRAS_ONCOGENIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">SRC_ONCOGENIC_SIGNATURE</td> | ||
+ | <td>BILD_SRC_ONCOGENIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">CTNNB1_oncogenic_signature</td> | ||
+ | <td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STANHILL_HRAS_TRANSFROMATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STANHILL_HRAS_TRANSFROMATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_MAMMARY_GLAND_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_MAMMARY_GLAND_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_PUBERTAL_MAMMARY_GLAND</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_CITED1_TARGETS_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_CITED1_TARGETS_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_CITED1_TARGETS_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOWLIN_CITED1_TARGETS_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GREER_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16">KAMMINGA_EZH2_TARGETS</td> | ||
+ | <td>KAMMINGA_EZH2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAMMINGA_SENESCENCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UREN_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YANG_OSTECLASTS_SIG</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YOSHIMURA_MAPK8_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YOSHIMURA_MAPK8_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KREPPEL_CD99_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KREPPEL_CD99_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_RESPONSE_TO_IONIZING_RADIATION_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_RESPONSE_TO_IONIZING_RADIATION_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_RESPONSE_TO_IONIZING_RADIATION_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_RESPONSE_TO_IONIZING_RADIATION_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_RESPONSE_TO_IONIZING_RADIATION_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RASHI_NFKB1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BALDWIN_PRKCI_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BALDWIN_PRKCI_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANCHEZ_MDM2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AUNG_GASTRIC_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MATSUDA_VALPHAINKT_DIFF</td> | ||
+ | <td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_LUNG_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_AMPLIFIED_IN_LUNG_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_TABLE_3S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YU_CMYC_UP</td> | ||
+ | <td>YU_MYC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">YU_CMYC_DN</td> | ||
+ | <td>YU_MYC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIEN_INTESTINE_PROBIOTICS_2HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIEN_INTESTINE_PROBIOTICS_2HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIEN_INTESTINE_PROBIOTICS_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIEN_INTESTINE_PROBIOTICS_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIEN_INTESTINE_PROBIOTICS_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BIDUS_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BIDUS_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HATADA_METHYLATED_IN_LUNG_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HATADA_METHYLATED_IN_LUNG_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHANK_TAL1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHANK_TAL1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEMBA_FHIT_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEMBA_FHIT_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_EMBRYONAL_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_EMBRYONAL_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_TERATOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_TERATOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_YOLK_SAC_TUMOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_YOLK_SAC_TUMOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_CHORIOCARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_CHORIOCARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_SEMINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_SEMINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_CORRELATED_WITH_POU5F1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">XU_CBP_UP</td> | ||
+ | <td>XU_CREBBP_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">XU_CBP_DN</td> | ||
+ | <td>XU_CREBBP_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_BREAST_CANCER_PROGRESSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDIS_BREAST_CANCER_PROGRESSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENK_UV_RESPONSE_EPIDERMIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENK_UV_RESPONSE_EPIDERMIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LA_MEN1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>REN_MIF_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>REN_MIF_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_TABLE_1_BE_VS_NE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_TABLE_1_BE_VS_NE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_BARRETTS_ESOPHAGUS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_BARRETTS_ESOPHAGUS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_ESOPHAGUS_CANCER_PROGRESSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_ESOPHAGUS_CANCER_PROGRESSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOMMAGANI_TP63_GAMMA_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GH_GHRHR_KO_24HRS_UP</td> | ||
+ | <td>GOVONI_GH1_TARGETS_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GH_GHRHR_KO_6HRS_UP</td> | ||
+ | <td>GOVONI_GH1_TARGETS_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GH_GHRHR_KO_24HRS_DN</td> | ||
+ | <td>GOVONI_GH1_TARGETS_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">GH_GHRHR_KO_6HRS_DN</td> | ||
+ | <td>GOVONI_GH1_TARGETS_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOOI_ST7_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOOI_ST7_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SOTIRIOU_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SOTIRIOU_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_LUNG_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_LUNG_CANCER_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_ALVEOLAR_EPITHELIUM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_ALVEOLAR_AND_BRONCHIOLAR_EPITHELIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOANE_BREAST_CANCER_CLASSES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOANE_BREAST_CANCER_CLASSES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOANE_RESPONSE_TO_ANDROGEN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOANE_RESPONSE_TO_ANDROGEN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOANE_BREAST_CANCER_ESR1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOANE_BREAST_CANCER_ESR1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GESERICK_TERT_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GESERICK_TERT_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GESERICK_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GESERICK_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HESS_HOXAANMEIS1_DN</td> | ||
+ | <td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HESS_HOXAANMEIS1_UP</td> | ||
+ | <td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MENSE_HYPOXIA_DN</td> | ||
+ | <td>MENSE_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MENSE_HYPOXIA_UP</td> | ||
+ | <td>MENSE_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MENSE_HYPOXIA_TRANSPORTER_GENES</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">MENSE_HYPOXIA_APOPTOSIS_GENES</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ODONNELL_TFRC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ODONNELL_TFRC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RUTELLA_HEMATOGFSNDCS_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RUTELLA_HEPATGFSNDCS_UP</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUTELLA_RESPONSE_TO_HGF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUTELLA_RESPONSE_TO_HGF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PROVENZANI_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PROVENZANI_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_LIVER_CANCER_HEPATOBLAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FURUKAWA_DUSP6_TARGETS_PCI35_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FURUKAWA_DUSP6_TARGETS_PCI35_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FURUKAWA_DUSP6_TARGETS_PK8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_CLUSTER_2B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4AS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4BS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4CS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4DS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4ES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4FS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_TABLE_4GS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EHRLICH_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EHRLICH_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PIEPOLI_LGI1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PIEPOLI_LGI1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_EPITHELIOID_MESOTHELIOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTHELIOMA_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MESOTHELIOMA_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAEGERSTRAND_RESPONSE_TO_IMATINIB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DITTMER_PTHLH_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DITTMER_PTHLH_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAYBURD_RESPONSE_TO_L663536_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAYBURD_RESPONSE_TO_L663536_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_TABLE_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_TABLE_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HYPOXIA_BY_DMOG_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HYPOXIA_BY_DMOG_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HIF1A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HIF1A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HIF2A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HIF2A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUND_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUND_SILENCED_BY_METHYLATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UDAYAKUMAR_MED1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UDAYAKUMAR_MED1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOLLMAN_APOPTOSIS_VIA_CD40_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOLLMAN_APOPTOSIS_VIA_CD40_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINNEPENNINCKX_MELANOMA_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_5S_6S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_5S_6S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_7S_8S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_7S_8S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_9S_10S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_9S_10S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_11S_12S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_11S_12S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_13S_14S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_13S_14S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_15S_16S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_15S_16S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_3S_4S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_TABLE_3S_4S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARADONNA_TARGETS_OF_KRAS_AND_CDC25_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARADONNA_TARGETS_OF_KRAS_AND_CDC25_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARADONNA_KRAS_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARADONNA_KRAS_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARADONNA_CDC25_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIARADONNA_CDC25_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AFFAR_YY1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AFFAR_YY1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">HOUSTIS_ROS</td> | ||
+ | <td>HOUSTIS_ROS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VIEMANN_TNF_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BILBAN_B_CLL_LPL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BILBAN_B_CLL_LPL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BILBAN_TABLE_2S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BILBAN_TABLE_2S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_PROSTATE_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_PROSTATE_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_SOX4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_SOX4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NGUYEN_KERATO_UP</td> | ||
+ | <td>NGUYEN_NOTCH1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">NGUYEN_KERATO_DN</td> | ||
+ | <td>NGUYEN_NOTCH1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KARAKAS_TGFB1_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KARAKAS_TGFB1_SIGNALING_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KARAKAS_TGFB1_SIGNALING_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">FLOTHO_CASP8AP2_MRD_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">—</td> | ||
+ | <td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PRAMOONJAGO_SOX4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PRAMOONJAGO_SOX4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PRAMOONJAGO_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PRAMOONJAGO_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PRAMOONJAGO_TABLE_4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PRAMOONJAGO_TABLE_4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONKEN_UVEAL_MELANOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONKEN_UVEAL_MELANOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEIMAN_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEIMAN_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEIMAN_TABLE_1S_TF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEIMAN_TABLE_1S_TF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEIMAN_TABLE_1S_END_STAGE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEIMAN_TABLE_1S_END_STAGE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUNNE_TABLE_5_ONE_MORE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PATTERSON_DOCETAXEL_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMANAKA_GLIOMA_SURVIVAL_PROGNOSIS_POOR_VS_GOOD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">RADMACHER_AMLNORMALKARYTYPE_SIG</td> | ||
+ | <td>RADMACHER_AML_PROGNOSIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROYLANCE_BREAST_CANCER_CHR16Q_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROYLANCE_BREAST_CANCER_CHR16Q_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIBAS_KINASE_PROQINASE_SELECTIVITY_PANEL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">WALKER_MM_SNP_DIFF</td> | ||
+ | <td>Deprecated</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAPOSI_LIVER_CANCER_POOR_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAERVINEN_TABLES_2S_AND_4S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAERVINEN_TABLES_2S_AND_4S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAERVINEN_TABLE_3S_AND_5S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAERVINEN_TABLE_3S_AND_5S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_CD1_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD1_VS_CD2_DN</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_MOLECULAR_CLASSI_UP</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_LB_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD1_VS_CD2_UP</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_PR_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_PR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_CD2_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_MF_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_MF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_MS_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_MS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_CD138_HP_VS_REST</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_HP_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">ZHAN_MM_MOLECULAR_CLASSI_DN</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_CD2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_LB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_HP_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_MF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHAN_MULTIPLE_MYELOMA_PR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ESTECIO_METHYLATED_IN_HEAD_AND_NECK_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ESTECIO_METHYLATED_IN_HEAD_AND_NECK_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OSMAN_BLADDER_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OSMAN_BLADDER_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_10</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_20</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_28</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_19</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_ANDROGEN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_ANDROGEN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_FORSKOLIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RESPONSE_TO_FORSKOLIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMEL_BURKITTS_LYMPHOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUMMEL_BURKITTS_LYMPHOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BROWN_GRAN_MONO_DIFFERENTIATION</td> | ||
+ | <td>BROWN_MYELOID_CELL_DEVELOPMENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl24">BROWN_MYELOID_PROLIF_AND_SELF_RENEWAL</td> | ||
+ | <td>BROWN_MYELOID_CELL_DEVELOPMENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BROWN_CD131_MUTATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEWMAN_ERCC6_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEWMAN_ERCC6_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEWMAN_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NEWMAN_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PACHER_TARGETS_OF_IGF1_AND_IGF2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PACHER_TARGETS_OF_IGF1_AND_IGF2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PACHER_TABLES_2_5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PACHER_TABLES_2_5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OHASHI_AURKA_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OHASHI_AURKB_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSAI_DNAJB4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSAI_DNAJB4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OZANNE_AP1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OZANNE_AP1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HWANG_PROSTATE_CANCER_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIMOFEEVA_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIMOFEEVA_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAIHO_COLORECTAL_CANCER_SERRATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAIHO_COLORECTAL_CANCER_SERRATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAIHO_TABLE_3S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAIHO_TABLE_3S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROESCH_HEAD_NECK_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROESCH_HEAD_NECK_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOTAMED_RESPONSE_TO_ANDROGEN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOTAMED_RESPONSE_TO_ANDROGEN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOTEM_TABLE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_ACINAR_DEVELOPMENT_LATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_ACINAR_DEVELOPMENT_LATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_TABLES_4S_AND_5S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_TABLES_4S_AND_5S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_TABLES_2S_AND_3S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_TABLES_2S_AND_3S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAM_FXYD5_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAM_FXYD5_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRASOR_TAMOXIFEN_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRASOR_TAMOXIFEN_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EGUCHI_CELL_CYCLE_RB1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIRAISHI_PLZF_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIRAISHI_PLZF_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLDREN_GEFITINIB_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLDREN_GEFITINIB_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HANNA_CHEMOKINE_AND_ANGIOGENIC_FACTOR_EXPRESSION_IN_DNK_CELLS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALLUZZI_PERMEABILIZE_MITOCHONDRIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUDHU_LIVER_CANCER_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUDHU_LIVER_CANCER_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_TABLE_1S_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_TABLE_1S_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_TABLE_1S_96H_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOKKINAKIS_TABLE_1S_96H_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHOI_ATL_CHRONIC_VS_ACUTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHOI_ATL_CHRONIC_VS_ACUTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHOI_ATL_ACUTE_STAGE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHOI_ATL_STAGE_PREDICTOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OLSSON_E2F3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OLSSON_E2F3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTELLANO_HRAS_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTELLANO_HRAS_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTELLANO_HRAS_AND_NRAS_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTELLANO_HRAS_AND_NRAS_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTELLANO_NRAS_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASTELLANO_NRAS_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CODY_NON_TUMORIGENIC_HYBRIDS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CODY_NON_TUMORIGENIC_HYBRIDS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CODY_MULTIPLE_CHROMOSOME_3P_TUMOR_SUPPRESSOR_GENES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CODY_MULTIPLE_CHROMOSOME_3P_TUMOR_SUPPRESSOR_GENES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONG_RNA_KNOCKDOWN_OF_E2F1_AND_E2F3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONG_E2F1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONG_E2F3_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUELLER_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUELLER_METHYLATED_IN_GLIOBLASTOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENGUPTA_EBNA1_ANTICORRELATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_SEZARY_SYNDROM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_SEZARY_SYNDROM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_MYCOSIS_FUNGOIDES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_MYCOSIS_FUNGOIDES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_CTCL_CUTANEOUS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAHTOLA_CTCL_PATHOGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NADERI_BREAST_CANCER_PROGNOSIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NADERI_BREAST_CANCER_PROGNOSIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PASTURAL_RIZ1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PASTURAL_RIZ1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAMAI_APOPTOSIS_VIA_TRAIL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_CDX2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_CDX2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASORELLI_TABLE_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CASORELLI_TABLE_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATHEW_FANCONI_ANEMIA_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STREICHER_FIG_8B_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STREICHER_FIG_8B_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STREICHER_LSM1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STREICHER_LSM1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIN_BREAST_CANCER_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIN_BREAST_CANCER_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ABDULRAHMAN_KIDNEY_CANCER_VHL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ABDULRAHMAN_KIDNEY_CANCER_VHL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HO_LIVER_CANCER_VASCULAR_INVASION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURNER_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURNER_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOWIE_ECM_HMEC_LX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOWIE_TAM_HMEC_LX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOWIE_RESPONSE_TO_TAMOXIFEN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YEMELYANOV_GR_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YEMELYANOV_GR_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAL_LEUKEMIC_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAL_LEUKEMIC_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CORRADETTI_MTOR_PATHWAY_REGULATORS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CORRADETTI_MTOR_PATHWAY_REGULATORS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRIER_COLON_CANCER_RECURRENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRIER_COLON_CANCER_RECURRENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AIYAR_COBRA1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AIYAR_COBRA1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHONG_EPIGENETIC_SILENCING_IN_LUNG_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHONG_EPIGENETIC_SILENCING_IN_LUNG_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CROSBY_E2F4_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_ENDMETRIUM_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_ENDMETRIUM_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_ENDOMETRIAL_CANCER_LATE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATANABE_COLON_CANCER_MSI_VS_MSS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATANABE_COLON_CANCER_MSI_VS_MSS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_5FU_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_ADRIAMYCIN_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_CYTOXAN_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_DOCETAXEL_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_ETOPOSIDE_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_PACLITAXEL_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTI_TOPOTECAN_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GILMORE_DROSOPHILA_NFKAPPAB_CORE_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GILMORE_CORE_NFKB_PATHWAY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHEIDEREIT_IKK_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUTTA_APOPTOSIS_VIA_NFKB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_CISPLATIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_CISPLATIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BASAKI_YBX1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BASAKI_YBX1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IVANOV_MUTATED_IN_COLON_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IVANOV_TABLE_1A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HORIUCHI_WTAP_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HORIUCHI_WTAP_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_AKT1_TARGETS_6HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_AKT1_TARGETS_48HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_8S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_9S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_9S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAVILIO_TABLE_1S_1M</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAVILIO_TABLE_1S_4M</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DODD_NASOPHARYNGEAL_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DODD_NASOPHARYNGEAL_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMAN_MLL_AF4_FUSION_VS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMAN_MLL_AF4_FUSION_VS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_AF4_MLL_FUSION_VS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_AF4_MLL_FUSION_VS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_AND_AF4_MLL_FUSIONS_VS_CONTROL_DN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_AND_AF4_MLL_FUSIONS_VS_CONTROL_DN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGASHIMA_NRG1_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGASHIMA_NRG1_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGASHIMA_EGF_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGASHIMA_EGF_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMAHL_PDGF_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOBAYASHI_EGFR_SIGNALING_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOBAYASHI_EGFR_SIGNALING_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOBAYASHI_EGFR_SIGNALING_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOBAYASHI_EGFR_SIGNALING_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAIGUSA_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEBOTAEV_GR_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEBOTAEV_GR_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_NEURON_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_ASTROCYTE_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_OLIGODENDROCYTE_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_CHOROID_PLEXUS_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_MIDBRAIN_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_PONS_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_MEDULLA_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_CEREBELLUM_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEIN_MRNA_TARGETING_ASTROCYTES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_SUPPLEMENT_2_APOPTOSIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_SUPPLEMENT_2_APOPTOSIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOEBEKE_ACUTE_MYELOID_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOEBEKE_ACUTE_MYELOID_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOEBEKE_LYMPHOID_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMLINS_PROSTATE_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMLINS_PROSTATE_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMLINS_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMLINS_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VILIMAS_NOTCH1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VILIMAS_NOTCH1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VILIMAS_FIG_1A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRABARCZYK_BCL11B_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRABARCZYK_BCL11B_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZERBINI_RESPONSE_TO_SULINDAC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZERBINI_RESPONSE_TO_SULINDAC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTRAM_ALZGENE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTRAM_ALLELE VS. GENOTYPE CONTRASTS FOR POLYMORPHISMS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTRAM_ALLELIC CONTRASTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTRAM_ALZGENE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTRAM_ALZGENE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAMPE_CROHN_DISEASE_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLESINGER_METHYLATED_IN_COLON_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WIDSCHWENDTER_NORMAL_OVARIES_VS_OVARIAN CANCERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIELMAN_SNP GENOTYPES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WHITEFORD_PEDIATRIC_CANCER_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_COLON_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_COLON_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_COLON_AND_RECTAL_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_COLON_AND_RECTAL_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_COLON_VS_RECTAL_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRADE_COLON_VS_RECTAL_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LABBE_WNT3A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LABBE_WNT3A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LABBE_TGFB1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LABBE_TGFB1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_CANCER_MICROENVIRONMENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_CANCER_MICROENVIRONMENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_TABLE_1_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_TABLE_1_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_METASTASIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_METASTASIS_MODEL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_METASTASIS_MODEL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRATIAS_RETINOBLASTOMA_16Q24</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OHM_METHYLATED_IN_ADULT_CANCERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OHM_EMBRYONIC_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OHM_EMBRYONIC_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_TRANSFORMED_BY_RHOA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERENJENO_TRANSFORMED_BY_RHOA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION_CCNE1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION_HBZ</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION_HEMGN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION_6HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZ_ERYTHROID_DIFFERENTIATION_12HR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHI_SPARC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHI_SPARC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOHANKUMAR_TLX1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOHANKUMAR_TLX1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>APPIERTO_RESPONSE_TO_FENRETINIDE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_TR_CELL_EFFECTOR_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_T4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_P2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_P3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_P4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_P6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_FOXP3_TARGETS_CLUSTER_P7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_PDE3B_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEST_ADRENOCORTICAL_TUMOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEST_ADRENOCORTICAL_TUMOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DONATO_CELL_CYCLE_TRETINOIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHO_NR4A1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BHATI_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BHATI_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CLIMENT_BREAST_CANCER_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CLIMENT_BREAST_CANCER_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_BOUND_BY_FOXP3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_FOXP3_TARGETS_IN_THYMUS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_FOXP3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_FOXP3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_BOUND_BY_FOXP3_STIMULATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_BOUND_BY_FOXP3_UNSTIMULATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_BOUND_BY_E2F4_UNSTIMULATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_FOXP3_TARGETS_STIMULATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_FOXP3_TARGETS_STIMULATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_FOXP3_CORE_DIRECT_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_TCELL_BIOLOGY_FOXP3_TARGET_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_SUPPLEMENTARY_TABLE_7B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_SUPPLEMENTARY_TABLE_8B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_SUPPLEMENTARY_TABLE_10</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_FOXP3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARSON_FOXP3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HE_PTEN_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HE_PTEN_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MURATA_VIRULENCE_OF_H_PILORI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUSA_SAM68_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUSA_SAM68_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANAKA_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANAKA_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_MULTIPLE_MYELOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_MULTIPLE_MYELOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMIDA_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMIDA_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMIDA_LUNG_CANCER_POOR_SURVIVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAWSON_METHYLATED_IN_LYMPHOMA_TCL1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEINTZMAN_TSS CLASSES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HEINTZMAN_TSS CLASSES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHARMA_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHARMA_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSUDA_ALVEOLAR_SOFT_PART_SARCOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAGUE_PRETUMOR_DRUG_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAGUE_PRETUMOR_DRUG_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAYAMA_FGF2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKL_HTLV1_INFECTION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKL_HTLV1_INFECTION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAEGER_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAEGER_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ERCAN_DCC_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LUDWICZEK_TREATING_IRON_OVERLOAD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAKASUGI_HAVE_ZNF143_BINDING_SITES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IGARASHI_ATF4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IGARASHI_ATF4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WIKMAN_ASBESTOS_LUNG_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WIKMAN_ASBESTOS_LUNG_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NOJIMA_SFRP2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NOJIMA_SFRP2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAKAYAMA_BOUND_BY_AR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VECCHI_GASTRIC_CANCER_EARLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VECCHI_GASTRIC_CANCER_EARLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BRUECKNER_TARGETS_OF_LET7_MICRORNA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BRUECKNER_TARGETS_OF_LET7_MICRORNA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PODAR_RESPONSE_TO_ADAPHOSTIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TUMOR_VASCULATURE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TUMOR_VASCULATURE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TABLE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TUMOR_ENDOTHELIAL_MARKERS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TUMOR_ENDOTHELIAL_MARKERS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TUMOR_ANGIOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TUMOR_ANGIOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_LOW_STRINGENCY_RADIATION_RESPONSE_NORMAL_VS_P53_LOF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_LOW_STRINGENCY_RADIATION_RESPONSE_NORMAL_VS_P53_LOF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_DROSOPHILA_P53_LOF_VS_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_DROSOPHILA_P53_LOF_VS_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_RIPD GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_P53</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AKDEMIR_RIPD_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_FIG_4GS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_DELAYED_EARLY_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_20_HELA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_40_HELA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_60_HELA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_120_HELA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_240_HELA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_480_HELA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_20_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_40_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_60_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_120_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_240_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_RESPONSE_480_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_EGF_PEAK 240 MIN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_SERUM_RESPONSE_20_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_SERUM_RESPONSE_40_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_SERUM_RESPONSE_60_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_SERUM_RESPONSE_120_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_SERUM_RESPONSE_240_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMIT_SERUM_RESPONSE_480_MCF10A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKS_HDAC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKS_HDAC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKS_ACETYLATED_NON_HISTONE_PROTEINS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAHADEVAN_IMATINIB_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAHADEVAN_IMATINIB_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAHADEVAN_RESPONSE_TO_MP470_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAHADEVAN_RESPONSE_TO_MP470_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUANG_DASATINIB_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUANG_DASATINIB_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUANG_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUANG_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_HCP_IN_SPERM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_HCP_IN_SPERM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_ICP_IN_FIBROBLAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_ICP_IN_SPERM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_ICP_IN_SPERM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_LCP_IN_SPERM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEBER_METHYLATED_LCP_IN_SPERM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIRA_SMOKERS_LUNG_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIRA_SMOKERS_LUNG_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIRA_TABLE_3S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SPIRA_TABLE_3S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_DCC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_DCC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_NTN1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_NTN1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_NTN1_AND_DCC_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GREENMAN_KINASES_WITH_DRIVER_MUTATIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CORRE_MULTIPLE_MYELOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CORRE_MULTIPLE_MYELOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOK_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOOK_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTHEWS_TABLE_1BS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATTHEWS_AP1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>QI_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>QI_PLASMACYTOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>QI_PLASMACYTOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_GENES_IN_PAR1_CANDIDATE_REGION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZINDY_FIG_3CB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAU_APOPTOSIS_CDKN2A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAU_APOPTOSIS_CDKN2A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANSOM_APC_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANSOM_APC_MYC_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANSOM_APC_TARGETS_REQUIRE_MYC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANSOM_SUPPLEMENTAL_TABLE_3A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANSOM_SUPPLEMENTAL_TABLE_3B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANSOM_WNT_PATHWAY_REQUIRE_MYC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_AML1>2.0_FOXP3>2.0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_AML1>2.0_FOXP3<0.5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_AML1<0.5_FOXP3>2.0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_AML1<0.5_FOXP3<0.5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_0.5<AML1<2.0_FOXP3>2.0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_0.5<AML1<2.0_FOXP3<0.5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_AML1>2.0_0.5<FOXP3<2.0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_CD4+_T_CELLS_AML1<0.5_0.5<FOXP3<2.0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_AML1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_AML1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_FOXP3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONO_FOXP3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_LSD1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_LSD1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAVOLT_TARGETS_OF_TP53_AND_TP63</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHASSOT_SKIN_WOUND</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_THYROID_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RODRIGUES_THYROID_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KROEGER_TABLE_1S_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KROEGER_TABLE_1S_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KROEGER_TABLE_1S_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KROEGER_TABLE_1S_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KROEGER_TABLE_1S_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KROEGER_TABLE_1S_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUPER_BREAST_BASAL_VS_LUMINAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUPER_BREAST_BASAL_VS_LUMINAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MALONEY_RESPONSE_TO_17AAG_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MALONEY_RESPONSE_TO_17AAG_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BLUM_RESPONSE_TO_SALIRASIB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BLUM_RESPONSE_TO_SALIRASIB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CUI_GLUCOSE_DEPRIVATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINTER_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINTER_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINTER_HYPOXIA_METAGENE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINTER_TABLE_2S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WINTER_TABLE_2S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALONSO_METASTASIS_EMT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALONSO_METASTASIS_EMT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALONSO_METASTASIS_NEURAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALONSO_METASTASIS_NEURAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALONSO_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALONSO_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HU_HSF1_TRANSCRIPTION_FACTOR_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WHITEHURST_PACLITAXEL_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHANDRAN_METASTASIS_TOP50_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHANDRAN_METASTASIS_TOP50_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHANDRAN_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHANDRAN_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_WT1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_WT1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_WT1_TARGETS_8HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_WT1_TARGETS_8HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_WT1_TARGETS_12HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_WT1_TARGETS_12HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANAKA_BAC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_TUMOR_INVASIVENESS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_TUMOR_INVASIVENESS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JIANG_TIP30_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JIANG_TIP30_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRESHOCK_CANCER_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRESHOCK_CANCER_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TSAI_RESPONSE_TO_RADIATION_THERAPY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKI_COEXPRESSED_WITH_CYP19A1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NGO_MALIGNANT_GLIOMA_1P_LOH</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEGMEIER_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WELCH_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WELCH_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIERICK_DROSOPHILA_SEROTONIN_FUNCTION_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIERICK_SEROTONIN_FUNCTION_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_TARGETS_OF_PTCH1_AND_SUFU_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_LMO4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_LMO4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_CLIM2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_CLIM2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKEY_RB1_CHRONIC_LOF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKEY_RB1_CHRONIC_LOF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKEY_RB1_ACUTE_LOF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARKEY_RB1_ACUTE_LOF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VARKI_SIALIC_ACID_BIOLOGY_HUMANS_VERSUS_OTHER_HOMINIDS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>THEODOROU_MAMMARY_TUMORIGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUI_MAPK14_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUI_MAPK14_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SENESE_HDAC3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAIRKEE_TERT_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAIRKEE_TERT_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEIER_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEIER_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEIER_GLIOMA_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEIER_GLIOMA_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEMMER_TABLE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEMMER_TABLE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEMMER_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEMMER_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_C_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_C_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_PCA1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_PCA1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_PCA3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYLAN_MULTIPLE_MYELOMA_PCA3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLEBREKERS_TABLE_5S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GU_PDEF_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GU_PDEF_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PARENT_MTOR_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PARENT_MTOR_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOOKER_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOOKER_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOOKER_GEMCITABINE_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOOKER_GEMCITABINE_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOOKER_RESPONSE_TO_BEXAROTENE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOOKER_RESPONSE_TO_BEXAROTENE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AIGNER_ZEB1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOOD_EBV_EBNA1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOOD_EBV_EBNA1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_HCP_PROSTATE_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_FIG_1D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_FIG_1D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_3_4WK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_4_5WK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_5_6WK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_6_7WK_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_TERMINAL_END_BUD_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_TERMINAL_END_BUD_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_FIG_1C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_FIG_5B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCBRYAN_TABLE_2S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JU_AGING_TERC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JU_AGING_TERC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK1_AND_MAPK2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK8_AND_MAPK9_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK7_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK11_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK14_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK12_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TURJANSKI_MAPK13_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALA_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALA_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALA_AND_RALB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALA_AND_RALB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALA_OR_RALB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OXFORD_RALA_OR_RALB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PYEON_HPV_POSITIVE_TUMORS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PYEON_HPV_POSITIVE_TUMORS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PYEON_TABLE_4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PYEON_TABLE_4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASER_ONCOGENE_TABLE_6S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASER_TUMOR_SUPPRESSOR_TABLE_6S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EBAUER_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_SKIN_TUMOR_PROMOTER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_RISK_LOW_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_RISK_LOW_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_RISK_HIGH_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_RISK_HIGH_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_PROGRESSION_RISK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EASTON_SNPS_ASSOCIATED_WITH_BREAST_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LASTOWSKA_COAMPLIFIED_WITH_MYCN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LASTOWSKA_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANG_SENESCENCE_TP53_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANG_SENESCENCE_TP53_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHINTAPALLI_DROSOPHILA TISSUES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHINTAPALLI_DROSOPHILA MELANOGASTER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOSTER_INFLAMMATORY_RESPONSE_LPS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FOSTER_INFLAMMATORY_RESPONSE_LPS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DEN_INTERACT_WITH_LCA5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANAGISAWA_LUNG_CANCER_RECURRENCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PEREZ_TP53_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PEREZ_TP63_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PEREZ_TP53_AND_TP63_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_HUMAN_ES_4D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_HUMAN_ES_4D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_HUMAN_ES_5D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_HUMAN_ES_5D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_EPISC_3D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_EPISC_3D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_EPISC_4D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_EPISC_4D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_MOUSE_ES_3D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_MOUSE_ES_3D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_MOUSE_ES_D4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_ALK_TARGETS_MOUSE_ES_D4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_JAK_TARGETS_MOUSE_ES_D3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TESAR_JAK_TARGETS_MOUSE_ES_D3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_MLL_SIGNATURE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_MLL_SIGNATURE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_MLL_SIGNATURE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_MLL_SIGNATURE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_NPM1_SIGNATURE_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MULLIGHAN_NPM1_SIGNATURE_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SUZUKI_AMPLIFIED_IN_ORAL_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_4S_NPC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_4S_NPC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_4S_MEF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_4S_MEF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_ICP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_LCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_LCP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_NPC_ICP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_NPC_WITH_LCP_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_NPC_LCP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_4S_MEF_ICP_K27</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANDHU_SNP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANDHU_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIEN_BREAST_CARCINOMA_METAPLASTIC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>THUM_SYSTOLIC_HEART_FAILURE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>THUM_SYSTOLIC_HEART_FAILURE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALCALA_APOPTOSIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_THYROID_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_THYROID_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_TABLE_4S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_TABLE_2S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_TABLE_2S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_TABLE_3S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_TABLE_3S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DELYS_TABLE_5S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KESHELAVA_MULTIPLE_DRUG_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIGNOT_RLS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OKAWA_NEUROBLASTOMA_1P36_31_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JI_METASTASIS_REPRESSED_BY_STK11</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JI_FIG_10S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JI_FIG_10S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JI_FIG_8S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEIKE_LUNG_CANCER_POOR_SURVIVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAKER_SAGA_COMPONENTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_SAGA_COMPONENTS_YEAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_ADA_COMPONENTS_YEAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_TFTC_COMPONENTS_HUMAN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_STAGA_COMPONENTS_HUMAN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_ATAC_COMPONENTS_HUMAN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_SAGA_COMPONENTS_DROSOPHILA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_PCAF_COMPONENTS_HUMAN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAGY_ATAC_COMPONENTS_DROSOPHILA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAFON_NUA3_COMPONENTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAFON_SAS_COMPONENTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAFON_NUA4_COMPONENTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTIN_INTERACT_WITH_HDAC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLIAMS_ESR1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLIAMS_ESR1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLIAMS_TABLE_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLIAMS_TABLE_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLIAMS_ESR2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLIAMS_ESR2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_HIF1A_ONLY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_ELK3_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_ELK3_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_ELK3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_ELK3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HIF1A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HIF1A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_HIF1A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_HIF1A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_ELK3_ONLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COWLING_MYCN_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCIBETTA_KDM5B_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCIBETTA_KDM5B_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANNO_HUMAN_ERYTHROBLAST_CULTURE_DAY_7_VS_DAY_14_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANNO_HUMAN_ERYTHROBLAST_CULTURE_DAY_7_VS_DAY_14_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TANNO_TGFB_SUPERFAMILY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUNNE_GENDER_EFFECT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RUNNE_GENDER_EFFECT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FALVELLA_SMOKERS_WITH_LUNG_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUYTTEN_NIPP1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUYTTEN_NIPP1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUYTTEN_EZH2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NUYTTEN_EZH2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOZGIT_ESR1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOZGIT_ESR1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROY_WOUND_BLOOD_VESSEL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROY_WOUND_BLOOD_VESSEL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WAGNER_APO2_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIXON_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIXON_TABLE_2S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIXON_TABLE_3AS_NON_MHC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DIXON_TABLE_3AS_MHC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PALOMERO_GSI_SENSITIVITY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PALOMERO_GSI_SENSITIVITY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MONTERO_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>INGRAM_SHH_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>INGRAM_SHH_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARY_CD5_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARY_CD5_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OZEN_MIR125B1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAUFFMANN_MELANOMA_RELAPSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAUFFMANN_MELANOMA_RELAPSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAUFFMANN_DNA_REPAIR_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAUFFMANN_DNA_REPLICATION_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SOUCEK_MYC_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MANTOVANI_NFKB_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MANTOVANI_NFKB_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MANTOVANI_VIRAL_GPCR_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MANTOVANI_VIRAL_GPCR_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JIANG_CORE_DUPLICON_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_XPRSS_INT_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BRCA1_PCC_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BRCA2_PCC_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_ATM_PCC_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_CHEK2_PCC_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_TABLE_4S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BCN_DIRECT_SUBNETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BRCA_CENTERED_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JEPSEN_SMRT_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAY_ALZHEIMERS_DISEASE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICE_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICE_TABLE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAKER_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAKER_HEMATOPOESIS_STAT1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAKER_HEMATOPOIESIS_STAT3_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAKER_HEMATOPOESIS_STAT5_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEKI_INFLAMMATORY_RESPONSE_LPS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SEKI_INFLAMMATORY_RESPONSE_LPS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YIN_ATF3_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HARADA_UPD_REGIONS_IN_PANCREATIC_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HARADA_COPY_NUMBER_ANALYSIS_IN_PANCREATIC_CANCER_CELLS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HARADA_COPY_NUMBER_ANALYSIS_IN_PANCREATIC_CANCER_CELLS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAZIN_EPIGENETIC_SILENCING_BY_KRAS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PIONTEK_PKD1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PIONTEK_PKD1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_GENES_SPECIFIC_TO_EXPRESSION_OF_T_UM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_ATY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_ATY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_ATY_FTA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_ATY_FTA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_ATY_PTC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_ATY_PTC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_PTC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_PTC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_PTC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_TABLE_1S_FTA_PTC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RECURRENT_LIVER_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_RECURRENT_LIVER_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZEITLINGER_SIGNAL_TRANSDUCTION_GENES_STALLED_POL2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZEITLINGER_STALLED_POL2_AT_MUSCLE_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUSE_EXPRESSION_LEVELS_CHANGED_BY_NELF-RNAI_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUSE_EXPRESSION_LEVELS_CHANGED_BY_NELF-RNAI_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALIE_TUMOR_ANGIOGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALIE_TUMOR_STEMNESS_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_PROBABLE_TARGETS_OF_MIR_145</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_PROBABLE_TARGETS_OF_MIR_143</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_PROBABLE_TARGETS_OF_MIR_368</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_PROBABLE_TARGETS_OF_MIR_497</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_PROBABLE_TARGETS_OF_MIR_218</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_PROBABLE_TARGETS_OF_MIR_200C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_INFLAMMATORY_RESPONSE_LPS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KHETCHOUMIAN_TRIM24_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KHETCHOUMIAN_TRIM24_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHWAB_TARGETS_OF_BMYB_S427G_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHWAB_TARGETS_OF_BMYB_S427G_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHWAB_TARGETS_OF_BMYB_I624M_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHWAB_TARGETS_OF_BMYB_I624M_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_NEURAL_CREST_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_NEURAL_CREST_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUIJL_KINASES_CONTROLLING_INTRACELLULAR_SALMONELA_GROWTH_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUIJL_KINASES_CONTROLLING_INTRACELLULAR_SALMONELA_GROWTH_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUNSBERGER_EXERCISE_REGULATED_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PASQUALUCCI_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PASQUALUCCI_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PHILLIPS_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILCOX_PRESPONSE_TO_ROGESTERONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILCOX_PRESPONSE_TO_ROGESTERONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NAKAYAMA_FRA2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SABATES_COLORECTAL_ADENOMA_SIZE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SABATES_COLORECTAL_ADENOMA_SIZE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SABATES_COLORECTAL_ADENOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SABATES_COLORECTAL_ADENOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EHLERS_ANEUPLOIDY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>EHLERS_ANEUPLOIDY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUO_MIRNA_GENES_CORRELATED_WITH_ESOPHAGEAL_CANCER_SURVIVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEARMAN_TUMOR_FIELD_EFFECT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEARMAN_TUMOR_FIELD_EFFECT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_TABLE_4S_AZA_DC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_TABLE_3S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_SILENCED_BY_METHYLATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_SILENCED_BY_METHYLATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_HDAC_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_HDAC_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CLAUS_PGR_POSITIVE_MENINGIOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CLAUS_PGR_POSITIVE_MENINGIOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAVAZOIE_METASTASIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLER_SNP_ASSOCIATION_WITH_HDL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLER_SNP_ASSOCIATION_WITH_LDL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILLER_SNP_ASSOCIATION_WITH_TRIGLYCERIDES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_LIPIDS_OR_LIPOPROTEINS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_LDL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_HDL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_TRIGLYCERIDES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATHIRESAN_EFFECTS_OF_LOCI_ON_MULTIPLE_LIPOPROTEIN_OR_LIPID_TRAITS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KWAN_TRANSCRIPT_ISOFORM_CHANGES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COURTOIS_SENESCENCE_TRIGGERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_MITOCHONDRIA_GENE_MODULE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_PROTEASOME_GENE_MODULE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_GAMMA_RADIATION_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_GAMMA_RADIATION_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_TABLE_4S_D0</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COATES_MACROPHAGE_M1_VS_M2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COATES_MACROPHAGE_M1_VS_M2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COATES_TABLE_3S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COATES_TABLE_3S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MBD_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPEZ_TABLE_3S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WENDT_COHESIN_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WENDT_COHESIN_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_TLX_TARGETS_36HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_TLX_TARGETS_36HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_TLX_TARGETS_60HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_TLX_TARGETS_60HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_TLX_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_TLX_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_METASTASIS_AND_RNA_PROCESSING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_METASTASIS_AND_RNA_PROCESSING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIN_MELANOMA_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIN_MELANOMA_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_RB1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_RB1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_TP53_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_TP53_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_RB1_AND_TP53_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINETTI_BREAST_CANCER_KINOME_RED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINETTI_BREAST_CANCER_KINOME_GREEN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINETTI_BREAST_CANCERS_KINOME_BLUE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINETTI_BREAST_CANCERS_KINOME_GRAY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASSARWEH_TAMOXIFEN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASSARWEH_RESPONSE_TO_ESTRADIOL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LAGUINGE_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WALLACE_TABLE_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WALLACE_TABLE_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WALLACE_PROSTATE_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WALLACE_PROSTATE_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WALLACE_PROSTATE_CANCER_RACE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WALLACE_PROSTATE_CANCER_RACE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARREIRO_GENES_WITH_STRONGEST_SIGNATURES_FOR_POSITIVE_NATURAL_SELECTION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JONES_TCOF1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_IL22_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_IL22_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AUJLA_IL22_AND_IL17A_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROPERO_HDAC2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_PROTEINS_UNIQUE_TO_AP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_PROTEINS_UNIQUE_TO_CAP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_PROTEINS_UNIQUE_TO_CP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STROMNES_TABLE_2S_BRAIN_GROUP_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STROMNES_TABLE_2S_CORD_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STROMNES_TABLE_2S_CORD_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUILLETTE_CLL_13Q14_DELETION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUILLETTE_CLL_13Q14_DELETION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YOKOE_CANCER_TESTIS_ANTIGENS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARZEC_IL2_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MARZEC_IL2_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IWANAGA_CARCINOGENESIS_BY_KRAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IWANAGA_CARCINOGENESIS_BY_KRAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BRUNEAU_SEPTATION_ATRIAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BRUNEAU_SEPTATION_VENTRICULAR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MELLMAN_TUT1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MELLMAN_TUT1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUNT_ASSOCIATION_FOR_CELIAC_DISEASE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUNT_CIS_EFFECTS_OF_CELIAC_ASSOCIATED_SNPS_ON_GENE_EXPRESSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUNT_CIS_EFFECTS_OF_CELIAC_ASSOCIATED_SNPS_ON_GENE_EXPRESSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAMPS_COLON_CANCER_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAMPS_COLON_CANCER_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZKI_TUMOR_INVASIVENESS_3D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZKI_TUMOR_INVASIVENESS_3D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZKI_TUMOR_INVASIVENESS_2D_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIZKI_TUMOR_INVASIVENESS_2D_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_FIG_1C_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_FIG_1C_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUJII_YBX1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUJII_YBX1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOUYER_TUMOR_INVASIVENESS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOUYER_TATI_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GOUYER_TATI_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_BREAST_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_NASOPHARYNGEAL_CARCINOMA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_COMMON_CANCER_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_FIG_5A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_FIG_5A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_SATB1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HAN_SATB1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OSADA_ASCL1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OSADA_ASCL1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHENG_IMPRINTED_BY_ESTRADIOL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DE_YY1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DE_YY1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BIERIE_INFLAMMATORY_RESPONSE_TGFB1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCABE_BOUND_BY_HOXC6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCABE_HOXC6_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCABE_HOXC6_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCABE_HOXC6_TARGETS_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCABE_HOXC6_TARGETS_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POS_RESPONSE_TO_HISTAMINE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POS_RESPONSE_TO_HISTAMINE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POS_HISTAMINE_RESPONSE_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_METABOLIC_SYNDROM_NETWORK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_LIVER_METABOLISM_QTL_CIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZEGGINI_T2D_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOMLINSON_SNPS_ASSOCIATED_WITH_COLORECTAL_CANCER_SUSCEPTABILITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LU_POSSIBLE_TARGET_GENES_OF_MIR_21</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAIRKEE_CANCER_PRONE_RESPONSE_E2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_SILENCED_BY_METHYLATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_METHYLATED_IN_PROSTATE_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUYANG_PROSTATE_CANCER_PROGRESSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUYANG_PROSTATE_CANCER_PROGRESSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>OUYANG_PROSTATE_CANCER_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGI_EWING_SARCOMA_PROGENITOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGI_EWING_SARCOMA_PROGENITOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGI_SUPPL_DATA_1_DBDM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGI_SUPPL_DATA_1_DBDM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGI_SUPPL_DATA_2A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGI_FIG_3C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAUTSCHI_SRC_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VICENT_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>VICENT_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENGELMANN_CANCER_PROGENITORS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENGELMANN_CANCER_PROGENITORS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WORSCHECH_TUMOR_REJECTION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WORSCHECH_TUMOR_REJECTION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WORSCHECH_TABLE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOO_LIVER_CANCER_RECURRENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOO_LIVER_CANCER_RECURRENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LETTRE_HEIGHT_ASSOCIATED_VARIANTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUDBJARTSSON_SNPS_WITH_STRONGEST_HEIGHT_ASSOCIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUDBJARTSSON_SNP_ASSOCIATION_WITH_HEIGHT_BETWEEN_10-5_AND_10-7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUDBJARTSSON_GENES_NEAR_LOCI_SHOWING_SUGGESTIVE_ASSOCIATION_WITH_HEIGHT</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEEDON_SNPS_ASSOCIATED_WITH_HEIGHT_VARIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOCKWOOD_TABLE_2S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_EMBRYONIC_STEM_CELL_CORE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WONG_ADULT_TISSUE_STEM_MODULE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UNGER_CHROMOSOMAL_CHANGES_IN_PAPILLARY_THYROID_CARCINOMAS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UNGER_ALTERATIONS_IN_RET_PTC_POSITIVE_AND_NEGATIVE_TUMORS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>UNGER_ALTERATIONS_IN_RET_PTC_POSITIVE_AND_NEGATIVE_TUMORS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TING_SILENCED_BY_DICER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOYERINAS_ONCOFETAL_TARGETS_OF_LET7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_TABLE_23S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_TABLE_23S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_METHYLATED_IN_LIVER_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOQUE_METHYLATED_IN_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NADELLA_PRKAR1A_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NADELLA_PRKAR1A_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAGIV_CD24_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAGIV_CD24_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BLEWITT_GENES_IN_MOMMED1_LINKED_INTERVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FREDERICK_PRKCI_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRANKE_SNPS_ASSOCIATED_WITH_ULCERATIVE_COLITIS_OR_CROHN'S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FISHER_SNPS_ASSOCIATED_WITH_ULCERATIVE_COLITIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_2_V_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_2_V_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FINAK_BREAST_CANCER_SDPP_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAHMAN_TP53_TARGETS_PHOSPHORYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_ES_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_ES_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_NANOG_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_OCT4_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_SOX2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_NOS_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_NOS_TARGETS_TRANSCRIPTION_FACTORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_SUZ12_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_EED_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_ES_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_PRC2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_MYC_TARGETS_WITH_EBOX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_MYC_MAX_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_PROLIFERATION_BY_GO</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_CYCLING_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_PROLIFERATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_ES_TRANSCRIPTION_REGULATORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_ES_CORE_NINE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BENPORATH_ES_CORE_NINE_CORRELATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_CARDIAC_HYPERTROPHY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_BLOOD_PRESSURE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_BLOOD_PRESSURE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_HEART_MASS_QTL_CIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_HEART_MASS_QTL_CIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEHMOARAS_TABLE_1S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BEHMOARAS_TABLE_1S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_LUMINAL_B_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_LUMINAL_B_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_LUMINAL_A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_LUMINAL_A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_ERBB2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_ERBB2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_NORMAL_LIKE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_NORMAL_LIKE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_BASAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SMID_BREAST_CANCER_BASAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUMAMOTO_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ITO_PTTG1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ITO_PTTG1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LE_SKI_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LE_SKI_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILI_PSEUDOPODIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILI_PSEUDOPODIA_CHEMOTAXIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHAMBERS_SNPS_ASSOCIATED_WITH_INSULIN_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUELLER_X_LINKED_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUELLER_X_LINKED_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_8HR_5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_8HR_5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_8HR_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_8HR_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_24HR_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_24HR_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_24HR_5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAFFAREL_RESPONSE_TO_THC_24HR_5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STARK_HYPPOCAMPUS_22Q11_DELETION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STARK_HYPPOCAMPUS_22Q11_DELETION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STARK_BRAIN_22Q11_DELETION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STARK_TABLE_3S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZON_HSC_DEVELOPMENTAL_REGULATORS_AND_SELF-RENEWAL_FACTORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEHRA_FIG_1AS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KURLAND_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_TARGETS_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_TARGETS_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_TARGETS_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_TARGETS_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_TARGETS_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_TARGETS_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ONDER_CDH1_SIGNALING_VIA_CTNNB1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZEILSTRA_CD44_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZEILSTRA_CD44_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PUCA_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOEPER_IKZF1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CONNEROTTE_TABLE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GUDBJARTSSON_PIGMENTATION_VARIANTS_ASSOCIATED_WITH_CM_OR_SKIN_CANCERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SULEM_ASSOCIATION_WITH_PIGMENTATION_CHARACTERISTICS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_TO_EYE_COLOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_TO_HAIR_COLOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_WITH_SKIN_SENSITIVITY_TO_SUN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_TABLE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_PROSTATE_CANCER_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_COLON_CANCER_HCP_WITH_H3K27ME1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_COLON_CANCER_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KONDO_EZH2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAKAMOTO_SNPS_ASSOCIATED_WITH_GASTRIC_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIAO_HAVE_SOX4_BINDING_SITES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIAO_METASTASIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEI_MIR34A_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WEI_MYCN_TARGETS_WITH_E_BOX</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DUBOIS_ULCERATIVE_COLITIS_ASSOCIATED_REGIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_PLURIPOTENT_STATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_PLURIPOTENT_STATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_DEDIFFERENTIATED_STATE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_DEDIFFERENTIATED_STATE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_ICP_BIV</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_LCP_BIV</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_MCV81_HCP_K27</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_ICP_K27</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_LCP_K27</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_ICP_K4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_LCP_K4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_TABLE_2S_ES_HCP_NONE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MCV6_ICP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MCV6_LCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_MEF_LCP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_LCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MIKKELSEN_IPS_LCP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_2S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_2S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_4S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>XU_TABLE_4S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CERVERA_FIG_4C_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CERVERA_FIG_4C_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CERVERA_SDHB_TARGETS_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CERVERA_SDHB_TARGETS_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CERVERA_SDHB_TARGETS_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROZANOV_MMP14_TARGETS_SUBSET</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROZANOV_MMP14_CORRELATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROZANOV_MMP14_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ROZANOV_MMP14_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KARP_FIG_2B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_LIVER_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LEE_LIVER_CANCER_TOP50</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MISHRA_UP_IN_NAIVE_MESENCHYMAL_STEM_CELLS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANGIORGI_COPY_NUMBER_POLYMORPHISMS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SANGIORGI_COPY_NUMBER_POLYMORPHISMS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_GATA6_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_GATA6_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HASEGAWA_TUMORIGENESIS_BY_RET_C634R</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SUH_COEXPRESSED_WITH_ID1_AND_ID2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHOEN_NFKB_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_BREAST_CANCER_PROGENITORS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOTTON_RUNX_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WOTTON_RUNX_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KERKEL_SEQUENCE_DEPENDENCE_OF_ASM_AT_SNP_TAGGED_LOCI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUJIWARA_PARK2_IN_LIVER_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FUJIWARA_PARK2_IN_LIVER_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PHAROAH_ASSOCIATIONS_WITH_PIGMENTATION_CM_AND_BCC</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ALLEN_POLYMORPHISMS_SHOWING_SUMMARY_ORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRETT_CD_RISK_LOCI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRETT_CROHN'S_RISK_LOCI_WITH_CORRELATED_NONSYNONYMOUS_SNP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARRETT_CIS-EQTL_EFFECTS_FOR_CD_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUANG_FOXA2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HUANG_FOXA2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_TABLE_2S_5002</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_TABLE_2S_5002_ZN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_TABLE_2S_5002_ZN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_FC_5002_VS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_FC_5002_VS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_FC_5003_VS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAGDA_FC_5003_VS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZENG_RESPONSE_TO_ID8_SUPERNATENT_VERSUS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZENG_RESPONSE_TO_ID8_SUPERNATENT_VERSUS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZENG_RESPONSE_TO_ID8_TUMOR_VERSUS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZENG_RESPONSE_TO_ID8_TUMOR_VERSUS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZENG_RESPONSE_TO_ID8_IRRADIATED_TUMOR_VERSUS_CONTROL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZENG_RESPONSE_TO_ID8_IRRADIATED_TUMOR_VERSUS_CONTROL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_BASAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_CELLULAR_IMMUNSYSTEM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_HUMORAL_IMMUNSYSTEM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_INTERFERON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_PROLIFERATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_ESTROGEN_RECEPTOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_CHR_17</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_STROMAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_NORMAL_LIKE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_JUN-FOS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHMIDT_TRANSCRIPTION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_ES_ICP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_ICP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_BRAIN_HCP_WITH_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_BRAIN_ICP_WITH_H3K4ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_NPC_HCP_WITH_H3K4ME2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALI_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALI_TP53_TARGETS_APOPTOTIC_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GALI_TP53_TARGETS_APOPTOTIC_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOSERLE_IFNA_RESPONSE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MOSERLE_TABLE_4S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCGARVEY_TABLE_2S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GAURNIER_PSMD4_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCGOWAN_RSP6_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCGOWAN_RSP6_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD D</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD F</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD G</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD H</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METHOD J</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METHOD K</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 35</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 69</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 40</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 41</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 74</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 79</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 19</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 86</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_SUPPL. DATA 1: METAGENE 31</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_GENES_USED_TO_CLASSIFY_METHOD_B_RISK</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOCHKIS_MODEL_FOR_HEPATIC_BILE_ACID_HOMEOSTASIS_BY_FOXA2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BOCHKIS_FOXA2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TONG_INTERACT_WITH_PTTG1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAEK_PROTEINS_DERIVED_FROM_MESSAGES_WITH_7-8MER_39-UTR_SITE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAEK_PROTEINS_DERIVED_FROM_MESSAGES_WITH_7-8MER_39-UTR_SITE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDEMAINE_LUNG_METASTASIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LANDEMAINE_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMBS_TABLE_1S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>AMBS_TABLE_2S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHANG_POU5F1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHANG_POU5F1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_PROSTATE_CANCER_RELATED_GENES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_PROSTATE_CANCER_RELATED_GENES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_INFLAMMATION_RELATED_GENES_IN_PROSTATE_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_INFLAMMATION_RELATED_GENES_IN_PROSTATE_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_GENES_IN_NETWORK_2_AND_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_GENES_IN_NETWORK_2_AND_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_VAV3_TARGETS_AND_NF-KAPPA-B_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_VAV3_PROSTATE_CARCINOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_INFLAMMATION_RELATED_GENES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_INFLAMMATION_RELATED_GENES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_NETWORK_2_AND_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_NETWORK_2_AND_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STONER_ESOPHAGEAL_CARCINOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STONER_ESOPHAGEAL_CARCINOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>O'DONOVAN_SCHIZOPHRENIA_ASSOCIATION_LOCI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TABLE_3S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_HEAD_AND_NECK_CANCER_A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_HEAD_AND_NECK_CANCER_B</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_HEAD_AND_NECK_CANCER_C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_HEAD_AND_NECK_CANCER_D</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_HEAD_AND_NECK_CANCER_E</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_HEAD_AND_NECK_CANCER_F</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RICKMAN_TABLE_9S</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRISHNAN_FURIN_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRISHNAN_FURIN_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOUGLAS_TABLE_1BS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOUGLAS_TABLE_1BS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOUGLAS_BMI1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DOUGLAS_BMI1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>REN_ALVEOLAR_RHABDOMYOSARCOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRIGE_AMINO_ACID_DEPRIVATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GHO_ATF5_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GHO_ATF5_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YASUDA_DIABETES_MELLITUS_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRIDMAN_SENESCENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRIDMAN_SENESCENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRIDMAN_IMMORTALIZATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FRIDMAN_IMMORTALIZATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ISHIKAWA_STING_SIGNALING</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MUELLER_PLURINET</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HONMA_DOCETAXEL_RESISTANCE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WU_CELL_MIGRATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAUCH_SUPPLEMENTARY_FILE_1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAUCH_SUPPLEMENTARY_FILE_1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAUCH_HEDGEHOG_PARACRINE_SIGNALING_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAUCH_HEDGEHOG_PARACRINE_SIGNALING_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_PANCREATIC_EXOCRINE_PROGENITOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHOU_PANCREATIC_BETA_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_CYTIDINE_ANALOGS_CYCTOTOXICITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LI_CYTIDINE_ANALOG_PATHWAY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KIM_LRRC3B_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERNARD_PPAPDC1B_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BERNARD_PPAPDC1B_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KUGATHASAN_INFLAMMATORY_BOWEL_DISEASE_ASSOCIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TAGHAVI_NEOPLASTIC_TRANSFORMATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_ALTERATIONS_IDENTIFIED_BY_RAE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_ALTERATIONS_IDENTIFIED_BY_RAE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_GTS_DEFINED_REGIONS_OF_INFORMATIVE_CNAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_GTS_DEFINED_REGIONS_OF_INFORMATIVE_CNAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TCGA_GLIOBLASTOMA_MUTATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPES_METHYLATED_IN_COLON_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LOPES_METHYLATED_IN_COLON_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_TABLE_3S_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_MUC2_TARGETS_DUODENUM_3MO_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_MUC2_TARGETS_DUODENUM_3MO_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_MUC2_TARGETS_DUODENUM_6MO_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_MUC2_TARGETS_DUODENUM_6MO_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_MUC2_TARGETS_COLON_3MO_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_MUC2_TARGETS_COLON_3MO_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_TABLE_3S_2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_TABLE_3S_2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_TABLE_3S_3_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YANG_TABLE_3S_3_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RAYCHAUDHURI_SNPS_ASSOCIATED_WITH_RHEUMATOID_ARTHRITIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOPP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_ASSOCIATED_VARIANTS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BARTON_RHEUMATOID_ARTHRITIS_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FIRESTEIN_CTNNB1_PATHWAY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>FIRESTEIN_PROLIFERATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WILENSKY_RESPONSE_TO_DARAPLADIB</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIN_NPAS4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIN_NPAS4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAZAN-MAMCZARZ_QIN_TABLE_2S_HUR_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAZAN-MAMCZARZ_QIN_TABLE_2S_HUR_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MAZAN-MAMCZARZ_TABLE_2S_AUF1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAKSCH_TABLE_1S_CACO2_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAKSCH_TABLE_1S_CACO2_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAKSCH_TABLE_1S_WM115_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JAKSCH_TABLE_1S_WM115_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SINGH_NFE2L2_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIU_FN1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CONRAD_STEM_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CONRAD_GERMLINE_STEM_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CADWELL_ATG16L1_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CADWELL_ATG16L1_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATTAH_SURFACE_MARKERS_ASSOCIATED_WITH_ACTIVATED_OR_RESTING_T_CELLS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KATTAH_SAM-IDENTIFIED_MARKERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHIANG_COEXPRESSIONS_OF_UPSTREAM_EFFECTORS_AND_COX2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTER_I-1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTER_I-2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTERS_II_III_IV</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTERS_I_II_III-1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTERS_I_II_III-2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTERS_II_IV</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTER_III-1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTER_III-2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTER_IV-1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_CLUSTER_IV_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_PRE_BI_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_PRE_BI_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_LARGE_PRE_BII_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_LARGE_PRE_BII_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_SMALL_PRE_BII_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_SMALL_PRE_BII_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_IMMATURE_B_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_IMMATURE_B_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_MATURE_B_LYMPHOCYTE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_MATURE_B_LYMPHOCYTE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_PLASMA_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_PLASMA_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_SURVIVAL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_SURVIVAL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BONCI_TARGETS_OF_MIR15A_AND_MIR16_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_HIGHLY_MUTATED_GENES_SHOW_COPY_NUMBER_VARIATIONS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_LUNG_CANCER_MUTATED_FREQUENTLY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_MUTATED_GENES_IN_LUNG_ADENOCARCINOMAS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_COPY_NUMBER_AND_EXPRESSION_CORRELATION_IN_HIGHLY_MUTATED_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_MUTATION_AND_COPY_NUMBER_CHANGE_CORRELATION_IN_LUNG_ADENOCARCINOMAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_MUTATION_AND_COPY_NUMBER_CHANGE_CORRELATION_IN_LUNG_ADENOCARCINOMAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_MUTATION_AND_EXPRESSION_CORRELATION_IN_LUNG_ADENOCARCINOMAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_MUTATION_AND_EXPRESSION_CORRELATION_IN_LUNG_ADENOCARCINOMAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_LANG_CANCER_MUTATED</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_LUNG_CANCER_MUTATED_RECURRENTLY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>DING_LUNG_CANCER_BY_MUTATION_RATE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHENG_GLIOBLASTOMA_PLASTICITY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESRRA_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESRRA_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_TABLE_2S_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_TABLE_2S_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESR1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESRRA_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGINS_FIG_6A</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGINS_TAMOXIFEN_RESISTANCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>RIGGINS_TAMOXIFEN_RESISTANCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YEGNASUBRAMANIAN_PROSTATE_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COOPER_TYPE_1_DIABETES_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>COOPER_TYPE_1_DIABETES_ASSOCIATED_SNPS_EXCLUDING_KNOWN_LOCI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOYAMA_SEMA3B_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KOYAMA_SEMA3B_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_OVULATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_CUMULUS_EXPANSION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_FERTILIZATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_MATERNAL_EFFECT</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_IMPLANTATION_AND_UTERINE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_POST-IMPLANTATION_AND_POST-PARTUM</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_STEROIDOGENESIS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_MEIOTIC_AND_DNA_REPAIR</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_CENTRAL_FOR_FEMALE_FERTILITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_EMBRYONIC_GERM_CELL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_EARLY_ANTRAL_FOLLICLE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_SECONDARY_FOLLICLE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_PRIMARY_FOLLICLE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_PRIMORDIAL_FOLLICLE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_LUTEAL_GENES</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_PREOVULATORY_FOLLICLE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_MALE_REPRODUCTION_SERTOLI</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_SPERMATOGONIA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_SPERMATOCYTE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_SPERMATID_DIFFERENTIATION</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_SPERMATOZOA</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_GENETIC_MODEL_OF_MALE_REPRODUCTIVE_DEFECTS_IN_MICE_OTHER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>MATZUK_MALE_REPRODUCTIVE_DISORDERS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_3</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_4</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_5</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_6</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_7</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_8</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_9</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHIN_B_CELL_LYMPHOMA_CLUSTER_10</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAFNA_MUC4_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>BAFNA_MUC4_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ABOLHASSANI_FIG_1C</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_5P15_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_7P22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_7P15_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_16P13_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_17P11_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_19P13_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_20P13_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_20P12_P11_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOULSTON_COLORECTAL_CANCER_ASSOCIATED_SNPS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAO_ADAPTIVE_YEAST_CLONE_GENOTYPE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAO_EXPRESSION_CHANGED_IN_ACTIVATED_GPA2_AND_RAS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>KAO_EXPRESSION_CHANGED_IN_ACTIVATED_GPA2_AND_RAS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHUNG_BLISTER_CYTOTOXICITY_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHUNG_BLISTER_CYTOTOXICITY_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>THUM_MIR-21_TARGETS_IN_HEART</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>THUM_MIR21_TARGETS_HEART_DISEASE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>THUM_MIR21_TARGETS_HEART_DISEASE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JEON_SMAD6_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>JEON_SMAD6_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERRERO_EXPRESSION_EFFECTS_OF_PM02734_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HERRERO_EXPRESSION_EFFECTS_OF_PM02734_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SUNG_METASTASIS_STROMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SUNG_METASTASIS_STROMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_HYPOXIA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_HYPOXIA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_LACTIC_ACIDOSIS_RESPONSE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_LACTIC_ACIDOSIS_RESPONSE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_INVASIVENESS_GENE_SIGNATURE</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CHEN_WOUND_HEALING_SIGNATURE_CORRELATING_WITH_TUMORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR_PROGNOSIS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR_PROGNOSIS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_HEPATOBLASTOMA_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_HEPATOBLASTOMA_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_HEPATOBLASTOMA_CLASSES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_HEPATOBLASTOMA_CLASSES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_LIVER_DEVELOPMENT_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_LIVER_DEVELOPMENT_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>POTTIER_CORTICOSTEROID_SENSITIVITY</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HARRIS_BRAIN_CANCER_PROGENITORS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GEORGES_CELL_CYCLE_MIR192_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HILLION_HMGA1_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HILLION_HMGA1B_TARGETS</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEN_SMARCA2_TARGETS_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SHEN_SMARCA2_TARGETS_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>ENJUANES_SNPS_ASSOCIATED_WITH_RISK_OF_CLL</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YAMASHITA_LIVER_CANCER_STEM_CELL_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td> | ||
+ | </tr> | ||
+ | <tr height="16"> | ||
+ | <td height="16" class="xl25">—</td> | ||
+ | <td>HOSHIDA_LIVER_CANCER_SUBCLASS_S3</td> | ||
</tr> | </tr> | ||
+ | <!--EndFragment--> | ||
</tbody> | </tbody> | ||
</table> | </table> |
Revision as of 10:25, 2 August 2010
<a href="http://www.broadinstitute.org/gsea/">GSEA Home</a> | <a href="http://www.broadinstitute.org/gsea/downloads.jsp">Downloads</a> | <a href="http://www.broadinstitute.org/gsea/msigdb/">Molecular Signatures Database</a> | Documentation | <a href="http://www.broadinstitute.org/gsea/contact.jsp">Contact</a>
Gene set names are case insensitive. In MSigDB v2, all gene set names are uppercase.
<meta content="text/html; charset=utf-8" http-equiv="Content-Type" />
<meta content="Excel.Sheet" name="ProgId" />
<meta content="Microsoft Excel 2008" name="Generator" />
<link href="file://localhost/Users/judymcla/Library/Caches/TemporaryItems/msoclip/0/clip.htm" rel="Main-File" id="Main-File" /> <style type="text/css">
</style>
<a name="RANGE!A1:B12">v2.5_name or status</a> |
v3.0_name or status |
CMV_ALL_UP | ZHU_CMV_ALL_UP |
CMV_8HRS_DN | ZHU_CMV_8_HR_DN |
CMV_24HRS_DN | ZHU_CMV_24_HR_DN |
CMV_ALL_DN | ZHU_CMV_ALL_DN |
CMV_24HRS_UP | ZHU_CMV_24_HR_UP |
CMV_8HRS_UP | ZHU_CMV_8_HR_UP |
— | DER_IFN_ALPHA_RESPONSE_UP |
DER_IFNB_DN | DER_IFN_BETA_RESPONSE_DN |
DER_IFNB_UP | DER_IFN_BETA_RESPONSE_UP |
DER_IFNG_DN | DER_IFN_GAMMA_RESPONSE_DN |
DER_IFNG_UP | DER_IFN_GAMMA_RESPONSE_UP |
IFN_ALL_UP | Deprecated |
IFN_BETA_UP | Deprecated |
IFN_ANY_UP | Deprecated |
IFN_GAMMA_UP | Deprecated |
IFN_ALPHA_UP | Deprecated |
DER_IFNA_UP | DER_IFN_ALPHA_RESPONSE_DN |
CALRES_MOUSE_UP | LEE_CALORIE_RESTRICTION_MUSCLE_UP |
AGED_MOUSE_MUSCLE_DN | LEE_AGING_MUSCLE_DN |
CALRES_MOUSE_DN | LEE_CALORIE_RESTRICTION_MUSCLE_DN |
AGED_MOUSE_MUSCLE_UP | LEE_AGING_MUSCLE_UP |
GOLUB_ALL_VS_AML_UP | GOLUB_ALL_VS_AML_UP |
GOLUB_ALL_VS_AML_DN | GOLUB_ALL_VS_AML_DN |
BRCA1_SW480_DN | MACLACHLAN_BRCA1_TARGETS_DN |
BRCA1_SW480_UP | MACLACHLAN_BRCA1_TARGETS_UP |
COLLER_MYC_UP | COLLER_MYC_TARGETS_UP |
COLLER_MYC_DN | COLLER_MYC_TARGETS_DN |
HG_PROGERIA_DN | LY_AGING_PREMATURE_DN |
MIDDLEAGE_UP | LY_AGING_MIDDLE_UP |
OLDAGE_DN | LY_AGING_OLD_DN |
MIDDLEAGE_DN | LY_AGING_MIDDLE_DN |
— | LY_AGING_OLD_UP |
— | LY_AGING_PREMATURE_UP |
HPV31_DN | CHANG_IMMORTALIZED_BY_HPV31_DN |
HPV31_UP | CHANG_IMMORTALIZED_BY_HPV31_UP |
AGED_MOUSE_NEOCORTEX_DN | LEE_AGING_NEOCORTEX_DN |
CALRES_MOUSE_NEOCORTEX_UP | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP |
AGED_MOUSE_CEREBELLUM_DN | LEE_AGING_CEREBELLUM_DN |
AGED_MOUSE_NEOCORTEX_UP | LEE_AGING_NEOCORTEX_UP |
AGED_MOUSE_CEREBELLUM_UP | LEE_AGING_CEREBELLUM_UP |
CALRES_MOUSE_NEOCORTEX_DN | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN |
HDACI_COLON_CURSUL_DN | Deprecated |
HDACI_COLON_TSA_UP | Deprecated |
HDACI_COLON_SUL48HRS_DN | Deprecated |
HDACI_COLON_TSA48HRS_UP | Deprecated |
HDACI_COLON_TSABUT_DN | Deprecated |
HDACI_COLON_CLUSTER7 | MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7 |
HDACI_COLON_SUL12HRS_DN | Deprecated |
HDACI_COLON_SUL_DN | Deprecated |
HDACI_COLON_CLUSTER8 | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8 |
HDACI_COLON_CURSUL_UP | Deprecated |
HDACI_COLON_SUL30MIN_DN | Deprecated |
HDACI_COLON_CUR48HRS_UP | Deprecated |
HDACI_COLON_BUT30MIN_DN | Deprecated |
HDACI_COLON_TSA2HRS_UP | Deprecated |
HDACI_COLON_SUL_UP | Deprecated |
HDACI_COLON_BUT_UP | Deprecated |
HDACI_COLON_CUR12HRS_UP | Deprecated |
HDACI_COLON_BUT2HRS_DN | Deprecated |
HDACI_COLON_CLUSTER10 | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN |
HDACI_COLON_CUR24HRS_DN | Deprecated |
HDACI_COLON_SUL16HRS_DN | Deprecated |
HDACI_COLON_SUL24HRS_DN | Deprecated |
HDACI_COLON_CLUSTER9 | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP |
HDACI_COLON_SUL12HRS_UP | Deprecated |
HDACI_COLON_TSA24HRS_DN | Deprecated |
HDACI_COLON_BUT48HRS_DN | Deprecated |
HDACI_COLON_BUT16HRS_UP | Deprecated |
HDACI_COLON_BUT24HRS_DN | Deprecated |
HDACI_COLON_CLUSTER4 | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4 |
HDACI_COLON_CUR16HRS_DN | Deprecated |
HDACI_COLON_BUT16HRS_DN | Deprecated |
HDACI_COLON_TSA12HRS_UP | Deprecated |
HDACI_COLON_CUR_DN | Deprecated |
HDACI_COLON_SUL16HRS_UP | Deprecated |
HDACI_COLON_SUL2HRS_UP | Deprecated |
HDACI_COLON_CLUSTER5 | MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5 |
HDACI_COLON_CUR2HRS_UP | Deprecated |
HDACI_COLON_SUL2HRS_DN | Deprecated |
HDACI_COLON_BUT12HRS_UP | Deprecated |
HDACI_COLON_BUT12HRS_DN | Deprecated |
HDACI_COLON_TSA_DN | Deprecated |
HDACI_COLON_BUT2HRS_UP | Deprecated |
HDACI_COLON_CUR_UP | Deprecated |
HDACI_COLON_CUR24HRS_UP | Deprecated |
HDACI_COLON_BUT48HRS_UP | Deprecated |
HDACI_COLON_CLUSTER6 | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 |
HDACI_COLON_SUL24HRS_UP | Deprecated |
HDACI_COLON_TSA2HRS_DN | Deprecated |
HDACI_COLON_SUL48HRS_UP | Deprecated |
HDACI_COLON_BUT_DN | Deprecated |
HDACI_COLON_TSABUT_UP | Deprecated |
HDACI_COLON_TSA30MIN_DN | Deprecated |
HDACI_COLON_BUT24HRS_UP | Deprecated |
HDACI_COLON_TSA48HRS_DN | Deprecated |
— | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1 |
— | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2 |
— | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_3 |
PARP_KO_DN | SIMBULAN_PARP1_TARGETS_UP |
PARP_KO_UP | SIMBULAN_PARP1_TARGETS_DN |
NADLER_OBESITY_UP | NADLER_OBESITY_UP |
NADLER_OBESITY_DN | NADLER_OBESITY_DN |
NADLER_OBESITY_HYPERGLYCEMIA | NADLER_HYPERGLYCEMIA_AT_OBESITY |
CORTEX_ENRICHMENT_EARLY_UP | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP |
CORTEX_ENRICHMENT_LATE_UP | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP |
— | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN |
— | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_DN |
DNMT1_KO_UP | JACKSON_DNMT1_TARGETS_UP |
DNMT1_KO_DN | JACKSON_DNMT1_TARGETS_DN |
SCHUMACHER_MYC_DN | SCHUHMACHER_MYC_TARGETS_DN |
SCHUMACHER_MYC_UP | SCHUHMACHER_MYC_TARGETS_UP |
AGED_MOUSE_CORTEX_UP | JIANG_AGING_CEREBRAL_CORTEX_UP |
AGED_MOUSE_HYPOTH_DN | JIANG_AGING_HYPOTHALAMUS_DN |
AGED_MOUSE_CORTEX_DN | JIANG_AGING_CEREBRAL_CORTEX_DN |
AGED_MOUSE_HYPOTH_UP | JIANG_AGING_HYPOTHALAMUS_UP |
BREASTCA_THREE_CLASSES | HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC |
BREASTCA_TWO_CLASSES | HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 |
HOHENKIRK_MONOCYTE_DEND_UP | LENAOUR_DENDRITIC_CELL_MATURATION_UP |
HOHENKIRK_MONOCYTE_DEND_DN | LENAOUR_DENDRITIC_CELL_MATURATION_DN |
TGFBETA_ALL_UP | Deprecated |
TGFBETA_C2_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C2 |
TGFBETA_C1_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C1 |
TGFBETA_C5_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C5 |
TGFBETA_EARLY_UP | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 |
TGFBETA_LATE_UP | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 |
TGFBETA_C4_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C4 |
TGFBETA_C3_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C3 |
— | VERRECCHIA_RESPONSE_TO_TGFB1_C6 |
CALRES_RHESUS_DN | KAYO_CALORIE_RESTRICTION_MUSCLE_DN |
AGED_RHESUS_UP | KAYO_AGING_MUSCLE_UP |
AGED_RHESUS_DN | KAYO_AGING_MUSCLE_DN |
CALRES_RHESUS_UP | KAYO_CALORIE_RESTRICTION_MUSCLE_UP |
E2F1_DNA_UP | KALMA_E2F1_TARGETS |
BRCA1_MES_UP | APRELIKOVA_BRCA1_TARGETS |
KANNAN_P53_UP | KANNAN_TP53_TARGETS_UP |
KANNAN_P53_DN | KANNAN_TP53_TARGETS_DN |
GH_IGF_CHONDROCYTES_UP | Deprecated |
HYPOPHYSECTOMY_RAT_UP | Deprecated |
HYPOPHYSECTOMY_RAT_DN | Deprecated |
GH_HYPOPHYSECTOMY_RAT_UP | Deprecated |
GH_HYPOPHYSECTOMY_RAT_DN | Deprecated |
— | ISHIDA_E2F_TARGETS |
BUT_TSA_UP | DELLA_RESPONSE_TO_TSA_AND_BUTYRATE |
HIPPOCAMPUS_DEVELOPMENT_POSTNATAL | MODY_HIPPOCAMPUS_POSTNATAL |
HIPPOCAMPUS_DEVELOPMENT_NEONATAL | MODY_HIPPOCAMPUS_NEONATAL |
HIPPOCAMPUS_DEVELOPMENT_PRENATAL | MODY_HIPPOCAMPUS_PRENATAL |
HBX_NL_DN | WU_HBX_TARGETS_2_DN |
HBX_HCC_DN | WU_HBX_TARGETS_1_DN |
HBX_HEP_UP | WU_HBX_TARGETS_3_UP |
HBX_HEP_DN | WU_HBX_TARGETS_3_DN |
HBX_HCC_UP | WU_HBX_TARGETS_1_UP |
HBX_NL_UP | WU_HBX_TARGETS_2_UP |
LIAN_MYELOID_DIFF_RECEPTORS | Deprecated |
LIAN_MYELOID_DIFF_TF | Deprecated |
LIAN_MYELOID_DIFF_GRANULE | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS |
HOFMANN_MANTEL_LYMPHOMA_VS_LYMPH_NODES_DN | HOFMANN_CELL_LYMPHOMA_DN |
HOFMANN_MANTEL_LYMPHOMA_VS_LYMPH_NODES_UP | HOFMANN_CELL_LYMPHOMA_UP |
DSRNA_DN | GEISS_RESPONSE_TO_DSRNA_DN |
DSRNA_UP | GEISS_RESPONSE_TO_DSRNA_UP |
NAKAJIMA_MCSMBP_EOS | NAKAJIMA_EOSINOPHIL |
NAKAJIMA_MCSMBP_MAST | NAKAJIMA_MAST_CELL |
BRG1_SW13_UP | LIU_SMARCA4_TARGETS |
HIF1_TARGETS | SEMENZA_HIF1_TARGETS |
LIN_WNT_UP | LIN_APC_TARGETS |
UVB_NHEK4_6HRS_DN | MURAKAMI_UV_RESPONSE_6HR_DN |
UVB_NHEK4_6HRS_UP | MURAKAMI_UV_RESPONSE_6HR_UP |
UVB_NHEK4_24HRS_DN | MURAKAMI_UV_RESPONSE_24HR |
— | MURAKAMI_UV_RESPONSE_1HR_UP |
— | MURAKAMI_UV_RESPONSE_1HR_DN |
IGF1_NIH3T3_UP | Deprecated |
INSULIN_NIH3T3_UP | Deprecated |
GRAEBER_BETA2_INTEGRINS | Deprecated |
CMV_HCMV_TIMECOURSE_20HRS_UP | BROWNE_HCMV_INFECTION_20HR_UP |
CMV_HCMV_TIMECOURSE_16HRS_UP | BROWNE_HCMV_INFECTION_16HR_UP |
CMV_HCMV_TIMECOURSE_1HR_DN | Deprecated |
UV-CMV_UNIQUE_HCMV_6HRS_DN | Deprecated |
CMV_UV-CMV_COMMON_HCMV_6HRS_DN | Deprecated |
CMV_HCMV_TIMECOURSE_16HRS_DN | BROWNE_HCMV_INFECTION_16HR_DN |
CMV_HCMV_TIMECOURSE_10HRS_DN | BROWNE_HCMV_INFECTION_10HR_DN |
CMV_HCMV_TIMECOURSE_ALL_UP | Deprecated |
CMV_HCMV_TIMECOURSE_24HRS_DN | BROWNE_HCMV_INFECTION_24HR_DN |
CMV_HCMV_TIMECOURSE_14HRS_DN | BROWNE_HCMV_INFECTION_14HR_DN |
IFNA_HCMV_6HRS_UP | BROWNE_INTERFERON_RESPONSIVE_GENES |
CMV_HCMV_TIMECOURSE_8HRS_UP | BROWNE_HCMV_INFECTION_8HR_UP |
CMV_HCMV_TIMECOURSE_20HRS_DN | BROWNE_HCMV_INFECTION_20HR_DN |
CMV-CHX_HCMV_6HRS_DN | Deprecated |
CMV_HCMV_TIMECOURSE_48HRS_DN | BROWNE_HCMV_INFECTION_48HR_DN |
CMV_HCMV_TIMECOURSE_48HRS_UP | BROWNE_HCMV_INFECTION_48HR_UP |
CMV_HCMV_TIMECOURSE_8HRS_DN | BROWNE_HCMV_INFECTION_8HR_DN |
CMV_HCMV_TIMECOURSE_14HRS_UP | BROWNE_HCMV_INFECTION_14HR_UP |
CMV_UV-CMV_COMMON_HCMV_6HRS_UP | Deprecated |
CMV-UV_HCMV_6HRS_UP | Deprecated |
CMV_HCMV_TIMECOURSE_18HRS_DN | BROWNE_HCMV_INFECTION_18HR_DN |
IFNA_UV-CMV_COMMON_HCMV_6HRS_UP | IFNA_UV-CMV_COMMON_HCMV_6HRS_UP |
CMV_HCMV_TIMECOURSE_18HRS_UP | BROWNE_HCMV_INFECTION_18HR_UP |
UV-CMV_UNIQUE_HCMV_6HRS_UP | Deprecated |
CMV_HCMV_TIMECOURSE_10HRS_UP | BROWNE_HCMV_INFECTION_10HR_UP |
CMV_HCMV_TIMECOURSE_12HRS_UP | BROWNE_HCMV_INFECTION_12HR_UP |
CMV_HCMV_6HRS_UP | BROWNE_HCMV_INFECTION_6HR_UP |
CMV_HCMV_TIMECOURSE_6HRS_DN | Deprecated |
CMV_HCMV_TIMECOURSE_24HRS_UP | BROWNE_HCMV_INFECTION_24HR_UP |
CMV_HCMV_TIMECOURSE_4HRS_DN | Deprecated |
CMV_HCMV_6HRS_DN | BROWNE_HCMV_INFECTION_6HR_DN |
CMV-UV_HCMV_6HRS_DN | Deprecated |
CMV_HCMV_TIMECOURSE_12HRS_DN | BROWNE_HCMV_INFECTION_12HR_DN |
CMV_HCMV_TIMECOURSE_ALL_DN | Deprecated |
— | BROWNE_HCMV_INFECTION_30MIN_UP |
— | BROWNE_HCMV_INFECTION_30MIN_DN |
— | BROWNE_HCMV_INFECTION_1HR_UP |
— | BROWNE_HCMV_INFECTION_1HR_DN |
— | BROWNE_HCMV_INFECTION_2HR_UP |
— | BROWNE_HCMV_INFECTION_2HR_DN |
— | BROWNE_HCMV_INFECTION_4HR_UP |
— | BROWNE_HCMV_INFECTION_4HR_DN |
ICF_UP | EHRLICH_ICF_SYNDROM_UP |
ICF_DN | EHRLICH_ICF_SYNDROM_DN |
ET743PT650_COLONCA_DN | MARTINEZ_RESPONSE_TO_TRABECTEDIN |
HSIAO_LIVER_SPECIFIC_GENES | HSIAO_LIVER_SPECIFIC_GENES |
— | HSIAO_HOUSEKEEPING_GENES |
HOFFMANN_BIVSBII_LGBII | Deprecated |
HOFFMANN_BIVSBII_BI | Deprecated |
HOFFMANN_BIVSBII_IMVM | Deprecated |
HOFFMANN_BIVSBII_BI_TABLE2 | Deprecated |
— | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP |
— | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN |
— | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP |
— | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN |
— | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP |
— | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN |
— | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP |
— | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN |
PARK_HSC_VS_MPP_DN | PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN |
PARK_HSC_VS_MPP_UP | PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP |
PARK_MSCS_BOTH | PARK_HSC_MARKERS |
PARK_MSCS_DIFF | PARK_HSC_AND_MULTIPOTENT_PROGENITORS |
PARK_MSCS_LIN2 | Deprecated |
SHIPP_DLBCL_CURED_DN | SHIPP_DLBCL_CURED_VS_FATAL_DN |
SHIPP_DLBCL_CURED_UP | SHIPP_DLBCL_CURED_VS_FATAL_UP |
SHIPP_FL_VS_DLBCL_DN | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN |
SHIPP_FL_VS_DLBCL_UP | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP |
REN_E2F1_TARGETS | REN_BOUND_BY_E2F |
POMEROY_DESMOPLASIC_VS_CLASSIC_MD_UP | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP |
POMEROY_DESMOPLASIC_VS_CLASSIC_MD_DN | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN |
POMEROY_MD_TREATMENT_GOOD_VS_POOR_UP | POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP |
POMEROY_MD_TREATMENT_GOOD_VS_POOR_DN | POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN |
MMC_RES_XENOGRAFTS_UP | Deprecated |
RESISTANCE_XENOGRAFTS_UP | Deprecated |
VLB_RES_XENOGRAFTS_UP | Deprecated |
MTX_RES_XENOGRAFTS_UP | Deprecated |
— | ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL |
— | ZEMBUTSU_SENSITIVITY_TO_CISPLATIN |
— | ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE |
— | ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN |
— | ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE |
— | ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN |
— | ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE |
— | ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE |
— | ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE |
VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_DN | VANTVEER_BREAST_CANCER_METASTASIS_DN |
VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_UP | VANTVEER_BREAST_CANCER_METASTASIS_UP |
BRCA_PROGNOSIS_POS | Deprecated |
BRCA_BRCA1_NEG | Deprecated |
BRCA_PROGNOSIS_NEG | Deprecated |
BRCA_BRCA1_POS | Deprecated |
BRCA_ER_NEG | Deprecated |
BRCA_ER_POS | Deprecated |
— | VANTVEER_BREAST_CANCER_ESR1_UP |
— | VANTVEER_BREAST_CANCER_ESR1_DN |
— | VANTVEER_BREAST_CANCER_BRCA1_UP |
— | VANTVEER_BREAST_CANCER_BRCA1_DN |
— | VANTVEER_BREAST_CANCER_POOR_PROGNOSIS |
DORSEY_DOXYCYCLINE_UP | DORSEY_GAB2_TARGETS |
ZHAN_MULTIPLE_MYELOMA_SUBCLASSES_DIFF | ZHAN_MULTIPLE_MYELOMA_SUBGROUPS |
ZHAN_PCS_MULTIPLE_MYELOMA_SPKD | ZHAN_MULTIPLE_MYELOMA_SPIKED |
ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_UP | ZHAN_MULTIPLE_MYELOMA_UP |
ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_DN | ZHAN_MULTIPLE_MYELOMA_DN |
DAC_BLADDER_UP | LIANG_SILENCED_BY_METHYLATION_2 |
DAC_CGI_BLADDER_UP | Deprecated |
DAC_IFN_BLADDER_UP | Deprecated |
DAC_FIBRO_UP | LIANG_SILENCED_BY_METHYLATION_UP |
DAC_FIBRO_DN | LIANG_SILENCED_BY_METHYLATION_DN |
CMV_IE86_UP | SONG_TARGETS_OF_IE86_CMV_PROTEIN |
UVB_NHEK3_C8 | SESTO_RESPONSE_TO_UV_C8 |
UVB_NHEK3_C4 | SESTO_RESPONSE_TO_UV_C4 |
UVB_NHEK3_C6 | SESTO_RESPONSE_TO_UV_C6 |
UVB_NHEK3_C2 | SESTO_RESPONSE_TO_UV_C2 |
UVB_NHEK3_ALL | Deprecated |
UVB_NHEK3_C0 | SESTO_RESPONSE_TO_UV_C0 |
UVB_NHEK3_C1 | SESTO_RESPONSE_TO_UV_C1 |
UVB_NHEK3_C7 | SESTO_RESPONSE_TO_UV_C7 |
UVB_NHEK3_C5 | SESTO_RESPONSE_TO_UV_C5 |
UVB_NHEK3_C3 | SESTO_RESPONSE_TO_UV_C3 |
INNEREAR_UP | ABE_INNER_EAR |
HYPOXIA_REVIEW | HARRIS_HYPOXIA |
HUMAN_TISSUE_PANCREAS | SU_PANCREAS |
HUMAN_TISSUE_SALIVARY | SU_SALIVARY_GLAND |
HUMAN_TISSUE_TESTIS | SU_TESTIS |
HUMAN_TISSUE_THYMUS | SU_THYMUS |
HUMAN_TISSUE_KIDNEY | SU_KIDNEY |
MOUSE_TISSUE_TESTIS | Deprecated |
MOUSE_TISSUE_KIDNEY | Deprecated |
HUMAN_TISSUE_LIVER | SU_LIVER |
HUMAN_TISSUE_PLACENTA | SU_PLACENTA |
RADAEVA_IFNA_DN | RADAEVA_IFN_ALPHA_RESPONSE_UP |
RADAEVA_IFNA_UP | RADAEVA_IFN_ALPHA_RESPONSE_DN |
IFNALPHA_NL_HCC_UP | Deprecated |
IFNALPHA_HCC_UP | Deprecated |
IFNALPHA_NL_UP | Deprecated |
STANELLE_E2F1_UP | STANELLE_E2F1_TARGETS |
SARCOMAS_HISTIOCYTOMA_UP | NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP |
SARCOMAS_SYNOVIAL_DN | NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN |
SARCOMAS_GISTROMAL_UP | NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP |
SARCOMAS_LIPOSARCOMA_DN | NIELSEN_LIPOSARCOMA_DN |
SARCOMAS_LIPOSARCOMA_UP | NIELSEN_LIPOSARCOMA_UP |
SARCOMAS_SYNOVIAL_UP | NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP |
SARCOMAS_SCHWANNOMA_UP | NIELSEN_SCHWANNOMA_UP |
SARCOMAS_LEIOMYOSARCOMA_CALP_UP | NIELSEN_LEIOMYOSARCOMA_CNN1_UP |
SARCOMAS_LEIOMYOSARCOMA_UP | NIELSEN_LEIOMYOSARCOMA_UP |
— | NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN |
— | NIELSEN_GIST |
— | NIELSEN_LEIOMYOSARCOMA_CNN1_DN |
— | NIELSEN_LEIOMYOSARCOMA_DN |
— | NIELSEN_SYNOVIAL_SARCOMA_UP |
— | NIELSEN_SYNOVIAL_SARCOMA_DN |
— | NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN |
— | NIELSEN_SCHWANNOMA_DN |
ADIPOCYTE_PPARG_UP | LI_ADIPOGENESIS_BY_ACTIVATED_PPARG |
UVB_NHEK2_UP | TAKAO_RESPONSE_TO_UVB_RADIATION_UP |
UVB_NHEK2_DN | TAKAO_RESPONSE_TO_UVB_RADIATION_DN |
MENSSEN_MYC_UP | MENSSEN_MYC_TARGETS |
GRANDVAUX_IFN_NOT_IRF3_UP | GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3 |
GRANDVAUX_IRF3_DN | GRANDVAUX_IRF3_TARGETS_UP |
GRANDVAUX_IRF3_UP | GRANDVAUX_IRF3_TARGETS_DN |
TSADAC_RKOSILENT_UP | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A |
TSADAC_RKOEXP_UP | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B |
TSA_RKO_UP | SUZUKI_RESPONSE_TO_TSA |
AS3_FIBRO_C2 | YIH_RESPONSE_TO_ARSENITE_C2 |
AS3_FIBRO_C4 | YIH_RESPONSE_TO_ARSENITE_C4 |
AS3_FIBRO_UP | Deprecated |
AS3_FIBRO_C3 | YIH_RESPONSE_TO_ARSENITE_C3 |
AS3_FIBRO_C1 | YIH_RESPONSE_TO_ARSENITE_C1 |
AS3_FIBRO_DN | Deprecated |
— | YIH_RESPONSE_TO_ARSENITE_C5 |
ADIP_VS_PREADIP_DN | ADIP_VS_PREADIP_DN |
ADIP_VS_FIBRO_DN | GERHOLD_ADIPOGENESIS_DN |
PREADIP_VS_FIBRO_UP | PREADIP_VS_FIBRO_UP |
ADIP_VS_PREADIP_UP | Deprecated |
TZD_ADIP_DN | Deprecated |
ADIP_VS_FIBRO_UP | GERHOLD_ADIPOGENESIS_UP |
— | GERHOLD_RESPONSE_TO_TZD_UP |
— | GERHOLD_RESPONSE_TO_TZD_DN |
WELCSH_BRCA_DN | Deprecated |
WELCSH_BRCA_UP | Deprecated |
BRCA1_OVEREXP_UP | WELCSH_BRCA1_TARGETS_1_UP |
BRCA1_OVEREXP_DN | WELCSH_BRCA1_TARGETS_1_DN |
NF90_UP | KRASNOSELSKAYA_ILF3_TARGETS_UP |
NF90_DN | KRASNOSELSKAYA_ILF3_TARGETS_DN |
LI_FETAL_VS_WT_KIDNEY_DN | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_DN |
LI_FETAL_VS_WT_KIDNEY_UP | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_UP |
— | LI_WILMS_TUMOR |
FERRANDO_T_CELL_DIFFERENTIATION_PATHWAY | Deprecated |
FERRANDO_TAL1_NEIGHBORS | FERRANDO_TAL1_NEIGHBORS |
FERRANDO_LYL1_NEIGHBORS | FERRANDO_LYL1_NEIGHBORS |
FERRANDO_CHEMO_RESPONSE_PATHWAY | Deprecated |
— | FERRANDO_HOX11_NEIGHBORS |
IL1_CORNEA_DN | MAHAJAN_RESPONSE_TO_IL1A_DN |
IL1_CORNEA_UP | MAHAJAN_RESPONSE_TO_IL1A_UP |
WILLERT_WNT_NCCIT_ALL_UP | WILLERT_WNT_SIGNALING |
BRCA2_BRCA1_DN | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN |
BRCA2_BRCA1_UP | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP |
PENG_LEUCINE_UP | PENG_LEUCINE_DEPRIVATION_UP |
PENG_GLUCOSE_UP | PENG_GLUCOSE_DEPRIVATION_UP |
PENG_GLUTAMINE_UP | PENG_GLUTAMINE_DEPRIVATION_UP |
PENG_LEUCINE_DN | PENG_LEUCINE_DEPRIVATION_DN |
PENG_GLUCOSE_DN | PENG_GLUCOSE_DEPRIVATION_DN |
PENG_RAPAMYCIN_DN | PENG_RAPAMYCIN_RESPONSE_DN |
PENG_RAPAMYCIN_UP | PENG_RAPAMYCIN_RESPONSE_UP |
PENG_GLUTAMINE_DN | PENG_GLUTAMINE_DEPRIVATION_DN |
MA_ATRA_EMP_DN | MA_MYELOID_DIFFERENTIATION_DN |
MA_ATRA_EMP_UP | MA_MYELOID_DIFFERENTIATION_UP |
ADIP_DIFF_CLUSTER5 | BURTON_ADIPOGENESIS_PEAK_AT_24HR |
ADIP_DIFF_CLUSTER2 | BURTON_ADIPOGENESIS_PEAK_AT_2HR |
ADIP_DIFF_CLUSTER1 | BURTON_ADIPOGENESIS_PEAK_AT_0HR |
ADIP_DIFF_CLUSTER3 | BURTON_ADIPOGENESIS_PEAK_AT_8HR |
ADIP_DIFF_CLUSTER4 | BURTON_ADIPOGENESIS_PEAK_AT_16HR |
P21_ANY_DN | Deprecated |
P21_EARLY_DN | Deprecated |
P21_P53_LATE_DN | Deprecated |
P21_P53_EARLY_DN | Deprecated |
P21_ANY_UP | Deprecated |
P21_MIDDLE_DN | Deprecated |
P21_P53_MIDDLE_DN | Deprecated |
P21_P53_ANY_DN | Deprecated |
— | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 |
— | WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 |
NELSON_ANDROGEN_DN | NELSON_RESPONSE_TO_ANDROGEN_DN |
NELSON_ANDROGEN_UP | NELSON_RESPONSE_TO_ANDROGEN_UP |
VEGF_HUVEC_2HRS_UP | ABE_VEGFA_TARGETS_2HR |
VEGF_HUVEC_UP | ABE_VEGFA_TARGETS |
VEGF_HUVEC_30MIN_UP | ABE_VEGFA_TARGETS_30MIN |
ET743_HELA_DN | GAJATE_RESPONSE_TO_TRABECTEDIN_DN |
ET743_HELA_UP | GAJATE_RESPONSE_TO_TRABECTEDIN_UP |
TIS7_OVEREXP_DN | VIETOR_IFRD1_TARGETS |
VEGF_MMMEC_6HRS_UP | WESTON_VEGFA_TARGETS_6HR |
VEGF_MMMEC_12HRS_UP | WESTON_VEGFA_TARGETS_12HR |
VEGF_MMMEC_ALL_UP | WESTON_VEGFA_TARGETS |
VEGF_MMMEC_3HRS_UP | WESTON_VEGFA_TARGETS_3HR |
MKK6EE_UP | Deprecated |
IGFR_IR_UP | MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP |
IGFR_IR_DN | MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN |
STEMCELL_COMMON_DN | RAMALHO_STEMNESS_DN |
STEMCELL_COMMON_UP | RAMALHO_STEMNESS_UP |
STEMCELL_NEURAL_UP | Deprecated |
STEMCELL_EMBRYONIC_UP | Deprecated |
STEMCELL_HEMATOPOIETIC_UP | Deprecated |
HSC_EARLYPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR |
HSC_HSC_ADULT | Deprecated |
HSC_MATURE_SHARED | IVANOVA_HEMATOPOIESIS_MATURE_CELL |
HSC_LATEPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR |
HSC_LTHSC_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM |
HSC_HSCANDPROGENITORS_ADULT | Deprecated |
HSC_HSC_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL |
HSC_MATURE_FETAL | HSC_MATURE_FETAL |
HSC_LTHSC_ADULT | Deprecated |
HSC_STHSC_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM |
HSC_LTHSC_FETAL | Deprecated |
HSC_LATEPROGENITORS_ADULT | Deprecated |
HSC_EARLYPROGENITORS_FETAL | Deprecated |
HSC_INTERMEDIATEPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR |
HSC_HSCANDPROGENITORS_FETAL | Deprecated |
HSC_MATURE_ADULT | Deprecated |
HSC_HSCANDPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR |
HSC_INTERMEDIATEPROGENITORS_ADULT | Deprecated |
HSC_LATEPROGENITORS_FETAL | Deprecated |
HSC_STHSC_ADULT | Deprecated |
HSC_EARLYPROGENITORS_ADULT | Deprecated |
HSC_HSC_FETAL | Deprecated |
HSC_STHSC_FETAL | Deprecated |
HSC_INTERMEDIATEPROGENITORS_FETAL | Deprecated |
IRITANI_ADPROX_VASC | Deprecated |
IRITANI_ADPROX_LYMPH | Deprecated |
IRITANI_ADPROX_DN | Deprecated |
IRITANI_ADPROX_UP | Deprecated |
— | IRITANI_MAD1_TARGETS_UP |
— | IRITANI_MAD1_TARGETS_DN |
JNK_DN | HAN_JNK_SINGALING_UP |
JNK_UP | HAN_JNK_SINGALING_DN |
LINDSTEDT_DEND_8H_VS_48H_DN | Deprecated |
LINDSTEDT_DEND_8H_VS_48H_UP | Deprecated |
LINDSTEDT_DEND_DN | Deprecated |
LINDSTEDT_DEND_UP | Deprecated |
— | LINDSTEDT_DENDRITIC_CELL_MATURATION_A |
— | LINDSTEDT_DENDRITIC_CELL_MATURATION_B |
— | LINDSTEDT_DENDRITIC_CELL_MATURATION_C |
— | LINDSTEDT_DENDRITIC_CELL_MATURATION_D |
— | CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB |
INOS_ALL_UP | ZAMORA_NOS2_TARGETS_UP |
INOS_ALL_DN | ZAMORA_NOS2_TARGETS_DN |
TPA_SENS_MIDDLE_DN | Deprecated |
TPA_RESIST_LATE_UP | Deprecated |
TPA_SENS_LATE_DN | Deprecated |
TPA_RESIST_EARLY_DN | Deprecated |
TPA_RESIST_MIDDLE_DN | Deprecated |
TPA_RESIST_EARLY_UP | Deprecated |
TPA_RESIST_MIDDLE_UP | Deprecated |
TPA_SENS_MIDDLE_UP | Deprecated |
TPA_SENS_EARLY_UP | Deprecated |
TPA_RESIST_LATE_DN | Deprecated |
TPA_SENS_LATE_UP | Deprecated |
TPA_SENS_EARLY_DN | Deprecated |
ASTIER_BCELL | Deprecated |
ASTIER_FN_DIFF | ASTIER_INTEGRIN_SIGNALING |
ZHAN_TONSIL_PCBC | Deprecated |
ZHAN_TONSIL_BONEMARROW | Deprecated |
ZHAN_MMPC_PC | Deprecated |
ZHAN_MMPC_EARLYVS | Deprecated |
ZHAN_MMPC_SIMAL | Deprecated |
ZHAN_MMPC_SIM_BC_AND_MM | Deprecated |
ZHAN_MMPC_SIM | ZHAN_V2_LATE_DIFFERENTIATION_GENES |
ZHAN_MMPC_LATEVS | Deprecated |
— | ZHAN_EARLY_DIFFERENTIATION_GENES_UP |
— | ZHAN_EARLY_DIFFERENTIATION_GENES_DN |
— | ZHAN_LATE_DIFFERENTIATION_GENES_UP |
— | ZHAN_LATE_DIFFERENTIATION_GENES_DN |
— | ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP |
— | ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN |
— | ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP |
— | ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN |
NAKAJIMA_MCS_UP | Deprecated |
HOGERKORP_ANTI_CD44_UP | Deprecated |
HOGERKORP_ANTI_CD44_DN | Deprecated |
HOGERKORP_CD44_DN | HOEGERKORP_CD44_TARGETS_DIRECT_DN |
HOGERKORP_CD44_TEMPORALLY_DN | HOEGERKORP_CD44_TARGETS_TEMPORAL_UP |
HOGERKORP_CD44_TEMPORALLY_UP | HOEGERKORP_CD44_TARGETS_TEMPORAL_DN |
HOGERKORP_CD44_UP | HOEGERKORP_CD44_TARGETS_DIRECT_UP |
HOFMANN_MDS_CD34_LOW_RISK | Deprecated |
HOFMANN_MDS_CD34_HIGH_RISK | Deprecated |
HOFMANN_MDS_CD34_LOW_AND_HIGH_RISK | Deprecated |
— | HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP |
— | HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN |
— | HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP |
— | HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN |
— | HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP |
— | HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN |
IFNALPHA_RESIST_DN | TRACEY_RESISTANCE_TO_IFNA2_DN |
— | TRACEY_RESISTANCE_TO_IFNA2_UP |
OXSTRESS_BREASTCA_DN | CHUANG_OXIDATIVE_STRESS_RESPONSE_DN |
OXSTRESS_BREASTCA_UP | CHUANG_OXIDATIVE_STRESS_RESPONSE_UP |
RETT_DN | TRAYNOR_RETT_SYNDROM_UP |
RETT_UP | TRAYNOR_RETT_SYNDROM_DN |
OXSTRESS_RPE_H2O2TBH_DN | WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2 |
OXSTRESS_RPETHREE_DN | WEIGEL_OXIDATIVE_STRESS_RESPONSE |
OXSTRESS_RPE_H2O2HNE_DN | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 |
OXSTRESS_RPETWO_DN | Deprecated |
OXSTRESS_RPE_HNETBH_DN | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH |
GNATENKO_PLATELET | GNATENKO_PLATELET_SIGNATURE |
GNATENKO_PLATELET_UP | Deprecated |
PLATELET_EXPRESSED | Deprecated |
GILDEA_BLADDER_UP | GILDEA_METASTASIS |
SHH_UP | INGRAM_SHH_TARGETS |
P53GENES_ALL | INGA_TP53_TARGETS |
METHOTREXATE_PROBCELL_DN | BRACHAT_RESPONSE_TO_METHOTREXATE_DN |
CISPLATIN_PROBCELL_UP | BRACHAT_RESPONSE_TO_CISPLATIN |
CANCERDRUGS_PROBCELL_DN | BRACHAT_RESPONSE_TO_CANCER_DRUGS_DN |
METHOTREXATE_PROBCELL_UP | BRACHAT_RESPONSE_TO_METHOTREXATE_UP |
CAMPTOTHECIN_PROBCELL_UP | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP |
CANCERDRUGS_PROBCELL_UP | BRACHAT_RESPONSE_TO_CANCER_DRUGS_UP |
CAMPTOTHECIN_PROBCELL_DN | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN |
METASTASIS_ADENOCARC_DN | RAMASWAMY_METASTASIS_DN |
METASTASIS_ADENOCARC_UP | RAMASWAMY_METASTASIS_UP |
O6BG_RESIST_MEDULLOBLASTOMA_DN | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN |
O6BG_RESIST_MEDULLOBLASTOMA_UP | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP |
CHAUHAN_2ME2 | Deprecated |
— | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP |
— | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN |
KLEIN_PEL_DN | KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN |
KLEIN_PEL_UP | KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP |
NI2_MOUSE_UP | MCDOWELL_ACUTE_LUNG_INJURY_UP |
NI2_MOUSE_DN | MCDOWELL_ACUTE_LUNG_INJURY_DN |
UNDERHILL_PROLIFERATION | Deprecated |
YAO_P4_KO_VS_WT_DN | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN |
YAO_P4_KO_VS_WT_UP | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8 |
— | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 |
SMITH_HCV_INDUCED_HCC_UP | SMITH_LIVER_CANCER |
ELONGINA_KO_UP | YAMAZAKI_TCEB3_TARGETS_UP |
ELONGINA_KO_DN | YAMAZAKI_TCEB3_TARGETS_DN |
H2O2_CSBDIFF_C1 | Deprecated |
H2O2_CSBRESCUED_C2_UP | Deprecated |
H2O2_CSBCOMBINED | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6 |
H2O2_CSBRESCUED_UP | KYNG_RESPONSE_TO_H2O2 |
H2O2_CSBDIFF_C2 | Deprecated |
H2O2_CSBRESCUED_C1_UP | Deprecated |
— | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP |
— | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN |
BRACX_UP | HEDENFALK_BREAST_CANCER_BRACX_UP |
BRACX_DN | HEDENFALK_BREAST_CANCER_BRACX_DN |
HEATSHOCK_OLD_UP | VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP |
AGEING_LYMPH_DN | VISALA_AGING_LYMPHOCYTE_DN |
HEATSHOCK_YOUNG_UP | VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN |
— | VISALA_AGING_LYMPHOCYTE_UP |
ROME_INSULIN_2F_UP | Deprecated |
ROME_INSULIN_2F_DN | Deprecated |
— | ROME_INSULIN_TARGETS_IN_MUSCLE_UP |
— | ROME_INSULIN_TARGETS_IN_MUSCLE_DN |
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN | MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN |
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP | MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP |
MAGRANGEAS_MULTIPLE_MYELOMA_IGL_VS_IGK_DN | MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN |
MAGRANGEAS_MULTIPLE_MYELOMA_IGL_VS_IGK_UP | MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP |
FERRANDO_MLL_T_ALL_UP | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP |
FERRANDO_MLL_T_ALL_DN | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN |
YE_INTRAMETASTATIC_HCC_UP | YE_METASTATIC_LIVER_CANCER |
TPA_SKIN_UP | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP |
TPA_SKIN_DN | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN |
BENNETT_SLE_UP | BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS |
ADIPOGENESIS_HMSC_CLASS1_UP | Deprecated |
ADIPOGENESIS_HMSC_CLASS2_UP | Deprecated |
ADIPOGENESIS_HMSC_CLASS3_UP | Deprecated |
ADIPOGENESIS_HMSC_CLASS5_UP | Deprecated |
ADIPOGENESIS_HMSC_CLASS8_DN | Deprecated |
— | NAKAMURA_ADIPOGENESIS_EARLY_DN |
— | NAKAMURA_ADIPOGENESIS_EARLY_UP |
— | NAKAMURA_ADIPOGENESIS_LATE_DN |
— | NAKAMURA_ADIPOGENESIS_LATE_UP |
YAMA_RECURRENT_HCC_UP | IIZUKA_RECURRENT_LIVER_CANCER |
ICHIBA_GVHD | Deprecated |
— | ICHIBA_D7_GRAFT_VERSUS_HOST_DISEASE_UP |
— | ICHIBA_D7_GRAFT_VERSUS_HOST_DISEASE_DN |
— | ICHIBA_D35_GRAFT_VERSUS_HOST_DISEASE_UP |
— | ICHIBA_D35_GRAFT_VERSUS_HOST_DISEASE_DN |
TARTE_BCELL | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN |
TARTE_PC | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP |
TARTE_PLASMA_BLASTIC | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN |
TARTE_MATURE_PC | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP |
NUTT_GBN_VS_AO_DN | Deprecated |
NUTT_GBN_VS_AO_UP | Deprecated |
— | NUTT_GBM_VS_AO_GLIOMA_UP |
— | NUTT_GBM_VS_AO_GLIOMA_DN |
HINATA_NFKB_UP | Deprecated |
HINATA_NFKB_DN | Deprecated |
— | HINATA_NFKB_TARGETS_KERATINOCYTE_UP |
— | HINATA_NFKB_TARGETS_KERATINOCYTE_DN |
— | HINATA_NFKB_TARGETS_FIBROBLAST_UP |
— | HINATA_NFKB_TARGETS_FIBROBLAST_DN |
TNFALPHA_4HRS_UP | ZHOU_TNF_SIGNALING_4HR |
TNFALPHA_ALL_UP | Deprecated |
TNFALPHA_30MIN_UP | ZHOU_TNF_SIGNALING_30MIN |
AS3_HEK293_DN | ZHENG_RESPONSE_TO_ARSENITE_DN |
AS3_HEK293_UP | ZHENG_RESPONSE_TO_ARSENITE_UP |
OSAWA_TNFA_HEPATOCYTE_UP | OSAWA_TNF_TARGETS |
VHL_NORMAL_UP | Deprecated |
VHL_RCC_UP | JIANG_VHL_TARGETS |
RCC_NL_UP | Deprecated |
HYPOXIA_NORMAL_UP | JIANG_HYPOXIA_NORMAL |
HYPOXIA_RCC_NOVHL_UP | JIANG_HYPOXIA_CANCER |
HYPOXIA_RCC_UP | Deprecated |
— | JIANG_HYPOXIA_VIA_VHL |
FERNANDEZ_MYC_TARGETS | FERNANDEZ_BOUND_BY_MYC |
HTERT_DN | LINDVALL_IMMORTALIZED_BY_TERT_UP |
HTERT_UP | LINDVALL_IMMORTALIZED_BY_TERT_DN |
CHEOK_MP_DN | CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN |
CHEOK_LDMTX_MP_UP | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP |
CHEOK_MP_UP | CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP |
CHEOK_HDMTX_DN | CHEOK_RESPONSE_TO_HD_MTX_DN |
CHEOK_HDMTX_UP | CHEOK_RESPONSE_TO_HD_MTX_UP |
CHEOK_LDMTX_MP_DN | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN |
— | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP |
— | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN |
SMITH_HTERT_DN | SMITH_TERT_TARGETS_UP |
SMITH_HTERT_UP | SMITH_TERT_TARGETS_DN |
RIBAVIRIN_RSV_DN | ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP |
RIBAVIRIN_RSV_UP | ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN |
TSADAC_HYPERMETH_OVCA_UP | Deprecated |
TSADAC_HYPOMETH_HYPERAC_OVCA_UP | Deprecated |
TSADAC_HYPERMETH_HYPERAC_OVCA_UP | Deprecated |
TSADAC_HYPOMETH_OVCA_UP | Deprecated |
TGZ_ADIP_UP | RUAN_RESPONSE_TO_TROGLITAZONE_UP |
TNFALPHA_ADIP_UP | RUAN_RESPONSE_TO_TNF_UP |
TNFALPHA_TGZ_ADIP_DN | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN |
TNFALPHA_ADIP_DN | RUAN_RESPONSE_TO_TNF_DN |
TNFALPHA_TGZ_ADIP_UP | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP |
ADIP_DIFF_UP | Deprecated |
— | RUAN_RESPONSE_TO_TROGLITAZONE_DN |
YAGI_AML_PROGNOSIS | YAGI_AML_RELAPSE_PROGNOSIS |
YAGI_AML_PROG_ASSOC | YAGI_AML_SURVIVAL |
YAGI_AML_PROG_FAB | YAGI_AML_FAB_MARKERS |
— | YAGI_AML_WITH_T_8_21_TRANSLOCATION |
— | YAGI_AML_WITH_INV_16_TRANSLOCATION |
— | YAGI_AML_WITH_T_9_11_TRANSLOCATION |
— | YAGI_AML_WITH_11Q23_REARRANGED |
NEMETH_TNF_UP | NEMETH_INFLAMMATORY_RESPONSE_LPS_UP |
NEMETH_TNF_DN | NEMETH_INFLAMMATORY_RESPONSE_LPS_DN |
UVB_NHEK1_C3 | DAZARD_UV_RESPONSE_CLUSTER_G3 |
UVB_SCC_DN | DAZARD_RESPONSE_TO_UV_SCC_DN |
UVB_NHEK1_UP | DAZARD_RESPONSE_TO_UV_NHEK_UP |
UVB_NHEK1_C4 | DAZARD_UV_RESPONSE_CLUSTER_G4 |
UVB_NHEK1_DN | DAZARD_RESPONSE_TO_UV_NHEK_DN |
UVB_SCC_UP | DAZARD_RESPONSE_TO_UV_SCC_UP |
UVB_NHEK1_C1 | DAZARD_UV_RESPONSE_CLUSTER_G1 |
UVB_NHEK1_C6 | DAZARD_UV_RESPONSE_CLUSTER_G6 |
UVB_NHEK1_C2 | DAZARD_UV_RESPONSE_CLUSTER_G2 |
— | DAZARD_UV_RESPONSE_CLUSTER_G5 |
— | DAZARD_UV_RESPONSE_CLUSTER_G24 |
— | DAZARD_UV_RESPONSE_CLUSTER_G28 |
SCHRAETS_MLL_UP | Deprecated |
— | SCHRAETS_MLL_TARGETS_UP |
— | SCHRAETS_MLL_TARGETS_DN |
CROONQUIST_RAS_STROMA_UP | Deprecated |
CROONQUIST_RAS_STROMA_DN | Deprecated |
CROONQUIST_IL6_STARVE_UP | Deprecated |
CROONQUIST_IL6_RAS_UP | Deprecated |
CROONQUIST_IL6_STROMA_UP | Deprecated |
CROONQUIST_IL6_RAS_DN | Deprecated |
— | CROONQUIST_IL6_DEPRIVATION_UP |
— | CROONQUIST_IL6_DEPRIVATION_DN |
— | CROONQUIST_STROMAL_STIMULATION_UP |
— | CROONQUIST_STROMAL_STIMULATION_DN |
— | CROONQUIST_NRAS_SIGNALING_UP |
— | CROONQUIST_NRAS_SIGNALING_DN |
— | CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP |
— | CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN |
GUO_HEX_UP | GUO_HEX_TARGETS_UP |
GUO_HEX_DN | GUO_HEX_TARGETS_DN |
P53_BRCA1_UP | ONGUSAHA_TP53_TARGETS |
— | ONGUSAHA_BRCA1_TARGETS_UP |
— | ONGUSAHA_BRCA1_TARGETS_DN |
MOOTHA_VOXPHOS | MOOTHA_VOXPHOS |
HUMAN_MITODB_6_2002 | MOOTHA_HUMAN_MITODB_6_2002 |
PGC | MOOTHA_PGC |
TCA | MOOTHA_TCA |
MITOCHONDRIA | MOOTHA_MITOCHONDRIA |
ROS | MOOTHA_ROS |
— | MOOTHA_PYR |
— | MOOTHA_FFA_OXYDATION |
— | MOOTHA_GLUCONEOGENESIS |
— | MOOTHA_GLYCOGEN_METABOLISM |
— | MOOTHA_GLYCOLYSIS |
GALINDO_ACT_UP | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN |
LVAD_HEARTFAILURE_DN | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN |
LVAD_HEARTFAILURE_UP | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP |
FSH_HUMAN_GRANULOSA_UP | SASSON_FSH_RESPONSE |
DAC_PANC50_UP | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 |
TSADAC_PANC50_UP | SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER |
TSA_PANC50_UP | SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER |
DAC_PANC_UP | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 |
OKUMURA_MC_LPS | OKUMURA_INFLAMMATORY_RESPONSE_LPS |
HYPOXIA_REG_UP | LEONARD_HYPOXIA |
REOVIRUS_HEK293_UP | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP |
REOVIRUS_HEK293_DN | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN |
PARK_RARALPHA_UP | Deprecated |
PARK_RARALPHA_MOD | Deprecated |
— | PARK_APL_PATHOGENESIS_UP |
— | PARK_APL_PATHOGENESIS_DN |
— | PARK_TRETINOIN_RESPONSE |
— | PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION |
— | PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION |
DISTECHE_XINACTIVATED_GENES | DISTECHE_ESCAPED_FROM_X_INACTIVATION |
UVC_HIGH_D9_DN | GENTILE_UV_RESPONSE_CLUSTER_D9 |
UVC_LOW_ALL_UP | GENTILE_UV_LOW_DOSE_UP |
UVC_HIGH_D4_DN | GENTILE_UV_RESPONSE_CLUSTER_D4 |
UVC_LOW_C2_DN | Deprecated |
UVC_HIGH_D5_DN | GENTILE_UV_RESPONSE_CLUSTER_D5 |
UVC_HIGH_D2_DN | GENTILE_UV_RESPONSE_CLUSTER_D2 |
UVC_HIGH_D7_DN | GENTILE_UV_RESPONSE_CLUSTER_D7 |
UVC_HIGH_D6_DN | GENTILE_UV_RESPONSE_CLUSTER_D6 |
UVC_LOW_A2_UP | Deprecated |
UVC_HIGH_ALL_DN | GENTILE_UV_HIGH_DOSE_DN |
UVC_HIGH_ALL_UP | GENTILE_UV_HIGH_DOSE_UP |
UVC_HIGH_D1_DN | GENTILE_UV_RESPONSE_CLUSTER_D1 |
UVC_LOW_C1_DN | Deprecated |
UVC_LOW_C3_DN | Deprecated |
UVC_LOW_ALL_DN | GENTILE_UV_LOW_DOSE_DN |
UVC_HIGH_D8_DN | GENTILE_UV_RESPONSE_CLUSTER_D8 |
UVC_HIGH_D3_DN | GENTILE_RESPONSE_CLUSTER_D3 |
LAMB_CYCLIN_D1_UP | LAMB_CCND1_TARGETS |
LAMB_CYCLIN_D3_GLOCUS | Deprecated |
NI2_LUNG_DN | CHENG_RESPONSE_TO_NICKEL_ACETATE |
VERNELL_PRB_CLSTR2 | VERNELL_RETINOBLASTOMA_PATHWAY_DN |
VERNELL_PRB_CLSTR1 | VERNELL_RETINOBLASTOMA_PATHWAY_UP |
DAVIES_MGUS_MM | Deprecated |
DAVIES_N | Deprecated |
— | DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP |
— | DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN |
MUNSHI_MM_UP | Deprecated |
MUNSHI_MM_VS_PCS_DN | MUNSHI_MULTIPLE_MYELOMA_DN |
MUNSHI_MM_VS_PCS_UP | MUNSHI_MULTIPLE_MYELOMA_UP |
BROCKE_IL6 | BROCKE_APOPTOSIS_REVERSED_BY_IL6 |
KRETZSCHMAR_IL6_DIFF | KRETZSCHMAR_IL6_DIFF |
HYPOXIA_FIBRO_UP | KIM_HYPOXIA |
ADIPOCYTE_BRCA_UP | IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS |
TAVOR_CEBP_DN | TAVOR_CEBPA_TARGETS_DN |
TAVOR_CEBP_UP | TAVOR_CEBPA_TARGETS_UP |
EGF_HDMEC_UP | ZHANG_PROLIFERATING_VS_QUIESCENT |
ZELLER_MYC_DN | Deprecated |
ZELLER_MYC_UP | Deprecated |
MYC_TARGETS | Deprecated |
— | DANG_REGULATED_BY_MYC_UP |
— | DANG_REGULATED_BY_MYC_DN |
— | DANG_MYC_TARGETS_UP |
— | DANG_MYC_TARGETS_DN |
— | DANG_BOUND_BY_MYC |
YEN_MYC_WT | Deprecated |
YEN_MYC_MUT | Deprecated |
— | ELLWOOD_MYC_TARGETS_UP |
— | ELLWOOD_MYC_TARGETS_DN |
BYSTROM_IL5_DN | BYSTROEM_CORRELATED_WITH_IL5_DN |
BYSTROM_IL5_UP | BYSTROEM_CORRELATED_WITH_IL5_UP |
WERNER_FIBRO_UP | Deprecated |
WERNERONLY_FIBRO_UP | Deprecated |
WERNER_FIBRO_DN | Deprecated |
OLDWERNER_FIBRO_DN | Deprecated |
WERNERONLY_FIBRO_DN | Deprecated |
OLD_FIBRO_UP | Deprecated |
OLDWERNER_FIBRO_UP | Deprecated |
OLDONLY_FIBRO_DN | Deprecated |
OLD_FIBRO_DN | Deprecated |
OLDONLY_FIBRO_UP | Deprecated |
— | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP |
— | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN |
— | KYNG_NORMAL_AGING_UP |
— | KYNG_NORMAL_AGING_DN |
— | KYNG_WERNER_SYNDROM_UP |
— | KYNG_WERNER_SYNDROM_DN |
INSULIN_ADIP_INSENS_UP | SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP |
INSULIN_ADIP_SENS_DN | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN |
INSULIN_ADIP_SENS_UP | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP |
INSULIN_ADIP_INSENS_DN | SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN |
— | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP |
— | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN |
EMT_UP | Deprecated |
EMT_DN | Deprecated |
DFOSB_BRAIN_8WKS_UP | MCCLUNG_DELTA_FOSB_TARGETS_8WK |
CREB_BRAIN_2WKS_UP | Deprecated |
CREB_BRAIN_8WKS_DN | MCCLUNG_CREB1_TARGETS_DN |
COCAINE_BRAIN_5D_UP | MCCLUNG_COCAINE_REWARD_5D |
DFOSB_BRAIN_2WKS_UP | MCCLUNG_DELTA_FOSB_TARGETS_2WK |
CREB_BRAIN_8WKS_UP | MCCLUNG_CREB1_TARGETS_UP |
COCAINE_BRAIN_4WKS_UP | MCCLUNG_COCAIN_REWARD_4WK |
CHEN_LUNG_SURVIVAL | CHEN_LUNG_CANCER_SURVIVAL |
ABBUD_LIF_DN | ABBUD_LIF_SIGNALING_1_DN |
ABBUD_LIF_GH3_UP | ABBUD_LIF_SIGNALING_2_UP |
ABBUD_LIF_UP | ABBUD_LIF_SIGNALING_1_UP |
ABBUD_LIF_GH3_DN | ABBUD_LIF_SIGNALING_2_DN |
BRENTANI_IMMUNE_FUNCTION | Deprecated |
BRENTANI_CYTOSKELETON | Deprecated |
BRENTANI_SIGNALING | Deprecated |
BRENTANI_REPAIR | Deprecated |
BRENTANI_TRANSPORT | Deprecated |
BRENTANI_CELL_CYCLE | Deprecated |
BRENTANI_ANGIOGENESIS | Deprecated |
BRENTANI_DEATH | Deprecated |
BRENTANI_CELL_ADHESION | Deprecated |
BRENTANI_TRANSPORT_OF_VESICLES | Deprecated |
BRENTANI_CANCER_TESTIS | Deprecated |
BRENTANI_DNA_METHYLATION_AND_MODIFICATION | Deprecated |
BRENTANI_TRANSCRIPTION_FACTORS | Deprecated |
BRENTANI_PROTEIN_MODIFICATION | Deprecated |
BRENTANI_HORMONAL_FUNCTION | Deprecated |
DORSAM_HOXA9_UP | DORSAM_HOXA9_TARGETS_UP |
DORSAM_HOXA9_DN | DORSAM_HOXA9_TARGETS_DN |
TSA_CD4_UP | MOREIRA_RESPONSE_TO_TSA_UP |
TSA_CD4_DN | MOREIRA_RESPONSE_TO_TSA_DN |
KUMAR_HOXA_DIFF | KUMAR_TARGETS_OF_MLL_AF9_FUSION |
HEDVAT_ELF_UP | HEDVAT_ELF4_TARGETS_UP |
HEDVAT_ELF_DN | HEDVAT_ELF4_TARGETS_DN |
CANTHARIDIN_UP | ZHANG_RESPONSE_TO_CANTHARIDIN_UP |
CANTHARIDIN_DN | ZHANG_RESPONSE_TO_CANTHARIDIN_DN |
BRG1_ALAB_UP | HENDRICKS_SMARCA4_TARGETS_UP |
BRG1_ALAB_DN | HENDRICKS_SMARCA4_TARGETS_DN |
CROMER_HYPOPHARYNGEAL_MET_VS_NON_UP | CROMER_METASTASIS_UP |
CROMER_HYPOPHARYNGEAL_MET_VS_NON_DN | CROMER_METASTASIS_DN |
— | CROMER_TUMORIGENESIS_UP |
— | CROMER_TUMORIGENESIS_DN |
CHIARETTI_T_ALL | Deprecated |
CHIARETTI_T_ALL_DIFF | Deprecated |
— | CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY |
— | CHIARETTI_T_ALL_RELAPSE_PROGNOSIS |
BRUNO_IL3_DN | BRUNO_HEMATOPOIESIS |
BASSO_HCL_DIFF | Deprecated |
— | BASSO_HAIRY_CELL_LEUKEMIA_UP |
— | BASSO_HAIRY_CELL_LEUKEMIA_DN |
CIS_RESIST_GASTRIC_UP | Deprecated |
5FU_RESIST_GASTRIC_DN | KANG_FLUOROURACIL_RESISTANCE_DN |
5FU_RESIST_GASTRIC_UP | KANG_FLUOROURACIL_RESISTANCE_UP |
DOX_RESIST_GASTRIC_UP | KANG_DOXORUBICIN_RESISTANCE_UP |
DOX_RESIST_GASTRIC_DN | KANG_DOXORUBICIN_RESISTANCE_DN |
— | KANG_CISPLATIN_RESISTANCE_UP |
— | KANG_CISPLATIN_RESISTANCE_DN |
CIS_RESIST_LUNG_UP | WHITESIDE_CISPLATIN_RESISTANCE_UP |
CIS_RESIST_LUNG_DN | WHITESIDE_CISPLATIN_RESISTANCE_DN |
CHANG_SERUM_RESPONSE_UP | Deprecated |
CHANG_SERUM_RESPONSE_DN | Deprecated |
SERUM_FIBROBLAST_CORE_DN | Deprecated |
SERUM_FIBROBLAST_CELLCYCLE | Deprecated |
SERUM_FIBROBLAST_CORE_UP | Deprecated |
— | CHANG_CORE_SERUM_RESPONSE_UP |
— | CHANG_CORE_SERUM_RESPONSE_DN |
— | CHANG_CYCLING_GENES |
ALZHEIMERS_INCIPIENT_UP | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP |
ALZHEIMERS_DISEASE_DN | BLALOCK_ALZHEIMERS_DISEASE_DN |
ALZHEIMERS_DISEASE_UP | BLALOCK_ALZHEIMERS_DISEASE_UP |
ALZHEIMERS_INCIPIENT_DN | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN |
RORIE_ES_PNET_UP | RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP |
RORIE_ES_PNET_DN | RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN |
FRASOR_ER_UP | FRASOR_RESPONSE_TO_ESTRADIOL_UP |
FRASOR_ER_DN | FRASOR_RESPONSE_TO_ESTRADIOL_DN |
— | FRASOR_RESPONSE_TO_SERM_OR_ICI_UP |
— | FRASOR_RESPONSE_TO_SERM_OR_ICI_DN |
PDGF_ES_UP | CHEN_PDGF_TARGETS |
PASSERINI_APOPTOSIS | Deprecated |
PASSERINI_TRANSCRIPTION | Deprecated |
PASSERINI_EM | Deprecated |
PASSERINI_ADHESION | Deprecated |
PASSERINI_INFLAMMATION | Deprecated |
PASSERINI_SIGNAL | Deprecated |
PASSERINI_OXIDATION | Deprecated |
PASSERINI_IMMUNE | Deprecated |
PASSERINI_PROLIFERATION | Deprecated |
PASSERINI_GROWTH | Deprecated |
PASSERINI_COMPLEMENT | Deprecated |
STEFFEN_AML_PML_PLZF_TRGT | Deprecated |
— | MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP |
— | MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN |
LH_GRANULOSA_DN | Deprecated |
FSH_GRANULOSA_UP | Deprecated |
GN_CAMP_GRANULOSA_DN | Deprecated |
GN_CAMP_GRANULOSA_UP | Deprecated |
FSH_GRANULOSA_DN | Deprecated |
LH_GRANULOSA_UP | Deprecated |
— | SASSON_RESPONSE_TO_GONADOTROPHINS_UP |
— | SASSON_RESPONSE_TO_GONADOTROPHINS_DN |
— | SASSON_RESPONSE_TO_FORSKOLIN_UP |
— | SASSON_RESPONSE_TO_FORSKOLIN_DN |
JISON_SICKLE_CELL | Deprecated |
JISON_SICKLECELL_DIFF | Deprecated |
— | JISON_SICKLE_CELL_DISEASE_UP |
— | JISON_SICKLE_CELL_DISEASE_DN |
REFRACTORY_GASTRIC_UP | KIM_GASTRIC_CANCER_CHEMOSENSITIVITY |
IDX_TSA_DN_CLUSTER4 | BURTON_ADIPOGENESIS_10 |
IDX_TSA_DN_CLUSTER6 | BURTON_ADIPOGENESIS_12 |
IDX_TSA_UP_CLUSTER5 | BURTON_ADIPOGENESIS_5 |
IDX_TSA_UP_CLUSTER3 | BURTON_ADIPOGENESIS_3 |
IDX_TSA_DN_CLUSTER2 | BURTON_ADIPOGENESIS_8 |
IDX_TSA_UP_CLUSTER2 | BURTON_ADIPOGENESIS_2 |
IDX_TSA_UP_CLUSTER4 | BURTON_ADIPOGENESIS_4 |
IDX_TSA_UP_CLUSTER1 | BURTON_ADIPOGENESIS_1 |
IDX_TSA_DN_CLUSTER1 | BURTON_ADIPOGENESIS_7 |
IDX_TSA_DN_CLUSTER5 | BURTON_ADIPOGENESIS_11 |
IDX_TSA_DN_CLUSTER3 | BURTON_ADIPOGENESIS_9 |
IDX_TSA_UP_CLUSTER6 | BURTON_ADIPOGENESIS_6 |
STOSSI_ER_UP | STOSSI_ESTRADIOL_SIGNALING_VIA_ESTROGEN_RECEPTORS |
DIAB_NEPH_UP | BAELDE_DIABETIC_NEPHROPATHY_UP |
DIAB_NEPH_DN | BAELDE_DIABETIC_NEPHROPATHY_DN |
ADIP_HUMAN_UP | URS_ADIPOCYTE_DIFFERENTIATION_UP |
ADIP_HUMAN_DN | URS_ADIPOCYTE_DIFFERENTIATION_DN |
ROS_MOUSE_AORTA_UP | KEEN_RESPONSE_TO_ROSIGLITAZONE_UP |
ROS_MOUSE_AORTA_DN | KEEN_RESPONSE_TO_ROSIGLITAZONE_DN |
BHATTACHARYA_ESC_UP | BHATTACHARYA_EMBRYONIC_STEM_CELL |
— | VALK_AML_CLUSTER_1 |
— | VALK_AML_CLUSTER_2 |
— | VALK_AML_CLUSTER_3 |
— | VALK_AML_CLUSTER_4 |
— | VALK_AML_CLUSTER_5 |
— | VALK_AML_CLUSTER_6 |
— | VALK_AML_CLUSTER_7 |
— | VALK_AML_CLUSTER_8 |
— | VALK_AML_CLUSTER_9 |
— | VALK_AML_CLUSTER_10 |
— | VALK_AML_CLUSTER_11 |
— | VALK_AML_CLUSTER_12 |
— | VALK_AML_CLUSTER_13 |
— | VALK_AML_CLUSTER_15 |
— | VALK_AML_CLUSTER_16 |
— | VALK_AML_WITH_T_8_21_TRANSLOCATION |
— | VALK_AML_WITH_11Q23_REARRANGED |
— | VALK_AML_WITH_EVI1 |
— | VALK_AML_WITH_CEBPA |
— | VALK_AML_WITH_FLT3_ITD |
IL6_FIBRO_UP | Deprecated |
IL6_SCAR_FIBRO_UP | DASU_IL6_SIGNALING_SCAR_UP |
IL6_SCAR_FIBRO_DN | DASU_IL6_SIGNALING_SCAR_DN |
— | DASU_IL6_SIGNALING_UP |
— | DASU_IL6_SIGNALING_DN |
WIELAND_HEPATITIS_B_INDUCED | WIELAND_UP_BY_HBV_INFECTION |
HEARTFAILURE_ATRIA_DN | KAAB_FAILED_HEART_ATRIUM_DN |
ATRIA_UP | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP |
HEARTFAILURE_ATRIA_UP | KAAB_FAILED_HEART_ATRIUM_UP |
VENTRICLES_UP | KAAB_HEART_ATRIUM_VS_VENTRICLE_DN |
HEARTFAILURE_VENTRICLE_DN | KAAB_FAILED_HEART_VENTRICLE_DN |
— | KAAB_FAILED_HEART_VENTRICLE_UP |
LEI_MYB_REGULATED_GENES | LEI_MYB_TARGETS |
CIS_XPC_DN | WANG_CISPLATIN_RESPONSE_AND_XPC_DN |
CIS_XPC_UP | WANG_CISPLATIN_RESPONSE_AND_XPC_UP |
CHAUVIN_ANDROGEN_REGULATED_GENES | On Hold |
GENOTOXINS_4HRS_DISCR | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR |
GENOTOXINS_ALL_24HRS_REG | HU_GENOTOXIC_DAMAGE_24HR |
GENOTOXINS_24HRS_DISCR | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR |
GENOTOXINS_ALL_4HRS_REG | HU_GENOTOXIC_DAMAGE_4HR |
IGLESIAS_E2FMINUS_DN | IGLESIAS_E2F_TARGETS_DN |
IGLESIAS_E2FMINUS_UP | IGLESIAS_E2F_TARGETS_UP |
RAY_P210_DIFF | Deprecated |
BCRABL_HL60_CDNA_UP | Deprecated |
BCRABL_HL60_AFFY_UP | Deprecated |
BCRABL_HL60_AFFY_DN | Deprecated |
BCRABL_HL60_CDNA_DN | Deprecated |
— | RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP |
— | RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN |
CANCER_NEOPLASTIC_META_UP | RHODES_CANCER_META_SIGNATURE |
CANCER_UNDIFFERENTIATED_META_UP | RHODES_UNDIFFERENTIATED_CANCER |
KNUDSEN_PMNS_UP | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP |
KNUDSEN_PMNS_DN | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN |
WALLACE_JAK2_DIFF | Deprecated |
— | WALLACE_JAK2_TARGETS_UP |
— | WALLACE_JAK2_TARGETS_DN |
AGEING_BRAIN_DN | LU_AGING_BRAIN_DN |
AGEING_BRAIN_UP | LU_AGING_BRAIN_UP |
SANSOM_APC_LOSS4_UP | SANSOM_APC_TARGETS_UP |
SANSOM_APC_5_DN | SANSOM_APC_TARGETS_DN |
SANSOM_APC_4_DN | Deprecated |
SANSOM_APC_LOSS5_UP | Deprecated |
AGUIRRE_PANCREAS_CHR12 | Deprecated |
AGUIRRE_PANCREAS_CHR9 | Deprecated |
AGUIRRE_PANCREAS_CHR1 | Deprecated |
AGUIRRE_PANCREAS_CHR19 | Deprecated |
AGUIRRE_PANCREAS_CHR18 | Deprecated |
AGUIRRE_PANCREAS_CHR7 | Deprecated |
AGUIRRE_PANCREAS_CHR8 | Deprecated |
AGUIRRE_PANCREAS_CHR17 | Deprecated |
AGUIRRE_PANCREAS_CHR22 | Deprecated |
AGUIRRE_PANCREAS_CHR6 | Deprecated |
— | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP |
— | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN |
HALMOS_CEBP_DN | HALMOS_CEBPA_TARGETS_DN |
HALMOS_CEBP_UP | HALMOS_CEBPA_TARGETS_UP |
LEE_TCELLS10_UP | Deprecated |
LEE_TCELLS8_UP | Deprecated |
LEE_TCELLS9_UP | Deprecated |
LEE_TCELLS3_UP | Deprecated |
LEE_TCELLS4_UP | Deprecated |
LEE_TCELLS5_UP | Deprecated |
LEE_TCELLS1_UP | Deprecated |
LEE_TCELLS6_UP | Deprecated |
LEE_TCELLS7_UP | Deprecated |
LEE_TCELLS2_UP | Deprecated |
— | LEE_EARLY_T_LYMPHOCYTE_UP |
— | LEE_EARLY_T_LYMPHOCYTE_DN |
— | LEE_INTRATHYMIC_T_PROGENITOR |
— | LEE_DOUBLE_POLAR_THYMOCYTE |
— | LEE_SP4_THYMOCYTE |
— | LEE_RECENT_THYMIC_EMIGRANT |
— | LEE_NAIVE_T_LYMPHOCYTE |
— | LEE_DIFFERENTIATING_T_LYMPHOCYTE |
KIM_TH_CELLS_UP | KIM_GERMINAL_CENTER_T_HELPER_UP |
KIM_TH_CELLS_DN | KIM_GERMINAL_CENTER_T_HELPER_DN |
ROSS_CBF | ROSS_AML_OF_CBF_TYPE |
ROSS_PML_RAR | ROSS_AML_WITH_PML_RARA_FUSION |
ROSS_CBF_MYH | ROSS_AML_WITH_CBFB_MYH11_FUSION |
ROSS_MLL_FUSION | ROSS_AML_WITH_MLL_FUSIONS |
ROSS_CBF_LEUKEMIA | Deprecated |
ROSS_FAB_M7 | ROSS_AML_OF_FAB_M7_TYPE |
ROSS_AML1_ETO | ROSS_AML_WITH_AML1_ETO_FUSION |
— | ROSS_LEUKEMIA_WITH_MLL_FUSIONS |
HEMATOP_STEM_ALL_UP | GEORGANTAS_HSC_MARKERS |
ADDYA_K562_HEMIN_TREATMENT | ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN |
TENEDINI_MEGAKARYOCYTIC_GENES | TENEDINI_MEGAKARYOCYTE_MARKERS |
UEDA_MOUSE_SCN | UEDA_CENTRAL_CLOCK |
UEDA_MOUSE_LIVER | UEDA_PERIFERAL_CLOCK |
— | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP |
— | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN |
WELCH_GATA1 | On Hold |
MARTINELLI_IFNS_DIFF | Deprecated |
— | MARTINELLI_IMMATURE_NEUTROPHIL_UP |
— | MARTINELLI_IMMATURE_NEUTROPHIL_DN |
NOUZOVA_CPG_METHLTD | NOUZOVA_METHYLATED_IN_APL |
NOUZOVA_CPG_H4_UP | NOUZOVA_TRETINOIN_AND_H4_ACETYLATION |
ASTON_DEPRESSION_DN | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN |
ASTON_OLIGODENDROGLIA_MYELINATION_SUBSET | Deprecated |
ASTON_DEPRESSION_UP | ASTON_MAJOR_DEPRESSIVE_DISORDER_UP |
FLECHNER_KIDNEY_TRANSPLANT_WELL_PBL_DN | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN |
FLECHNER_KIDNEY_TRANSPLANT_REJECTION_UP | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP |
FLECHNER_KIDNEY_TRANSPLANT_WELL_PBL_UP | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP |
FLECHNER_KIDNEY_TRANSPLANT_REJECTION_PBL_DN | FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN |
FLECHNER_KIDNEY_TRANSPLANT_REJECTION_DN | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN |
FLECHNER_KIDNEY_TRANSPLANT_WELL_DN | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN |
FLECHNER_KIDNEY_TRANSPLANT_REJECTION_PBL_UP | FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP |
FLECHNER_KIDNEY_TRANSPLANT_WELL_UP | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP |
GREENBAUM_E2A_DN | GREENBAUM_E2A_TARGETS_DN |
GREENBAUM_E2A_UP | GREENBAUM_E2A_TARGETS_UP |
NAB_LUNG_DN | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN |
NAB_LUNG_UP | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP |
HADDAD_HSC_CD7_DN | Deprecated |
HADDAD_HSC_CD10_UP | Deprecated |
HADDAD_HSC_CD7_UP | Deprecated |
HADDAD_CD45CD7_PLUS_VS_MINUS_UP | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP |
HADDAD_HPCLYMPHO_ENRICHED | HADDAD_B_LYMPHOCYTE_PROGENITOR |
HADDAD_CD45CD7_PLUS_VS_MINUS_DN | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN |
BASSO_GERMINAL_CENTER_CD40_DN | BASSO_CD40_SIGNALING_DN |
BASSO_GERMINAL_CENTER_CD40_UP | BASSO_CD40_SIGNALING_UP |
TSA_HEPATOMA_UP | CHIBA_RESPONSE_TO_TSA |
NICK_RHAPC_UP | Deprecated |
— | NICK_RESPONSE_TO_PROC_TREATMENT_UP |
— | NICK_RESPONSE_TO_PROC_TREATMENT_DN |
— | LEE_LIVER_CANCER_SURVIVAL_DN |
— | LEE_LIVER_CANCER_SURVIVAL_UP |
SCHURINGA_STAT5A_UP | SCHURINGA_STAT5A_TARGETS_UP |
SCHURINGA_STAT5A_DN | SCHURINGA_STAT5A_TARGETS_DN |
MANALO_HYPOXIA_DN | MANALO_HYPOXIA_DN |
MANALO_HYPOXIA_UP | MANALO_HYPOXIA_UP |
FSH_OVARY_MCV152_DN | JI_RESPONSE_TO_FSH_DN |
FSH_OVARY_MCV152_UP | JI_RESPONSE_TO_FSH_UP |
ABRAHAM_MM_VS_AL_UP | Deprecated |
ABRAHAM_MM_VS_AL_DN | Deprecated |
ABRAHAM_AL_VS_MM_UP | ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP |
ABRAHAM_AL_VS_MM_DN | ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN |
KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_DN | KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN |
KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_UP | KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP |
TSA_HEPATOMA_CANCER_UP | CHIBA_RESPONSE_TO_TSA_UP |
TSA_HEPATOMA_CANCER_DN | CHIBA_RESPONSE_TO_TSA_DN |
HASLINGER_B_CLL_17P13 | HASLINGER_B_CLL_WITH_17P13_DELETION |
HASLINGER_B_CLL_MUTATED | HASLINGER_B_CLL_WITH_MUTATED_VH_GENES |
HASLINGER_B_CLL_13Q14 | HASLINGER_B_CLL_WITH_13Q14_DELETION |
HASLINGER_B_CLL_11Q23 | HASLINGER_B_CLL_WITH_11Q23_DELETION |
HASLINGER_B_CLL_12 | HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY |
HASLINGER_B_CLL_6Q21 | HASLINGER_B_CLL_WITH_6Q21_DELETION |
NING_COPD_DN | NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN |
NING_COPD_UP | NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP |
SASAKI_TCELL_LYMPHOMA_VS_CD4_UP | SASAKI_ADULT_T_CELL_LEUKEMIA |
SASAKI_ATL_UP | Deprecated |
IGF_VS_PDGF_DN | KUNINGER_IGF1_VS_PDGFB_TARGETS_DN |
IGF_VS_PDGF_UP | KUNINGER_IGF1_VS_PDGFB_TARGETS_UP |
PRMT5_KD_UP | PAL_PRMT5_TARGETS_UP |
PRMT5_KD_DN | PAL_PRMT5_TARGETS_DN |
HANSON_NFKAPPB_IND | HANSON_HRAS_SIGNALING_VIA_NFKB |
RUIZ_TENASCIN_TARGETS | Deprecated |
— | RUIZ_TNC_TARGETS_UP |
— | RUIZ_TNC_TARGETS_DN |
LOTEM_LEUKEMIA_UP | Deprecated |
MMS_HUMAN_LYMPH_LOW_4HRS_DN | Deprecated |
BLEO_HUMAN_LYMPH_HIGH_24HRS_UP | Deprecated |
MMS_HUMAN_LYMPH_HIGH_24HRS_DN | Deprecated |
BLEO_MOUSE_LYMPH_HIGH_24HRS_DN | Deprecated |
BLEO_HUMAN_LYMPH_HIGH_4HRS_UP | Deprecated |
MMS_MOUSE_LYMPH_HIGH_24HRS_UP | Deprecated |
MMS_MOUSE_LYMPH_HIGH_4HRS_UP | Deprecated |
BLEO_MOUSE_LYMPH_LOW_24HRS_DN | Deprecated |
MMS_HUMAN_LYMPH_HIGH_24HRS_UP | Deprecated |
BLEO_MOUSE_LYMPH_HIGH_4HRS_UP | Deprecated |
— | TERAMOTO_OPN_TARGETS_CLUSTER_1 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_2 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_3 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_4 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_5 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_6 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_7 |
— | TERAMOTO_OPN_TARGETS_CLUSTER_8 |
— | TERAMOTO_FIG_7C_UP |
— | TERAMOTO_FIG_7C_DN |
— | SCHLOSSER_SERUM_RESPONSE_UP |
— | SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC |
— | SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY |
— | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM |
— | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN |
— | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP |
— | SCHLOSSER_SERUM_RESPONSE_DN |
BRCA1_OVEREXP_PROSTATE_UP | Deprecated |
BRCA1KO_MEF_DN | Deprecated |
BRCA1_OVEREXP_PROSTATE_DN | Deprecated |
— | BAE_BRCA1_TARGETS_UP |
— | BAE_BRCA1_TARGETS_DN |
— | VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP |
— | VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN |
— | LI_TABLE_1_UP |
— | LI_TABLE_1_DN |
— | LI_WILMS_TUMOR_ANAPLASTIC_UP |
— | LI_WILMS_TUMOR_ANAPLASTIC_DN |
— | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP |
— | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN |
GOLDRATH_HP | GOLDRATH_HOMEOSTATIC_PROLIFERATION |
GOLDRATH_CYTOLYTIC | Deprecated |
GOLDRATH_CELLCYCLE | Deprecated |
GOLDRATH_MEMORY | GOLDRATH_IMMUNE_MEMORY |
— | GOLDRATH_ANTIGEN_RESPONSE |
STAEGE_EFTS_UP | STAEGE_EWING_FAMILY_TUMOR |
— | MEINHOLD_FIG_3S |
— | MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP |
— | MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN |
— | ODONNELL_METASTASIS_UP |
— | ODONNELL_METASTASIS_DN |
VANASSE_BCL2_TARGETS | VANASSE_BCL2_TARGETS |
— | VANASSE_BCL2_TARGETS_UP |
— | VANASSE_BCL2_TARGETS_DN |
AGEING_KIDNEY_SPECIFIC_DN | RODWELL_AGING_KIDNEY_NO_BLOOD_DN |
AGEING_KIDNEY_DN | RODWELL_AGING_KIDNEY_DN |
AGEING_KIDNEY_SPECIFIC_UP | RODWELL_AGING_KIDNEY_NO_BLOOD_UP |
AGEING_KIDNEY_UP | RODWELL_AGING_KIDNEY_UP |
LEE_ACOX1_DN | LEE_LIVER_CANCER_ACOX1_DN |
LEE_ACOX1_UP | LEE_LIVER_CANCER_ACOX1_UP |
LEE_CIP_DN | LEE_LIVER_CANCER_CIPROFIBRATE_DN |
LEE_CIP_UP | LEE_LIVER_CANCER_CIPROFIBRATE_UP |
LEE_DENA_DN | LEE_LIVER_CANCER_DENA_DN |
LEE_DENA_UP | LEE_LIVER_CANCER_DENA_UP |
LEE_E2F1_DN | LEE_LIVER_CANCER_E2F1_DN |
LEE_E2F1_UP | LEE_LIVER_CANCER_E2F1_UP |
LEE_MYC_DN | LEE_LIVER_CANCER_MYC_DN |
LEE_MYC_E2F1_DN | LEE_LIVER_CANCER_MYC_E2F1_DN |
LEE_MYC_E2F1_UP | LEE_LIVER_CANCER_MYC_E2F1_UP |
LEE_MYC_TGFA_DN | LEE_LIVER_CANCER_MYC_TGFA_DN |
LEE_MYC_TGFA_UP | LEE_LIVER_CANCER_MYC_TGFA_UP |
LEE_MYC_UP | LEE_LIVER_CANCER_MYC_UP |
JAIN_NEMO_DIFF | JAIN_NFKB_SIGNALING |
KANG_TERT_UP | KANG_IMMORTALIZED_BY_TERT_UP |
KANG_TERT_DN | KANG_IMMORTALIZED_BY_TERT_DN |
— | SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP |
— | SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN |
— | ANDRECHEK_ERBB2_TARGETS_UP |
— | ANDRECHEK_ERBB2_TARGETS_DN |
— | SCHRAMM_INHBA_TARGETS_UP |
— | SCHRAMM_INHBA_TARGETS_DN |
LU_IL4BCELL | LU_IL4_SIGNALING |
— | KRASNOSELSKY_TABLE_3 |
— | COLLIS_PRKDC_SUBSTRATES |
— | COLLIS_PRKDC_REGULATORS |
— | AGARWAL_AKT_PATHWAY_TARGETS |
— | YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN |
— | YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP |
— | HU_TABLE_1_UP |
— | HU_TABLE_1_DN |
— | HU_ANGIOGENESIS_UP |
— | HU_ANGIOGENESIS_DN |
— | JAZAG_TGFB1_SIGNALING_UP |
— | JAZAG_TGFB1_SIGNALING_DN |
— | JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP |
— | JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN |
— | KAN_RESPONSE_TO_ARSENIC_TRIOXIDE |
MARCINIAK_CHOP_DIFF | MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP |
ZUCCHI_EPITHELIAL_DN | ZUCCHI_METASTASIS_DN |
ZUCCHI_EPITHELIAL_UP | ZUCCHI_METASTASIS_UP |
CORDERO_KRAS_KD_VS_CONTROL_DN | SWEET_KRAS_TARGETS_DN |
CORDERO_KRAS_KD_VS_CONTROL_UP | SWEET_KRAS_TARGETS_UP |
— | SWEET_LUNG_CANCER_KRAS_UP |
— | SWEET_LUNG_CANCER_KRAS_DN |
— | SWEET_KRAS_ONCOGENIC_SIGNATURE |
— | TSUNODA_CISPLATIN_RESISTANCE_UP |
— | TSUNODA_CISPLATIN_RESISTANCE_DN |
— | TSUNODA_TABLE_2_UP |
— | TSUNODA_TABLE_2_DN |
— | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP |
— | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN |
— | LANG_MYB_FAMILY_TARGETS |
— | DACOSTA_TABLE_1S_XPCS_4_UP |
— | DACOSTA_TABLE_1S_XPCS_4_DN |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN |
— | DACOSTA_TABLE_1S_TTD_8_UP |
— | DACOSTA_TABLE_1S_TTD_8_DN |
— | DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP |
— | DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN |
— | DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP |
— | DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_UP |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN |
— | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP |
— | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP |
— | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN |
— | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP |
— | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN |
— | LUI_TABLE_1_UP |
— | LUI_TABLE_1_DN |
— | LUI_THYROID_CANCER_PAX8_PPARG_UP |
— | LUI_THYROID_CANCER_PAX8_PPARG_DN |
— | LUI_THYROID_CANCER_CLUSTER_1 |
— | LUI_THYROID_CANCER_CLUSTER_2 |
— | LUI_THYROID_CANCER_CLUSTER_3 |
— | LUI_THYROID_CANCER_CLUSTER_4 |
— | LUI_THYROID_CANCER_CLUSTER_5 |
— | LUI_TARGETS_OF_PAX8_PPARG_FUSION |
— | ZHANG_INTERFERON_RESPONSE |
BOQUEST_CD31PLUS_VS_CD31MINUS_DN | Deprecated |
BOQUEST_CD31PLUS_VS_CD31MINUS_UP | Deprecated |
— | BOQUEST_STEM_CELL_UP |
— | BOQUEST_STEM_CELL_DN |
— | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP |
— | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN |
WANG_MLL_CBP_VS_GMP_UP | WANG_TARGETS_OF_MLL_CBP_FUSION_UP |
WANG_MLL_CBP_VS_GMP_DN | WANG_TARGETS_OF_MLL_CBP_FUSION_DN |
— | WAESCH_ANAPHASE_PROMOTING_COMPLEX |
— | WAESCH_APC_YEAST |
— | SCHULTE_TRKB_0.5H VS TRKB |
— | SCHULTE_TRKB_1H VS TRKB |
— | SCHULTE_TRKB_6H VS TRKB |
— | SCHULTE_TRKB_24H VS TRKB |
— | SCHULTE_TRKA_0.5H VS TRKA |
— | SCHULTE_TRKA_1H VS TRKA |
— | SCHULTE_TRKA_6H VS TRKA |
— | SCHULTE_TRKA_24H VS TRKA |
— | SCHULTE_VEC_0.5H VS VEC |
— | SCHULTE_VEC_1H VS VEC |
— | SCHULTE_VEC_6H VS VEC |
— | SCHULTE_VEC_24H VS VEC |
— | MISSIAGLIA_REGULATED_BY_METHYLATION_UP |
— | MISSIAGLIA_REGULATED_BY_METHYLATION_DN |
KENNY_WNT_UP | KENNY_CTNNB1_TARGETS_UP |
KENNY_WNT_DN | KENNY_CTNNB1_TARGETS_DN |
— | LI_PROSTATE_CANCER_EPIGENETIC |
BECKER_ESTROGEN_RESPONSIVE_SUBSET_2 | Deprecated |
BECKER_TAMOXIFEN_RESISTANT_UP | BECKER_TAMOXIFEN_RESISTANCE_UP |
BECKER_IFN_INDUCIBLE_SUBSET_1 | Deprecated |
BECKER_CANCER_ASSOCIATED_SUBSET_1 | Deprecated |
BECKER_CANCER_ASSOCIATED_SUBSET_2 | Deprecated |
BECKER_TAMOXIFEN_RESISTANT_DN | BECKER_TAMOXIFEN_RESISTANCE_DN |
ET743_RESIST_UP | MARCHINI_TRABECTEDIN_RESISTANCE_UP |
ET743_RESIST_DN | MARCHINI_TRABECTEDIN_RESISTANCE_DN |
NUMATA_G_CSF_DIFF | NUMATA_CSF3_SIGNALING_VIA_STAT3 |
— | URBICH_MRNA_EXPRESSION_IN_EPC_UP |
— | URBICH_MRNA_EXPRESSION_IN_EPC_DN |
— | URBICH_MRNA_EXPRESSION_IN_HUVEC_UP |
— | URBICH_MRNA_EXPRESSION_IN_HUVEC_DN |
— | URBICH_RNA_EXPRESSION_IN_CD14+_MONOCYTES_UP |
— | URBICH_RNA_EXPRESSION_IN_CD14+_MONOCYTES_DN |
— | DIRMEIER_LMP1_RESPONSE_EARLY |
— | DIRMEIER_CLUSTER_2 |
— | DIRMEIER_LMP1_RESPONSE_LATE_UP |
— | DIRMEIER_LMP1_RESPONSE_LATE_DN |
— | NEBEN_FIG_3 |
— | NEBEN_FIG_1 |
— | NEBEN_AML_WITH_MUTATED_FLT3_OR_NRAS_UP |
— | NEBEN_AML_WITH_MUTATED_FLT3_OR_NRAS_DN |
— | NEBEN_TABLE_2_FLT3-TKD_UP |
— | NEBEN_TABLE_2_FLT3-TKD_DN |
— | NEBEN_TABLE_2_NRAS_UP |
— | NEBEN_TABLE_2_NRAS_DN |
— | BORLAK_LIVER_CANCER_EGF_UP |
— | BORLAK_LIVER_CANCER_EGF_DN |
— | CASTRO_APC IN YEAST |
— | CASTRO_S_POMBE |
— | CASTRO_ANAPHASE_PROMOTING_COMPLEX |
AD12_ANY_DN | Deprecated |
AD12_24HRS_DN | Deprecated |
AD12_32HRS_DN | Deprecated |
AD12_48HRS_DN | Deprecated |
— | DORN_ADENOVIRUS_INFECTION_12HR_UP |
— | DORN_ADENOVIRUS_INFECTION_12HR_DN |
— | DORN_ADENOVIRUS_INFECTION_24HR_UP |
— | DORN_ADENOVIRUS_INFECTION_24HR_DN |
— | DORN_ADENOVIRUS_INFECTION_32HR_UP |
— | DORN_ADENOVIRUS_INFECTION_32HR_DN |
— | DORN_ADENOVIRUS_INFECTION_48HR_UP |
— | DORN_ADENOVIRUS_INFECTION_48HR_DN |
— | HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER |
— | HEIDENBLAD_TABLE_1S |
— | HEIDENBLAD_AMPLICON_8Q24_UP |
— | HEIDENBLAD_AMPLICON_8Q24_DN |
— | HEIDENBLAD_AMPLICON_12P11_12_UP |
— | HEIDENBLAD_AMPLICON_12P11_12_DN |
— | BEGUM_FIG_5_UP |
— | BEGUM_FIG_5_DN |
— | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP |
— | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN |
— | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3 |
— | KANG_GIST_WITH_PDGFRA_UP |
— | KANG_GIST_WITH_PDGFRA_DN |
LE_MYELIN_DN | LE_EGR2_TARGETS_DN |
LE_MYELIN_UP | LE_EGR2_TARGETS_UP |
LEI_HOXC8_DN | LEI_HOXC8_TARGETS_UP |
LEI_HOXC8_UP | LEI_HOXC8_TARGETS_DN |
WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_UP | WONG_IFNA2_RESISTANCE_UP |
WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_DN | WONG_IFNA2_RESISTANCE_DN |
LIZUKA_G1_SM_G2 | IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN |
LIZUKA_G1_GR_G2 | IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP |
LIZUKA_G2_SM_G3 | IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN |
LIZUKA_G2_GR_G3 | IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP |
LIZUKA_L0_SM_L1 | IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN |
LIZUKA_L0_GR_L1 | IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP |
LIZUKA_L1_SM_G1 | IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN |
LIZUKA_L1_GR_G1 | IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP |
CHESLER_D6MIT150_TRANSCRIPTION_FACTORS_GLOCUS | Deprecated |
CHESLER_D6MIT150_CIS_GLOCUS | CHESLER_BRAIN_D6MIT150_QTL_CIS |
CHESLER_BRAIN_CIS_GENES | CHESLER_BRAIN_QTL_CIS |
CHESLER_BRAIN_ONLY_SUBSET | Deprecated |
CHESLER_BRAIN_TRANS_GENES | CHESLER_BRAIN_QTL_TRANS |
CHESLER_BRAIN_HIGHEST_VARIANCE_GENES | CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE |
CHESLER_HIGHEST_FOLD_RANGE_GENES | CHESLER_BRAIN_HIGHEST_EXPRESSION |
CHESLER_D6MIT150_NEURAL_TARGETS_GLOCUS | CHESLER_BRAIN_D6MIT150_QTL_TRANS |
CHESLER_BRAIN_NEURAL_HIGH_GENES | Deprecated |
BYSTRYKH_SCP2_QTL | BYSTRYKH_SCP2_QTL |
BYSTRYKH_FGF3_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 |
BYSTRYKH_HSC_CIS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS |
BYSTRYKH_HSC_AND_BRAIN_TRANS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS |
BYSTRYKH_HSC_AND_BRAIN_CIS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS |
BYSTRYKH_RUNX1_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1 |
BYSTRYKH_HSC_TRANS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS |
BYSTRYKH_FLI1_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1 |
BYSTRYKH_IL3RA_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA |
BYSTRYKH_HSC_TRANS_REGULATED_BY_QTL_SCP2 | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS |
TNFA_NFKB_DEP_UP | Deprecated |
— | TIAN_TNF_SIGNALING_VIA_NFKB |
— | TIAN_TNF_SIGNALING_NOT_VIA_NFKB |
BRG1_H1299_UP | MEDINA_SMARCA4_TARGETS |
— | NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF |
— | FUNG_IL2_SIGNALING_2 |
— | FUNG_IL2_SIGNALING_1 |
— | FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1 |
— | FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES |
— | PATIL_TABLE_2 |
— | PATIL_LIVER_CANCER |
— | DAUER_STAT3_TARGETS_UP |
— | DAUER_STAT3_TARGETS_DN |
— | WANG_METHYLATED_IN_BREAST_CANCER |
— | WOERNER_TABLE_3 |
— | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP |
— | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN |
— | SILIGAN_BOUND_BY_EWS_FLT1_FUSION |
— | MATTIOLI_MGUS_VS_PCL |
— | MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA |
— | MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS |
— | MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS |
— | CAIRO_PML_TARGETS_BOUND_BY_MYC_UP |
— | CAIRO_PML_TARGETS_BOUND_BY_MYC_DN |
PEART_HISTONE_UP | PEART_HDAC_PROLIFERATION_CLUSTER_UP |
PEART_HISTONE_DN | PEART_HDAC_PROLIFERATION_CLUSTER_DN |
ROTH_HTERT_DIFF | Deprecated |
ROTH_HTERT_DN | ROETH_TERT_TARGETS_DN |
ROTH_HTERT_UP | ROETH_TERT_TARGETS_UP |
SANA_TNFA_ENDOTHELIAL_DN | SANA_RESPONSE_TO_TNF_DN |
SANA_IFNG_ENDOTHELIAL_UP | SANA_RESPONSE_TO_IFNG_UP |
SANA_TNFA_ENDOTHELIAL_UP | SANA_RESPONSE_TO_TNF_UP |
SANA_IFNG_ENDOTHELIAL_DN | SANA_RESPONSE_TO_IFNG_DN |
— | MANN_RESPONSE_TO_AMIFOSTINE_UP |
— | MANN_RESPONSE_TO_AMIFOSTINE_DN |
— | JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP |
— | JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN |
— | JOHANSSON_TABLE_2_PDGFRX |
— | JOHANSSON_TABLE_2_TUMOR |
— | JOHANSSON_TABLE_2_BTL |
— | JOHANSSON_TABLE_2_OTHER |
— | JOHANSSON_TABLE_2_DIFF |
— | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP |
— | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN |
WANG_HOXA9_VS_MEIS1_DN | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN |
WANG_HOXA9_VS_MEIS1_UP | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP |
APPEL_IMATINIB_UP | APPEL_IMATINIB_RESPONSE |
CHEN_HOXA5_TARGETS_UP | Deprecated |
CHEN_HOXA5_TARGETS_DN | Deprecated |
— | CHEN_HOXA5_TARGETS_6HR_UP |
— | CHEN_HOXA5_TARGETS_6HR_DN |
— | CHEN_HOXA5_TARGETS_9HR_UP |
— | CHEN_HOXA5_TARGETS_9HR_DN |
— | KARLSSON_TABLE_2 |
BASSO_REGULATORY_HUBS | BASSO_B_LYMPHOCYTE_NETWORK |
— | BARIS_THYROID_CANCER_UP |
— | BARIS_THYROID_CANCER_DN |
FALT_BCLL_IG_MUTATED_VS_WT_UP | FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP |
FALT_BCLL_IG_MUTATED_VS_WT_DN | FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN |
FALT_BCLL_DN | FAELT_B_CLL_WITH_VH3_21_DN |
FALT_BCLL_UP | FAELT_B_CLL_WITH_VH3_21_UP |
— | AMUNDSON_DNA_DAMAGE_RESPONSE_TP53 |
— | AMUNDSON_SUPPL_DATA_SET_3 |
— | AMUNDSON_GENOTOXIC_SIGNATURE |
— | AMUNDSON_RESPONSE_TO_ARSENITE |
— | MAINA_HYPOXIA_VHL_TARGETS_UP |
— | MAINA_HYPOXIA_VHL_TARGETS_DN |
— | MAINA_VHL_TARGETS_UP |
— | MAINA_VHL_TARGETS_DN |
— | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS |
— | SNIJDERS_TABLE_1S |
MOREAUX_TACI_XG_13_UP | Deprecated |
MOREAUX_TACI_HI_IN_PPC_UP | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN |
MOREAUX_TACI_BAFF_DN | Deprecated |
MOREAUX_TACI_XG_13_DN | Deprecated |
MOREAUX_TACI_BAFF_UP | Deprecated |
MOREAUX_TACI_HI_VS_LOW_UP | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP |
MOREAUX_TACI_HI_VS_LOW_DN | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN |
MOREAUX_TACI_HI_IN_BMPC | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP |
— | WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION |
MARSHALL_SPLEEN_BAL | Deprecated |
— | MARSHALL_VIRAL_INFECTION_RESPONSE_UP |
— | MARSHALL_VIRAL_INFECTION_RESPONSE_DN |
ALCALAY_AML_NPMC_UP | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP |
ALCALAY_AML_NPMC_DN | ALCALAY_AML_BY_NPM1_LOCALIZATION_DN |
TCELL_ANERGIC_UP | SAFFORD_T_LYMPHOCYTE_ANERGY |
— | VAN_VUGT_MITOTIC_EXIT_GENES |
GH_EXOGENOUS_EARLY_UP | Deprecated |
GH_EXOGENOUS_LATE_UP | Deprecated |
GH_EXOGENOUS_ANY_UP | XU_GH1_EXOGENOUS_TARGETS_UP |
GH_EXOGENOUS_EARLY_DN | Deprecated |
GH_AUTOCRINE_UP | XU_GH1_AUTOCRINE_TARGETS_UP |
GH_EXOGENOUS_ANY_DN | XU_GH1_EXOGENOUS_TARGETS_DN |
GH_AUTOCRINE_DN | XU_GH1_AUTOCRINE_TARGETS_DN |
GH_EXOGENOUS_ALL_UP | Deprecated |
GH_EXOGENOUS_MIDDLE_UP | Deprecated |
GH_EXOGENOUS_LATE_DN | Deprecated |
— | SASAKI_TARGETS_OF_TP73_AND_TP63 |
— | RUGO_TABLE_1S |
— | RUGO_ENVIRONMENTAL_STRESS_RESPONSE_UP |
— | RUGO_ENVIRONMENTAL_STRESS_RESPONSE_DN |
— | RUGO_RESPONSE_TO_4NQO |
— | RUGO_RESPONSE_TO_GAMMA_RADIATION |
— | RUGO_UV_RESPONSE |
— | RUGO_STRESS_RESPONSE_SUBSET_F |
— | RUGO_STRESS_RESPONSE_SUBSET_H |
— | RUGO_STRESS_RESPONSE_SUBSET_G |
— | RUGO_TABLE_2S_UP |
— | RUGO_TABLE_2S_DN |
— | YANAGIDA_CIS_AT_26 |
— | YANAGIDA_RIS_AT_20 |
— | YANAGIDA_RIS_AT_5 |
— | CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP |
— | CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN |
— | POOLA_INVASIVE_BREAST_CANCER_UP |
— | POOLA_INVASIVE_BREAST_CANCER_DN |
CARIES_PULP_HIGH_UP | Deprecated |
CARIES_PULP_DN | MCLACHLAN_DENTAL_CARIES_DN |
CARIES_PULP_UP | MCLACHLAN_DENTAL_CARIES_UP |
MYOD_NIH3T3_DN | DELASERNA_MYOD_TARGETS_DN |
MYOD_NIH3T3_UP | DELASERNA_MYOD_TARGETS_UP |
MYOD_BRG1_UP | DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4 |
— | KORKOLA_TABLE_1S |
— | KORKOLA_EMBRYONAL_CARCINOMA |
— | KORKOLA_TERATOMA |
— | KORKOLA_YOLK_SAC_TUMOR |
— | KORKOLA_CHORIOCARCINOMA |
PITUITARY_FETAL_DN | MA_PITUITARY_FETAL_VS_ADULT_DN |
PITUITARY_FETAL_UP | MA_PITUITARY_FETAL_VS_ADULT_UP |
IRS1_KO_ADIP_DN | TSENG_IRS1_TARGETS_DN |
IRS1_KO_ADIP_UP | TSENG_IRS1_TARGETS_UP |
IRS_KO_ADIP_DN | TSENG_ADIPOGENIC_POTENTIAL_DN |
IRS_KO_ADIP_UP | TSENG_ADIPOGENIC_POTENTIAL_UP |
ET743_SARCOMA_24HRS_UP | Deprecated |
ET743_SARCOMA_UP | MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP |
ET743_SARCOMA_72HRS_DN | Deprecated |
ET743_SARCOMA_72HRS_UP | Deprecated |
ET743_SARCOMA_24HRS_DN | Deprecated |
ET743_SARCOMA_6HRS_UP | Deprecated |
ET743_SARCOMA_DN | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN |
ET743_SARCOMA_48HRS_DN | Deprecated |
— | WEINMANN_ADAPTATION_TO_HYPOXIA_UP |
— | WEINMANN_ADAPTATION_TO_HYPOXIA_DN |
— | YANAGIHARA_ESX1_TARGETS |
— | ZIRN_TRETINOIN_RESPONSE_WT1_UP |
— | ZIRN_TRETINOIN_RESPONSE_WT1_DN |
— | ZIRN_TRETINOIN_RESPONSE_UP |
— | ZIRN_TRETINOIN_RESPONSE_DN |
— | LANDIS_ERBB2_BREAST_TUMORS_65_UP |
— | LANDIS_ERBB2_BREAST_TUMORS_65_DN |
— | LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP |
— | LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN |
— | LANDIS_TABLE_1S_UP |
— | LANDIS_TABLE_1S_DN |
— | LANDIS_ERBB2_BREAST_TUMORS_324_UP |
— | LANDIS_ERBB2_BREAST_TUMORS_324_DN |
— | GRUETZMANN_PANCREATIC_CANCER_UP |
— | GRUETZMANN_PANCREATIC_CANCER_DN |
GAMMA_UNIQUE_FIBRO_DN | Deprecated |
UV_ESR_OLD_UNREG | Deprecated |
UV_ESR_WS_UNREG | Deprecated |
GAMMA-UV_FIBRO_DN | Deprecated |
4NQO_UNIQUE_FIBRO_DN | Deprecated |
4NQO_UNIQUE_FIBRO_UP | Deprecated |
UV-4NQO_FIBRO_UP | Deprecated |
ESR_FIBROBLAST_DN | Deprecated |
UV_UNIQUE_FIBRO_DN | Deprecated |
4NQO_ESR_OLD_UNREG | Deprecated |
UV_UNIQUE_FIBRO_UP | Deprecated |
GAMMA_ESR_WS_UNREG | Deprecated |
GAMMA-UV_FIBRO_UP | Deprecated |
UV-4NQO_FIBRO_DN | Deprecated |
4NQO_ESR_WS_UNREG | Deprecated |
GAMMA_ESR_OLD_UNREG | Deprecated |
GAMMA_UNIQUE_FIBRO_UP | Deprecated |
ESR_FIBROBLAST_UP | Deprecated |
— | KYNG_DNA_DAMAGE_BY_4NQO |
— | KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION |
— | KYNG_DNA_DAMAGE_BY_UV |
— | KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION |
— | KYNG_DNA_DAMAGE_BY_4NQO_OR_UV |
— | KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS |
— | KYNG_DNA_DAMAGE_UP |
— | KYNG_DNA_DAMAGE_DN |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP |
— | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN |
— | FARMER_BREAST_CANCER_APOCRINE VS LUMINAL |
— | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL |
— | FARMER_BREAST_CANCER_BASAL_VS_LULMINAL |
— | FARMER_BREAST_CANCER_CLUSTER_1 |
— | FARMER_BREAST_CANCER_CLUSTER_8 |
— | FARMER_BREAST_CANCER_CLUSTER_7 |
— | FARMER_BREAST_CANCER_CLUSTER_6 |
— | FARMER_BREAST_CANCER_CLUSTER_5 |
— | FARMER_BREAST_CANCER_CLUSTER_4 |
— | FARMER_BREAST_CANCER_CLUSTER_2 |
— | FARMER_BREAST_CANCER_CLUSTER_3 |
ZHANG_EFT_EWSFLI1_UP | ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION |
— | GLINSKY_CANCER_DEATH_UP |
— | GLINSKY_CANCER_DEATH_DN |
— | VANHARANTA_UTERINE_FIBROID_UP |
— | VANHARANTA_UTERINE_FIBROID_DN |
— | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP |
— | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN |
— | VANHARANTA_TABLE_1 |
— | KERLEY_RESPONSE_TO_CISPLATIN_UP |
— | KERLEY_RESPONSE_TO_CISPLATIN_DN |
— | OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
— | OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN |
— | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
— | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN |
— | OUELLET_TABLE_11S_UP |
— | OUELLET_TABLE_11S_DN |
— | OUELLET_TABLE_12S_UP |
— | OUELLET_TABLE_12S_DN |
— | OUELLET_TABLE_3_UP |
— | OUELLET_TABLE_3_DN |
— | OUELLET_TABLE_2_UP |
— | OUELLET_TABLE_2_DN |
FERRARI_4HPR_UP | FERRARI_4HPR_UP |
— | FERRARI_RESPONSE_TO_FENRETINIDE_UP |
— | FERRARI_RESPONSE_TO_FENRETINIDE_DN |
AGED_MOUSE_HIPPOCAMPUS_MULTI_UP | Deprecated |
AGED_MOUSE_HIPPOCAMPUS_ANY_DN | Deprecated |
AGED_MOUSE_RETINA_ANY_UP | Deprecated |
AGED_MOUSE_HIPPOCAMPUS_ANY_UP | Deprecated |
AGED_MOUSE_RETINA_ANY_DN | Deprecated |
BCNU_GLIOMA_NOMGMT_24HRS_UP | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP |
BCNU_GLIOMA_MGMT_24HRS_DN | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN |
BCNU_GLIOMA_NOMGMT_48HRS_UP | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP |
BCNU_GLIOMA_NOMGMT_48HRS_DN | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN |
BCNU_GLIOMA_MGMT_48HRS_DN | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN |
BCNU_GLIOMA_MGMT_48HRS_UP | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP |
— | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN |
— | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP |
GERY_CEBP_TARGETS | GERY_CEBP_TARGETS |
CPR_LOW_LIVER_UP | WENG_POR_TARGETS_GLOBAL_UP |
CPR_LOW_LIVER_DN | WENG_POR_TARGETS_GLOBAL_DN |
CPR_NULL-LOW_LIVER_UP | WENG_POR_DOSAGE |
CPR_NULL_LIVER_UP | WENG_POR_TARGETS_LIVER_UP |
CPR_NULL_LIVER_DN | WENG_POR_TARGETS_LIVER_DN |
HYPERME_COLONCA_SW48 | WEBER_METHYLATED_IN_COLON_CANCER |
— | INAMURA_LUNG_CANCER_SCC_UP |
— | INAMURA_LUNG_CANCER_SCC_DN |
— | INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP |
— | INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN |
— | ROSTY_TABLE_4S_UP |
— | ROSTY_TABLE_4S_DN |
— | ROSTY_TABLE_5S_UP |
— | ROSTY_TABLE_5S_DN |
— | ROSTY_TABLE_1S |
— | ROSTY_TABLE_2S |
— | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER |
— | ROSTY_TABLE_6S |
— | YAN_ESCAPE_FROM_ANOIKIS |
— | EINAV_INTERFERON_SIGNATURE_IN_CANCER |
— | LUCAS_TABLE_2_UP |
— | LUCAS_TABLE_2_DN |
— | LUCAS_HNF4A_TARGETS_UP |
— | LUCAS_HNF4A_TARGETS_DN |
— | GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION |
— | SIMBULAN_UV_RESPONSE_NORMAL_UP |
— | SIMBULAN_UV_RESPONSE_NORMAL_DN |
— | SIMBULAN_UV_RESPONSE_IMMORTALIZED_UP |
— | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN |
— | WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP |
— | WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN |
— | WATTEL_FIG_1_DN |
— | WATTEL_FIG_1_UP |
NOVA2_KO_SPLICING | ULE_SPLICING_VIA_NOVA2 |
— | GYORFFY_TABLE_2_UP |
— | GYORFFY_TABLE_2_DN |
— | GYORFFY_TABLE_2_AGAIN_UP |
— | GYORFFY_TABLE_2_AGAIN_DN |
— | GYORFFY_FIG_2A_UP |
— | GYORFFY_FIG_2A_DN |
— | GYORFFY_FIG_2B_UP |
— | GYORFFY_FIG_2B_DN |
— | GYORFFY_DOXORUBICIN_RESISTANCE |
— | GYORFFY_MITOXANTRONE_RESISTANCE |
— | UROSEVIC_RESPONSE_TO_IMIQUIMOD |
ZMPSTE24_KO_DN | VARELA_ZMPSTE24_TARGETS_DN |
ZMPSTE24_KO_UP | VARELA_ZMPSTE24_TARGETS_UP |
— | BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP |
— | BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN |
— | BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP |
— | BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN |
— | TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP |
— | TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN |
— | GALE_APL_WITH_FLT3_MUTATED_DN |
— | GALE_APL_WITH_FLT3_MUTATED_UP |
ERM_KO_SERTOLI_DN | CHEN_ETV5_TARGETS_SERTOLI |
ERM_KO_TESTES_DN | CHEN_ETV5_TARGETS_TESTIS |
VERHAAK_AML_NPM1_MUT_VS_WT_UP | VERHAAK_AML_WITH_NPM1_MUTATED_UP |
VERHAAK_AML_NPM1_MUT_VS_WT_DN | VERHAAK_AML_WITH_NPM1_MUTATED_DN |
— | WU_ALZHEIMER_DISEASE_UP |
— | WU_ALZHEIMER_DISEASE_DN |
— | CHOW_RASSF1_TARGETS_UP |
— | CHOW_RASSF1_TARGETS_DN |
— | KIM_MYC_AMPLIFICATION_TARGETS_UP |
— | KIM_MYC_AMPLIFICATION_TARGETS_DN |
— | KIM_MYCN_AMPLIFICATION_TARGETS_UP |
— | KIM_MYCN_AMPLIFICATION_TARGETS_DN |
— | KIM_MYCL1_AMPLIFICATION_TARGETS_UP |
— | KIM_MYCL1_AMPLIFICATION_TARGETS_DN |
— | SYED_TABLE_1_UP |
— | SYED_TABLE_1_DN |
— | SYED_ESTRADIOL_RESPONSE |
TFF2_KO_UP | Deprecated |
— | BAUS_TFF2_TARGETS_UP |
— | BAUS_TFF2_TARGETS_DN |
LAL_KO_6MO_UP | LIAN_LIPA_TARGETS_6M |
LAL_KO_3MO_UP | LIAN_LIPA_TARGETS_3M |
— | MIZUKAMI_HYPOXIA_UP |
— | MIZUKAMI_HYPOXIA_DN |
BAF57_BT549_DN | WANG_SMARCE1_TARGETS_DN |
BAF57_BT549_UP | WANG_SMARCE1_TARGETS_UP |
IFN_BETA_GLIOMA_UP | NATSUME_RESPONSE_TO_INTERFERON_BETA_UP |
IFN_BETA_GLIOMA_DN | NATSUME_RESPONSE_TO_INTERFERON_BETA_DN |
XU_ATRA_PLUSNSC_UP | XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP |
XU_ATRA_UP | XU_RESPONSE_TO_TRETINOIN_UP |
XU_ATRA_DN | XU_RESPONSE_TO_TRETINOIN_DN |
XU_ATRA_PLUSNSC_DN | XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN |
SHEPARD_CRASH_AND_BURN_MUT_VS_WT_UP | SHEPARD_CRUSH_AND_BURN_MUTANT_UP |
SHEPARD_BMYB_MORPHOLINO_DN | SHEPARD_BMYB_MORPHOLINO_DN |
SHEPARD_GENES_COMMON_BW_CB_MO | SHEPARD_BMYB_TARGETS |
SHEPARD_CRASH_AND_BURN_MUT_VS_WT_DN | SHEPARD_CRUSH_AND_BURN_MUTANT_DN |
SHEPARD_BMYB_MORPHOLINO_UP | SHEPARD_BMYB_MORPHOLINO_UP |
SHEPARD_NEG_REG_OF_CELL_PROLIFERATION | Deprecated |
SHEPARD_CELL_PROLIFERATION | Deprecated |
SHEPARD_POS_REG_OF_CELL_PROLIFERATION | Deprecated |
— | LIU_TABLE_1 |
— | SEIDEN_MET_SIGNALING |
— | SEIDEN_ONCOGENESIS_BY_MET |
— | SEIDEN-LONG_TABLE_3 |
CHIARETTI_ZAP70_DIFF | CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 |
— | OSWALD_HEMATOPOIETIC_STEM_CELLS_IN_COLLAGEN_GEL_UP |
— | OSWALD_HEMATOPOIETIC_STEM_CELLS_IN_COLLAGEN_GEL_DN |
— | KOBAYASHI_RESPONSE_TO_ROMIDEPSIN |
— | KLEIN_TARGETS_OF_BCR_ABL1_FUSION |
— | LIU_CMYB_TARGETS_UP |
— | LIU_CMYB_TARGETS_DN |
— | LIU_VMYB_TARGETS_UP |
— | LIU_VMYB_TARGETS_DN |
— | LIU_TABLE_1S_CMYB_UP |
— | LIU_TABLE_1S_CMYB_DN |
— | LIU_TABLE_4S_UP |
— | LIU_TABLE_4S_DN |
— | LIU_TARGETS_OF_VMYB_VS_CMYB_UP |
— | LIU_TARGETS_OF_VMYB_VS_CMYB_DN |
— | HASINA_NOL7_TARGETS_UP |
— | HASINA_NOL7_TARGETS_DN |
POD1_KO_DN | CUI_TCF21_TARGETS_UP |
POD1_KO_MOST_DN | Deprecated |
POD1_KO_MOST_UP | CUI_TCF21_TARGETS_DN |
POD1_KO_UP | Deprecated |
— | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP |
— | JAATINEN_HEMATOPOIETIC_STEM_CELL_DN |
— | WANG_RESPONSE_TO_BEXAROTENE_UP |
— | WANG_RESPONSE_TO_BEXAROTENE_DN |
— | ROVERSI_GLIOMA_COPY_NUMBER_DN |
— | ROVERSI_GLIOMA_LOH_REGIONS |
— | ROVERSI_GLIOMA_COPY_NUMBER_UP |
— | KONDO_HYPOXIA |
— | TSAI_RESPONSE_TO_IONIZING_RADIATION |
— | HUMMERICH_CO. VS TPA_UP |
— | HUMMERICH_CO. VS TPA_DN |
— | HUMMERICH_BENIGN_SKIN_TUMOR_UP |
— | HUMMERICH_BENIGN_SKIN_TUMOR_DN |
— | HUMMERICH_CO. VS SCC_UP |
— | HUMMERICH_CO. VS SCC_DN |
— | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP |
— | HUMMERICH_MALIGNANT_SKIN_TUMOR_DN |
— | HUMMERICH_CO. VS PAP_MALIGNANT TUMOURS_UP |
— | HUMMERICH_CO. VS PAP_MALIGNANT TUMOURS_DN |
— | HUMMERICH_CO. VS TPA_MALIGNANT TUMOURS_UP |
— | HUMMERICH_CO. VS TPA_MALIGNANT TUMOURS_DN |
— | HUMMERICH_SKIN_CANCER_PROGRESSION_UP |
— | HUMMERICH_SKIN_CANCER_PROGRESSION_DN |
— | KOINUMA_COLON_CANCER_MSI_UP |
— | KOINUMA_COLON_CANCER_MSI_DN |
— | YANG_BREAST_CANCER_ESR1_UP |
— | YANG_BREAST_CANCER_ESR1_DN |
— | YANG_BREAST_CANCER_ESR1_LASER_UP |
— | YANG_BREAST_CANCER_ESR1_LASER_DN |
— | YANG_BREAST_CANCER_ESR1_BULK_UP |
— | YANG_BREAST_CANCER_ESR1_BULK_DN |
MYC_ONCOGENIC_SIGNATURE | BILD_MYC_ONCOGENIC_SIGNATURE |
E2F3_ONCOGENIC_SIGNATURE | BILD_E2F3_ONCOGENIC_SIGNATURE |
RAS_ONCOGENIC_SIGNATURE | BILD_HRAS_ONCOGENIC_SIGNATURE |
SRC_ONCOGENIC_SIGNATURE | BILD_SRC_ONCOGENIC_SIGNATURE |
CTNNB1_oncogenic_signature | BILD_CTNNB1_ONCOGENIC_SIGNATURE |
— | STANHILL_HRAS_TRANSFROMATION_UP |
— | STANHILL_HRAS_TRANSFROMATION_DN |
— | HOWLIN_MAMMARY_GLAND_UP |
— | HOWLIN_MAMMARY_GLAND_DN |
— | HOWLIN_PUBERTAL_MAMMARY_GLAND |
— | HOWLIN_CITED1_TARGETS_1_UP |
— | HOWLIN_CITED1_TARGETS_1_DN |
— | HOWLIN_CITED1_TARGETS_2_UP |
— | HOWLIN_CITED1_TARGETS_2_DN |
— | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP |
— | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN |
— | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP |
— | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN |
— | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP |
— | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN |
— | IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM |
— | IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM |
— | GREER_TABLE_1 |
KAMMINGA_EZH2_TARGETS | KAMMINGA_EZH2_TARGETS |
— | KAMMINGA_SENESCENCE |
— | UREN_TABLE_1 |
YANG_OSTECLASTS_SIG | Deprecated |
— | YOSHIMURA_MAPK8_TARGETS_UP |
— | YOSHIMURA_MAPK8_TARGETS_DN |
— | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP |
— | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN |
— | KREPPEL_CD99_TARGETS_UP |
— | KREPPEL_CD99_TARGETS_DN |
— | RASHI_RESPONSE_TO_IONIZING_RADIATION_1 |
— | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 |
— | RASHI_RESPONSE_TO_IONIZING_RADIATION_3 |
— | RASHI_RESPONSE_TO_IONIZING_RADIATION_4 |
— | RASHI_RESPONSE_TO_IONIZING_RADIATION_5 |
— | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 |
— | RASHI_NFKB1_TARGETS |
— | CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN |
— | BALDWIN_PRKCI_TARGETS_UP |
— | BALDWIN_PRKCI_TARGETS_DN |
— | SANCHEZ_MDM2_TARGETS |
— | AUNG_GASTRIC_CANCER |
— | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP |
— | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN |
MATSUDA_VALPHAINKT_DIFF | MATSUDA_NATURAL_KILLER_DIFFERENTIATION |
— | LI_TABLE_1S |
— | LI_LUNG_CANCER |
— | LI_AMPLIFIED_IN_LUNG_CANCER |
— | LI_TABLE_3S |
YU_CMYC_UP | YU_MYC_TARGETS_UP |
YU_CMYC_DN | YU_MYC_TARGETS_DN |
— | TIEN_INTESTINE_PROBIOTICS_2HR_UP |
— | TIEN_INTESTINE_PROBIOTICS_2HR_DN |
— | TIEN_INTESTINE_PROBIOTICS_6HR_UP |
— | TIEN_INTESTINE_PROBIOTICS_6HR_DN |
— | TIEN_INTESTINE_PROBIOTICS_24HR_UP |
— | TIEN_INTESTINE_PROBIOTICS_24HR_DN |
— | BIDUS_METASTASIS_UP |
— | BIDUS_METASTASIS_DN |
— | HATADA_METHYLATED_IN_LUNG_CANCER_UP |
— | HATADA_METHYLATED_IN_LUNG_CANCER_DN |
— | SHANK_TAL1_TARGETS_UP |
— | SHANK_TAL1_TARGETS_DN |
— | SEMBA_FHIT_TARGETS_UP |
— | SEMBA_FHIT_TARGETS_DN |
— | KORKOLA_EMBRYONAL_CARCINOMA_UP |
— | KORKOLA_EMBRYONAL_CARCINOMA_DN |
— | KORKOLA_TERATOMA_UP |
— | KORKOLA_TERATOMA_DN |
— | KORKOLA_YOLK_SAC_TUMOR_UP |
— | KORKOLA_YOLK_SAC_TUMOR_DN |
— | KORKOLA_CHORIOCARCINOMA_UP |
— | KORKOLA_CHORIOCARCINOMA_DN |
— | KORKOLA_SEMINOMA_UP |
— | KORKOLA_SEMINOMA_DN |
— | KORKOLA_CORRELATED_WITH_POU5F1 |
— | KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP |
— | KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN |
— | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP |
— | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN |
XU_CBP_UP | XU_CREBBP_TARGETS_UP |
XU_CBP_DN | XU_CREBBP_TARGETS_DN |
— | LANDIS_TABLE_1_UP |
— | LANDIS_TABLE_1_DN |
— | LANDIS_BREAST_CANCER_PROGRESSION_UP |
— | LANDIS_BREAST_CANCER_PROGRESSION_DN |
— | ENK_UV_RESPONSE_EPIDERMIS_UP |
— | ENK_UV_RESPONSE_EPIDERMIS_DN |
— | ENK_UV_RESPONSE_KERATINOCYTE_UP |
— | ENK_UV_RESPONSE_KERATINOCYTE_DN |
— | CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL |
— | LA_MEN1_TARGETS |
— | REN_MIF_TARGETS_UP |
— | REN_MIF_TARGETS_DN |
— | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP |
— | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN |
— | WANG_TABLE_1_BE_VS_NE_UP |
— | WANG_TABLE_1_BE_VS_NE_DN |
— | WANG_BARRETTS_ESOPHAGUS_UP |
— | WANG_BARRETTS_ESOPHAGUS_DN |
— | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP |
— | WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN |
— | WANG_ESOPHAGUS_CANCER_PROGRESSION_UP |
— | WANG_ESOPHAGUS_CANCER_PROGRESSION_DN |
— | KOMMAGANI_TP63_GAMMA_TARGETS |
GH_GHRHR_KO_24HRS_UP | GOVONI_GH1_TARGETS_24HR_UP |
GH_GHRHR_KO_6HRS_UP | GOVONI_GH1_TARGETS_6HR_UP |
GH_GHRHR_KO_24HRS_DN | GOVONI_GH1_TARGETS_24HR_DN |
GH_GHRHR_KO_6HRS_DN | GOVONI_GH1_TARGETS_6HR_DN |
— | WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP |
— | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN |
— | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP |
— | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN |
— | SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP |
— | SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_DN |
— | HOOI_ST7_TARGETS_UP |
— | HOOI_ST7_TARGETS_DN |
— | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP |
— | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN |
— | SOTIRIOU_TABLE_1S_UP |
— | SOTIRIOU_TABLE_1S_DN |
— | NAKAMURA_LUNG_CANCER |
— | NAKAMURA_LUNG_CANCER_MARKERS |
— | NAKAMURA_ALVEOLAR_EPITHELIUM |
— | NAKAMURA_ALVEOLAR_AND_BRONCHIOLAR_EPITHELIA |
— | NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA |
— | NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS |
— | DOANE_BREAST_CANCER_CLASSES_UP |
— | DOANE_BREAST_CANCER_CLASSES_DN |
— | DOANE_RESPONSE_TO_ANDROGEN_UP |
— | DOANE_RESPONSE_TO_ANDROGEN_DN |
— | DOANE_BREAST_CANCER_ESR1_UP |
— | DOANE_BREAST_CANCER_ESR1_DN |
— | GESERICK_TERT_TARGETS_UP |
— | GESERICK_TERT_TARGETS_DN |
— | GESERICK_TABLE_1S_UP |
— | GESERICK_TABLE_1S_DN |
— | CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP |
— | CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN |
— | CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP |
— | CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN |
HESS_HOXAANMEIS1_DN | HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN |
HESS_HOXAANMEIS1_UP | HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP |
MENSE_HYPOXIA_DN | MENSE_HYPOXIA_DN |
MENSE_HYPOXIA_UP | MENSE_HYPOXIA_UP |
MENSE_HYPOXIA_TRANSPORTER_GENES | Deprecated |
MENSE_HYPOXIA_APOPTOSIS_GENES | Deprecated |
— | ODONNELL_TFRC_TARGETS_UP |
— | ODONNELL_TFRC_TARGETS_DN |
— | ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP |
— | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN |
RUTELLA_HEMATOGFSNDCS_DIFF | Deprecated |
RUTELLA_HEPATGFSNDCS_UP | Deprecated |
— | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP |
— | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN |
— | RUTELLA_RESPONSE_TO_HGF_UP |
— | RUTELLA_RESPONSE_TO_HGF_DN |
— | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP |
— | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN |
— | PROVENZANI_METASTASIS_UP |
— | PROVENZANI_METASTASIS_DN |
— | LEE_LIVER_CANCER_HEPATOBLAST |
— | FURUKAWA_DUSP6_TARGETS_PCI35_UP |
— | FURUKAWA_DUSP6_TARGETS_PCI35_DN |
— | FURUKAWA_DUSP6_TARGETS_PK8 |
— | LINDGREN_BLADDER_CANCER_CLUSTER_1_UP |
— | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN |
— | LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP |
— | LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN |
— | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP |
— | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN |
— | LINDGREN_BLADDER_CANCER_CLUSTER_2B |
— | LINDGREN_TABLE_4AS |
— | LINDGREN_TABLE_4BS |
— | LINDGREN_TABLE_4CS |
— | LINDGREN_TABLE_4DS |
— | LINDGREN_TABLE_4ES |
— | LINDGREN_TABLE_4FS |
— | LINDGREN_TABLE_4GS |
— | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE |
— | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q |
— | EHRLICH_TABLE_1_DN |
— | EHRLICH_TABLE_1_UP |
— | PIEPOLI_LGI1_TARGETS_UP |
— | PIEPOLI_LGI1_TARGETS_DN |
— | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP |
— | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN |
— | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP |
— | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN |
— | LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP |
— | LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN |
— | LOPEZ_EPITHELIOID_MESOTHELIOMA |
— | LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP |
— | LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN |
— | LOPEZ_MESOTHELIOMA_SURVIVAL_UP |
— | LOPEZ_MESOTHELIOMA_SURVIVAL_DN |
— | WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP |
— | WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN |
— | HAEGERSTRAND_RESPONSE_TO_IMATINIB |
— | DITTMER_PTHLH_TARGETS_UP |
— | DITTMER_PTHLH_TARGETS_DN |
— | MAYBURD_RESPONSE_TO_L663536_UP |
— | MAYBURD_RESPONSE_TO_L663536_DN |
— | ELVIDGE_TABLE_3_UP |
— | ELVIDGE_TABLE_3_DN |
— | ELVIDGE_TABLE_1_UP |
— | ELVIDGE_TABLE_1_DN |
— | ELVIDGE_HYPOXIA_UP |
— | ELVIDGE_HYPOXIA_DN |
— | ELVIDGE_HYPOXIA_BY_DMOG_UP |
— | ELVIDGE_HYPOXIA_BY_DMOG_DN |
— | ELVIDGE_HIF1A_TARGETS_UP |
— | ELVIDGE_HIF1A_TARGETS_DN |
— | ELVIDGE_HIF2A_TARGETS_UP |
— | ELVIDGE_HIF2A_TARGETS_DN |
— | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP |
— | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN |
— | LUND_TABLE_1 |
— | LUND_SILENCED_BY_METHYLATION |
— | UDAYAKUMAR_MED1_TARGETS_UP |
— | UDAYAKUMAR_MED1_TARGETS_DN |
— | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP |
— | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN |
— | HOLLMAN_APOPTOSIS_VIA_CD40_UP |
— | HOLLMAN_APOPTOSIS_VIA_CD40_DN |
— | WINNEPENNINCKX_MELANOMA_METASTASIS_DN |
— | WINNEPENNINCKX_MELANOMA_METASTASIS_UP |
— | UZONYI_TABLE_5S_6S_UP |
— | UZONYI_TABLE_5S_6S_DN |
— | UZONYI_TABLE_7S_8S_UP |
— | UZONYI_TABLE_7S_8S_DN |
— | UZONYI_TABLE_9S_10S_UP |
— | UZONYI_TABLE_9S_10S_DN |
— | UZONYI_TABLE_11S_12S_UP |
— | UZONYI_TABLE_11S_12S_DN |
— | UZONYI_TABLE_13S_14S_UP |
— | UZONYI_TABLE_13S_14S_DN |
— | UZONYI_TABLE_15S_16S_UP |
— | UZONYI_TABLE_15S_16S_DN |
— | UZONYI_TABLE_3S_4S_UP |
— | UZONYI_TABLE_3S_4S_DN |
— | UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN |
— | CHIARADONNA_TARGETS_OF_KRAS_AND_CDC25_UP |
— | CHIARADONNA_TARGETS_OF_KRAS_AND_CDC25_DN |
— | CHIARADONNA_KRAS_TARGETS_UP |
— | CHIARADONNA_KRAS_TARGETS_DN |
— | CHIARADONNA_CDC25_TARGETS_UP |
— | CHIARADONNA_CDC25_TARGETS_DN |
— | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 |
— | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 |
— | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 |
— | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 |
— | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 |
— | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 |
— | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP |
— | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN |
— | AFFAR_YY1_TARGETS_UP |
— | AFFAR_YY1_TARGETS_DN |
HOUSTIS_ROS | HOUSTIS_ROS |
— | VIEMANN_TNF_SIGNATURE |
— | BILBAN_B_CLL_LPL_UP |
— | BILBAN_B_CLL_LPL_DN |
— | BILBAN_TABLE_2S_UP |
— | BILBAN_TABLE_2S_DN |
— | LIU_PROSTATE_CANCER_UP |
— | LIU_PROSTATE_CANCER_DN |
— | LIU_SOX4_TARGETS_UP |
— | LIU_SOX4_TARGETS_DN |
NGUYEN_KERATO_UP | NGUYEN_NOTCH1_TARGETS_UP |
NGUYEN_KERATO_DN | NGUYEN_NOTCH1_TARGETS_DN |
— | KARAKAS_TGFB1_SIGNALING |
— | KARAKAS_TGFB1_SIGNALING_2_UP |
— | KARAKAS_TGFB1_SIGNALING_2_DN |
FLOTHO_CASP8AP2_MRD_DIFF | Deprecated |
— | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP |
— | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN |
— | PRAMOONJAGO_SOX4_TARGETS_UP |
— | PRAMOONJAGO_SOX4_TARGETS_DN |
— | PRAMOONJAGO_TABLE_1_UP |
— | PRAMOONJAGO_TABLE_1_DN |
— | PRAMOONJAGO_TABLE_4_UP |
— | PRAMOONJAGO_TABLE_4_DN |
— | ONKEN_UVEAL_MELANOMA_UP |
— | ONKEN_UVEAL_MELANOMA_DN |
— | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP |
— | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN |
— | NEIMAN_TABLE_1S_UP |
— | NEIMAN_TABLE_1S_DN |
— | NEIMAN_TABLE_1S_TF_UP |
— | NEIMAN_TABLE_1S_TF_DN |
— | NEIMAN_TABLE_1S_END_STAGE_UP |
— | NEIMAN_TABLE_1S_END_STAGE_DN |
— | DUNNE_TABLE_1_UP |
— | DUNNE_TABLE_1_DN |
— | DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP |
— | DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN |
— | DUNNE_TABLE_5_UP |
— | DUNNE_TABLE_5_DN |
— | DUNNE_TABLE_2_UP |
— | DUNNE_TABLE_2_DN |
— | DUNNE_TABLE_3 |
— | DUNNE_TABLE_5_ONE_MORE |
— | PATTERSON_DOCETAXEL_RESISTANCE |
— | YAMANAKA_GLIOMA_SURVIVAL_PROGNOSIS_POOR_VS_GOOD |
— | YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP |
— | YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN |
RADMACHER_AMLNORMALKARYTYPE_SIG | RADMACHER_AML_PROGNOSIS |
— | ROYLANCE_BREAST_CANCER_CHR16Q_COPY_NUMBER_UP |
— | ROYLANCE_BREAST_CANCER_CHR16Q_COPY_NUMBER_DN |
— | RIBAS_KINASE_PROQINASE_SELECTIVITY_PANEL |
WALKER_MM_SNP_DIFF | Deprecated |
— | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP |
— | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN |
— | KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP |
— | KAPOSI_LIVER_CANCER_POOR_SURVIVAL_DN |
— | JAERVINEN_TABLES_2S_AND_4S_UP |
— | JAERVINEN_TABLES_2S_AND_4S_DN |
— | JAERVINEN_TABLE_3S_AND_5S_UP |
— | JAERVINEN_TABLE_3S_AND_5S_DN |
— | JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER |
ZHAN_MM_CD138_CD1_VS_REST | ZHAN_MULTIPLE_MYELOMA_CD1_UP |
ZHAN_MM_CD1_VS_CD2_DN | ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN |
ZHAN_MM_MOLECULAR_CLASSI_UP | ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP |
ZHAN_MM_CD138_LB_VS_REST | ZHAN_MULTIPLE_MYELOMA_LB_UP |
ZHAN_MM_CD1_VS_CD2_UP | ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP |
ZHAN_MM_CD138_PR_VS_REST | ZHAN_MULTIPLE_MYELOMA_PR_UP |
ZHAN_MM_CD138_CD2_VS_REST | ZHAN_MULTIPLE_MYELOMA_CD2_UP |
ZHAN_MM_CD138_MF_VS_REST | ZHAN_MULTIPLE_MYELOMA_MF_UP |
ZHAN_MM_CD138_MS_VS_REST | ZHAN_MULTIPLE_MYELOMA_MS_UP |
ZHAN_MM_CD138_HP_VS_REST | ZHAN_MULTIPLE_MYELOMA_HP_UP |
ZHAN_MM_MOLECULAR_CLASSI_DN | ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN |
— | ZHAN_MULTIPLE_MYELOMA_CD1_DN |
— | ZHAN_MULTIPLE_MYELOMA_CD2_DN |
— | ZHAN_MULTIPLE_MYELOMA_LB_DN |
— | ZHAN_MULTIPLE_MYELOMA_HP_DN |
— | ZHAN_MULTIPLE_MYELOMA_MF_DN |
— | ZHAN_MULTIPLE_MYELOMA_MS_DN |
— | ZHAN_MULTIPLE_MYELOMA_PR_DN |
— | HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER |
— | HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER |
— | ESTECIO_METHYLATED_IN_HEAD_AND_NECK_CANCER_UP |
— | ESTECIO_METHYLATED_IN_HEAD_AND_NECK_CANCER_DN |
— | OSMAN_BLADDER_CANCER_UP |
— | OSMAN_BLADDER_CANCER_DN |
— | PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP |
— | PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN |
— | GAZDA_TABLE_1S_UP |
— | GAZDA_TABLE_1S_DN |
— | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP |
— | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN |
— | GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP |
— | GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN |
— | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP |
— | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_4 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_10 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_20 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_28 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_19 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 |
— | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13 |
— | WANG_RESPONSE_TO_ANDROGEN_UP |
— | WANG_RESPONSE_TO_ANDROGEN_DN |
— | WANG_RESPONSE_TO_FORSKOLIN_UP |
— | WANG_RESPONSE_TO_FORSKOLIN_DN |
— | HUMMEL_BURKITTS_LYMPHOMA_UP |
— | HUMMEL_BURKITTS_LYMPHOMA_DN |
BROWN_GRAN_MONO_DIFFERENTIATION | BROWN_MYELOID_CELL_DEVELOPMENT_UP |
BROWN_MYELOID_PROLIF_AND_SELF_RENEWAL | BROWN_MYELOID_CELL_DEVELOPMENT_DN |
— | BROWN_CD131_MUTATED |
— | NEWMAN_ERCC6_TARGETS_UP |
— | NEWMAN_ERCC6_TARGETS_DN |
— | NEWMAN_TABLE_1S_UP |
— | NEWMAN_TABLE_1S_DN |
— | PACHER_TARGETS_OF_IGF1_AND_IGF2_UP |
— | PACHER_TARGETS_OF_IGF1_AND_IGF2_DN |
— | PACHER_TABLES_2_5_UP |
— | PACHER_TABLES_2_5_DN |
— | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP |
— | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN |
— | OHASHI_AURKA_TARGETS |
— | OHASHI_AURKB_TARGETS |
— | MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER |
— | TSAI_DNAJB4_TARGETS_UP |
— | TSAI_DNAJB4_TARGETS_DN |
— | OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP |
— | OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN |
— | BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER |
— | OZANNE_AP1_TARGETS_UP |
— | OZANNE_AP1_TARGETS_DN |
— | HWANG_PROSTATE_CANCER_MARKERS |
— | TIMOFEEVA_TABLE_1S_UP |
— | TIMOFEEVA_TABLE_1S_DN |
— | TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_UP |
— | TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN |
— | TAKEDA_TABLE_1S_UP |
— | TAKEDA_TABLE_1S_DN |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP |
— | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN |
— | LAIHO_COLORECTAL_CANCER_SERRATED_UP |
— | LAIHO_COLORECTAL_CANCER_SERRATED_DN |
— | LAIHO_TABLE_3S_UP |
— | LAIHO_TABLE_3S_DN |
— | ROESCH_HEAD_NECK_CANCER_UP |
— | ROESCH_HEAD_NECK_CANCER_DN |
— | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION |
— | MOTAMED_RESPONSE_TO_ANDROGEN_UP |
— | MOTAMED_RESPONSE_TO_ANDROGEN_DN |
— | LOTEM_TABLE_2 |
— | DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP |
— | DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN |
— | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP |
— | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN |
— | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP |
— | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN |
— | DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP |
— | DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN |
— | FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP |
— | FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN |
— | FOURNIER_ACINAR_DEVELOPMENT_LATE_UP |
— | FOURNIER_ACINAR_DEVELOPMENT_LATE_DN |
— | FOURNIER_TABLES_4S_AND_5S_UP |
— | FOURNIER_TABLES_4S_AND_5S_DN |
— | FOURNIER_TABLES_2S_AND_3S_UP |
— | FOURNIER_TABLES_2S_AND_3S_DN |
— | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 |
— | NAM_FXYD5_TARGETS_UP |
— | NAM_FXYD5_TARGETS_DN |
— | FRASOR_TAMOXIFEN_RESPONSE_UP |
— | FRASOR_TAMOXIFEN_RESPONSE_DN |
— | EGUCHI_CELL_CYCLE_RB1_TARGETS |
— | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
— | BORCZUK_MALIGNANT_MESOTHELIOMA_DN |
— | SHIRAISHI_PLZF_TARGETS_UP |
— | SHIRAISHI_PLZF_TARGETS_DN |
— | COLDREN_GEFITINIB_RESISTANCE_UP |
— | COLDREN_GEFITINIB_RESISTANCE_DN |
— | KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP |
— | KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN |
— | HANNA_CHEMOKINE_AND_ANGIOGENIC_FACTOR_EXPRESSION_IN_DNK_CELLS |
— | GALLUZZI_PERMEABILIZE_MITOCHONDRIA |
— | GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION |
— | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP |
— | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN |
— | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP |
— | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN |
— | BUDHU_LIVER_CANCER_METASTASIS_UP |
— | BUDHU_LIVER_CANCER_METASTASIS_DN |
— | KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP |
— | KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN |
— | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP |
— | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN |
— | KOKKINAKIS_TABLE_1S_48HR_UP |
— | KOKKINAKIS_TABLE_1S_48HR_DN |
— | KOKKINAKIS_TABLE_1S_96H_UP |
— | KOKKINAKIS_TABLE_1S_96H_DN |
— | CHOI_ATL_CHRONIC_VS_ACUTE_UP |
— | CHOI_ATL_CHRONIC_VS_ACUTE_DN |
— | CHOI_ATL_ACUTE_STAGE |
— | CHOI_ATL_STAGE_PREDICTOR |
— | OLSSON_E2F3_TARGETS_UP |
— | OLSSON_E2F3_TARGETS_DN |
— | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP |
— | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN |
— | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP |
— | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN |
— | CASTELLANO_HRAS_TARGETS_UP |
— | CASTELLANO_HRAS_TARGETS_DN |
— | CASTELLANO_HRAS_AND_NRAS_TARGETS_UP |
— | CASTELLANO_HRAS_AND_NRAS_TARGETS_DN |
— | CASTELLANO_NRAS_TARGETS_UP |
— | CASTELLANO_NRAS_TARGETS_DN |
— | CODY_NON_TUMORIGENIC_HYBRIDS_UP |
— | CODY_NON_TUMORIGENIC_HYBRIDS_DN |
— | CODY_MULTIPLE_CHROMOSOME_3P_TUMOR_SUPPRESSOR_GENES_UP |
— | CODY_MULTIPLE_CHROMOSOME_3P_TUMOR_SUPPRESSOR_GENES_DN |
— | KONG_RNA_KNOCKDOWN_OF_E2F1_AND_E2F3 |
— | KONG_E2F1_TARGETS |
— | KONG_E2F3_TARGETS |
— | MUELLER_TABLE_1 |
— | MUELLER_METHYLATED_IN_GLIOBLASTOMA |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP |
— | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN |
— | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP |
— | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN |
— | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP |
— | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN |
— | SENGUPTA_EBNA1_ANTICORRELATED |
— | HAHTOLA_SEZARY_SYNDROM_UP |
— | HAHTOLA_SEZARY_SYNDROM_DN |
— | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP |
— | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN |
— | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP |
— | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN |
— | HAHTOLA_MYCOSIS_FUNGOIDES_UP |
— | HAHTOLA_MYCOSIS_FUNGOIDES_DN |
— | HAHTOLA_CTCL_CUTANEOUS |
— | HAHTOLA_CTCL_PATHOGENESIS |
— | HUTTMANN_B_CLL_POOR_SURVIVAL_UP |
— | HUTTMANN_B_CLL_POOR_SURVIVAL_DN |
— | NADERI_BREAST_CANCER_PROGNOSIS_UP |
— | NADERI_BREAST_CANCER_PROGNOSIS_DN |
— | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP |
— | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN |
— | PASTURAL_RIZ1_TARGETS_UP |
— | PASTURAL_RIZ1_TARGETS_DN |
— | ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_UP |
— | ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN |
— | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP |
— | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN |
— | HAMAI_APOPTOSIS_VIA_TRAIL_UP |
— | HAMAI_APOPTOSIS_VIA_TRAIL_DN |
— | LIU_CDX2_TARGETS_UP |
— | LIU_CDX2_TARGETS_DN |
— | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP |
— | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN |
— | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP |
— | CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN |
— | CASORELLI_TABLE_3_UP |
— | CASORELLI_TABLE_3_DN |
— | HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2 |
— | MATHEW_FANCONI_ANEMIA_GENES |
— | STREICHER_FIG_8B_UP |
— | STREICHER_FIG_8B_DN |
— | STREICHER_LSM1_TARGETS_UP |
— | STREICHER_LSM1_TARGETS_DN |
— | CHIN_BREAST_CANCER_COPY_NUMBER_UP |
— | CHIN_BREAST_CANCER_COPY_NUMBER_DN |
— | ABDULRAHMAN_KIDNEY_CANCER_VHL_UP |
— | ABDULRAHMAN_KIDNEY_CANCER_VHL_DN |
— | HO_LIVER_CANCER_VASCULAR_INVASION |
— | TURNER_TABLE_2_UP |
— | TURNER_TABLE_2_DN |
— | BOWIE_ECM_HMEC_LX |
— | BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX |
— | BOWIE_TAM_HMEC_LX |
— | BOWIE_RESPONSE_TO_TAMOXIFEN |
— | YEMELYANOV_GR_TARGETS_UP |
— | YEMELYANOV_GR_TARGETS_DN |
— | GAL_LEUKEMIC_STEM_CELL_UP |
— | GAL_LEUKEMIC_STEM_CELL_DN |
— | CORRADETTI_MTOR_PATHWAY_REGULATORS_UP |
— | CORRADETTI_MTOR_PATHWAY_REGULATORS_DN |
— | BARRIER_COLON_CANCER_RECURRENCE_UP |
— | BARRIER_COLON_CANCER_RECURRENCE_DN |
— | AIYAR_COBRA1_TARGETS_UP |
— | AIYAR_COBRA1_TARGETS_DN |
— | ZHONG_EPIGENETIC_SILENCING_IN_LUNG_CANCER_UP |
— | ZHONG_EPIGENETIC_SILENCING_IN_LUNG_CANCER_DN |
— | CROSBY_E2F4_TARGETS |
— | WONG_ENDMETRIUM_CANCER_UP |
— | WONG_ENDMETRIUM_CANCER_DN |
— | WONG_ENDOMETRIAL_CANCER_LATE |
— | WATANABE_COLON_CANCER_MSI_VS_MSS_UP |
— | WATANABE_COLON_CANCER_MSI_VS_MSS_DN |
— | POTTI_5FU_SENSITIVITY |
— | POTTI_ADRIAMYCIN_SENSITIVITY |
— | POTTI_CYTOXAN_SENSITIVITY |
— | POTTI_DOCETAXEL_SENSITIVITY |
— | POTTI_ETOPOSIDE_SENSITIVITY |
— | POTTI_PACLITAXEL_SENSITIVITY |
— | POTTI_TOPOTECAN_SENSITIVITY |
— | GILMORE_DROSOPHILA_NFKAPPAB_CORE_SIGNALING |
— | GILMORE_CORE_NFKB_PATHWAY |
— | SCHEIDEREIT_IKK_TARGETS |
— | SCHEIDEREIT_IKK_INTERACTING_PROTEINS |
— | DUTTA_APOPTOSIS_VIA_NFKB |
— | DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS |
— | LI_CISPLATIN_RESISTANCE_DN |
— | LI_CISPLATIN_RESISTANCE_UP |
— | BASAKI_YBX1_TARGETS_UP |
— | BASAKI_YBX1_TARGETS_DN |
— | IVANOV_MUTATED_IN_COLON_CANCER |
— | IVANOV_TABLE_1A |
— | HORIUCHI_WTAP_TARGETS_UP |
— | HORIUCHI_WTAP_TARGETS_DN |
— | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP |
— | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN |
— | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP |
— | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN |
— | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP |
— | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN |
— | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP |
— | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN |
— | XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR |
— | XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR |
— | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP |
— | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN |
— | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP |
— | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN |
— | XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP |
— | XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN |
— | XU_AKT1_TARGETS_6HR |
— | XU_AKT1_TARGETS_48HR |
— | XU_TABLE_8S |
— | XU_TABLE_9S_UP |
— | XU_TABLE_9S_DN |
— | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP |
— | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN |
— | MAVILIO_TABLE_1S_1M |
— | MAVILIO_TABLE_1S_4M |
— | DODD_NASOPHARYNGEAL_CARCINOMA_UP |
— | DODD_NASOPHARYNGEAL_CARCINOMA_DN |
— | GAUSSMAN_MLL_AF4_FUSION_VS_CONTROL_UP |
— | GAUSSMAN_MLL_AF4_FUSION_VS_CONTROL_DN |
— | GAUSSMANN_AF4_MLL_FUSION_VS_CONTROL_UP |
— | GAUSSMANN_AF4_MLL_FUSION_VS_CONTROL_DN |
— | GAUSSMANN_MLL_AF4_AND_AF4_MLL_FUSIONS_VS_CONTROL_DN_UP |
— | GAUSSMANN_MLL_AF4_AND_AF4_MLL_FUSIONS_VS_CONTROL_DN_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP |
— | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN |
— | NAGASHIMA_NRG1_SIGNALING_UP |
— | NAGASHIMA_NRG1_SIGNALING_DN |
— | NAGASHIMA_EGF_SIGNALING_UP |
— | NAGASHIMA_EGF_SIGNALING_DN |
— | SCHMAHL_PDGF_SIGNALING |
— | KOBAYASHI_EGFR_SIGNALING_6HR_UP |
— | KOBAYASHI_EGFR_SIGNALING_6HR_DN |
— | KOBAYASHI_EGFR_SIGNALING_24HR_UP |
— | KOBAYASHI_EGFR_SIGNALING_24HR_DN |
— | SAIGUSA_TABLE_1 |
— | CHEBOTAEV_GR_TARGETS_UP |
— | CHEBOTAEV_GR_TARGETS_DN |
— | LEIN_NEURON_MARKERS |
— | LEIN_ASTROCYTE_MARKERS |
— | LEIN_OLIGODENDROCYTE_MARKERS |
— | LEIN_CHOROID_PLEXUS_MARKERS |
— | LEIN_MIDBRAIN_MARKERS |
— | LEIN_PONS_MARKERS |
— | LEIN_MEDULLA_MARKERS |
— | LEIN_CEREBELLUM_MARKERS |
— | LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES |
— | LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES |
— | LEIN_MRNA_TARGETING_ASTROCYTES |
— | GRAESSMANN_SUPPLEMENT_2_APOPTOSIS_UP |
— | GRAESSMANN_SUPPLEMENT_2_APOPTOSIS_DN |
— | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP |
— | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN |
— | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP |
— | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN |
— | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP |
— | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN |
— | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP |
— | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN |
— | HOEBEKE_ACUTE_MYELOID_LEUKEMIA_UP |
— | HOEBEKE_ACUTE_MYELOID_LEUKEMIA_DN |
— | HOEBEKE_LYMPHOID_STEM_CELL_UP |
— | HOEBEKE_LYMPHOID_STEM_CELL_DN |
— | TOMLINS_PROSTATE_CANCER_UP |
— | TOMLINS_PROSTATE_CANCER_DN |
— | TOMLINS_METASTASIS_UP |
— | TOMLINS_METASTASIS_DN |
— | VILIMAS_NOTCH1_TARGETS_UP |
— | VILIMAS_NOTCH1_TARGETS_DN |
— | VILIMAS_FIG_1A |
— | GRABARCZYK_BCL11B_TARGETS_UP |
— | GRABARCZYK_BCL11B_TARGETS_DN |
— | ZERBINI_RESPONSE_TO_SULINDAC_UP |
— | ZERBINI_RESPONSE_TO_SULINDAC_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G2 |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G5_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP |
— | BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN |
— | BERTRAM_ALZGENE |
— | BERTRAM_ALLELE VS. GENOTYPE CONTRASTS FOR POLYMORPHISMS |
— | BERTRAM_ALLELIC CONTRASTS |
— | BERTRAM_ALZGENE_UP |
— | BERTRAM_ALZGENE_DN |
— | BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP |
— | BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN |
— | HAMPE_CROHN_DISEASE_ASSOCIATED_SNPS |
— | SCHLESINGER_METHYLATED_IN_COLON_CANCER |
— | SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER |
— | SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER |
— | WIDSCHWENDTER_NORMAL_OVARIES_VS_OVARIAN CANCERS |
— | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP |
— | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN |
— | SPIELMAN_SNP GENOTYPES |
— | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP |
— | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN |
— | WHITEFORD_PEDIATRIC_CANCER_MARKERS |
— | GRADE_METASTASIS_UP |
— | GRADE_METASTASIS_DN |
— | GRADE_COLON_CANCER_UP |
— | GRADE_COLON_CANCER_DN |
— | GRADE_COLON_AND_RECTAL_CANCER_UP |
— | GRADE_COLON_AND_RECTAL_CANCER_DN |
— | GRADE_COLON_VS_RECTAL_CANCER_UP |
— | GRADE_COLON_VS_RECTAL_CANCER_DN |
— | LABBE_WNT3A_TARGETS_UP |
— | LABBE_WNT3A_TARGETS_DN |
— | LABBE_TGFB1_TARGETS_UP |
— | LABBE_TGFB1_TARGETS_DN |
— | LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP |
— | LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN |
— | NAKAMURA_CANCER_MICROENVIRONMENT_UP |
— | NAKAMURA_CANCER_MICROENVIRONMENT_DN |
— | NAKAMURA_TABLE_1_2_UP |
— | NAKAMURA_TABLE_1_2_DN |
— | NAKAMURA_METASTASIS |
— | NAKAMURA_METASTASIS_MODEL_UP |
— | NAKAMURA_METASTASIS_MODEL_DN |
— | GRATIAS_RETINOBLASTOMA_16Q24 |
— | OHM_METHYLATED_IN_ADULT_CANCERS |
— | OHM_EMBRYONIC_CARCINOMA_UP |
— | OHM_EMBRYONIC_CARCINOMA_DN |
— | CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP |
— | CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN |
— | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP |
— | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN |
— | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP |
— | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN |
— | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP |
— | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN |
— | BERENJENO_TRANSFORMED_BY_RHOA_UP |
— | BERENJENO_TRANSFORMED_BY_RHOA_DN |
— | RIZ_ERYTHROID_DIFFERENTIATION |
— | RIZ_ERYTHROID_DIFFERENTIATION_CCNE1 |
— | RIZ_ERYTHROID_DIFFERENTIATION_HBZ |
— | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN |
— | RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2 |
— | RIZ_ERYTHROID_DIFFERENTIATION_6HR |
— | RIZ_ERYTHROID_DIFFERENTIATION_12HR |
— | SHI_SPARC_TARGETS_UP |
— | SHI_SPARC_TARGETS_DN |
— | MOHANKUMAR_TLX1_TARGETS_UP |
— | MOHANKUMAR_TLX1_TARGETS_DN |
— | NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP |
— | NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN |
— | APPIERTO_RESPONSE_TO_FENRETINIDE_UP |
— | APPIERTO_RESPONSE_TO_FENRETINIDE_DN |
— | GAVIN_TR_CELL_EFFECTOR_GENES |
— | GAVIN_FOXP3_TARGETS_CLUSTER_T4 |
— | GAVIN_FOXP3_TARGETS_CLUSTER_T7 |
— | GAVIN_FOXP3_TARGETS_CLUSTER_P2 |
— | GAVIN_FOXP3_TARGETS_CLUSTER_P3 |
— | GAVIN_FOXP3_TARGETS_CLUSTER_P4 |
— | GAVIN_FOXP3_TARGETS_CLUSTER_P6 |
— | GAVIN_FOXP3_TARGETS_CLUSTER_P7 |
— | GAVIN_PDE3B_TARGETS |
— | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP |
— | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN |
— | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP |
— | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN |
— | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP |
— | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN |
— | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL |
— | WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP |
— | WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN |
— | WEST_ADRENOCORTICAL_TUMOR_UP |
— | WEST_ADRENOCORTICAL_TUMOR_DN |
— | WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP |
— | WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN |
— | DONATO_CELL_CYCLE_TRETINOIN |
— | CHO_NR4A1_TARGETS |
— | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP |
— | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN |
— | BHATI_TABLE_1S_UP |
— | BHATI_TABLE_1S_DN |
— | CLIMENT_BREAST_CANCER_COPY_NUMBER_UP |
— | CLIMENT_BREAST_CANCER_COPY_NUMBER_DN |
— | ZHENG_BOUND_BY_FOXP3 |
— | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP |
— | ZHENG_FOXP3_TARGETS_IN_THYMUS_DN |
— | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP |
— | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN |
— | ZHENG_FOXP3_TARGETS_UP |
— | ZHENG_FOXP3_TARGETS_DN |
— | MARSON_BOUND_BY_FOXP3_STIMULATED |
— | MARSON_BOUND_BY_FOXP3_UNSTIMULATED |
— | MARSON_BOUND_BY_E2F4_UNSTIMULATED |
— | MARSON_FOXP3_TARGETS_STIMULATED_UP |
— | MARSON_FOXP3_TARGETS_STIMULATED_DN |
— | MARSON_FOXP3_CORE_DIRECT_TARGETS |
— | MARSON_TCELL_BIOLOGY_FOXP3_TARGET_GENES |
— | MARSON_SUPPLEMENTARY_TABLE_7B |
— | MARSON_SUPPLEMENTARY_TABLE_8B |
— | MARSON_SUPPLEMENTARY_TABLE_10 |
— | MARSON_FOXP3_TARGETS_UP |
— | MARSON_FOXP3_TARGETS_DN |
— | HE_PTEN_TARGETS_UP |
— | HE_PTEN_TARGETS_DN |
— | MURATA_VIRULENCE_OF_H_PILORI |
— | BUSA_SAM68_TARGETS_UP |
— | BUSA_SAM68_TARGETS_DN |
— | TANAKA_TABLE_1S_UP |
— | TANAKA_TABLE_1S_DN |
— | DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP |
— | DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN |
— | GUTIERREZ_TABLE_1_UP |
— | GUTIERREZ_TABLE_1_DN |
— | GUTIERREZ_TABLE_2_UP |
— | GUTIERREZ_TABLE_2_DN |
— | GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP |
— | GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN |
— | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP |
— | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN |
— | GUTIERREZ_MULTIPLE_MYELOMA_UP |
— | GUTIERREZ_MULTIPLE_MYELOMA_DN |
— | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2 |
— | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP |
— | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN |
— | TOMIDA_METASTASIS_UP |
— | TOMIDA_METASTASIS_DN |
— | TOMIDA_LUNG_CANCER_POOR_SURVIVAL |
— | DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 |
— | HEINTZMAN_TSS CLASSES_UP |
— | HEINTZMAN_TSS CLASSES_DN |
— | SHARMA_TABLE_1_UP |
— | SHARMA_TABLE_1_DN |
— | SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM |
— | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP |
— | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN |
— | TSUDA_ALVEOLAR_SOFT_PART_SARCOMA |
— | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP |
— | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN |
— | YAGUE_PRETUMOR_DRUG_RESISTANCE_UP |
— | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN |
— | NAKAYAMA_FGF2_TARGETS |
— | PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP |
— | PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN |
— | AKL_HTLV1_INFECTION_UP |
— | AKL_HTLV1_INFECTION_DN |
— | JAEGER_METASTASIS_UP |
— | JAEGER_METASTASIS_DN |
— | ERCAN_DCC_TARGETS |
— | LUDWICZEK_TREATING_IRON_OVERLOAD |
— | WAKASUGI_HAVE_ZNF143_BINDING_SITES |
— | IGARASHI_ATF4_TARGETS_UP |
— | IGARASHI_ATF4_TARGETS_DN |
— | WIKMAN_ASBESTOS_LUNG_CANCER_UP |
— | WIKMAN_ASBESTOS_LUNG_CANCER_DN |
— | NOJIMA_SFRP2_TARGETS_UP |
— | NOJIMA_SFRP2_TARGETS_DN |
— | TAKAYAMA_BOUND_BY_AR |
— | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP |
— | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN |
— | VECCHI_GASTRIC_CANCER_EARLY_UP |
— | VECCHI_GASTRIC_CANCER_EARLY_DN |
— | BRUECKNER_TARGETS_OF_LET7_MICRORNA_UP |
— | BRUECKNER_TARGETS_OF_LET7_MICRORNA_DN |
— | PODAR_RESPONSE_TO_ADAPHOSTIN_UP |
— | PODAR_RESPONSE_TO_ADAPHOSTIN_DN |
— | LU_TUMOR_VASCULATURE_UP |
— | LU_TUMOR_VASCULATURE_DN |
— | LU_TABLE_2 |
— | LU_TUMOR_ENDOTHELIAL_MARKERS_UP |
— | LU_TUMOR_ENDOTHELIAL_MARKERS_DN |
— | LU_TUMOR_ANGIOGENESIS_UP |
— | LU_TUMOR_ANGIOGENESIS_DN |
— | LU_TABLE_1S_UP |
— | LU_TABLE_1S_DN |
— | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK |
— | AKDEMIR_LOW_STRINGENCY_RADIATION_RESPONSE_NORMAL_VS_P53_LOF_UP |
— | AKDEMIR_LOW_STRINGENCY_RADIATION_RESPONSE_NORMAL_VS_P53_LOF_DN |
— | AKDEMIR_DROSOPHILA_P53_LOF_VS_NORMAL_UP |
— | AKDEMIR_DROSOPHILA_P53_LOF_VS_NORMAL_DN |
— | AKDEMIR_RIPD GENES |
— | AKDEMIR_P53 |
— | AKDEMIR_RIPD_GENES |
— | AMIT_FIG_4GS |
— | AMIT_DELAYED_EARLY_GENES |
— | AMIT_EGF_RESPONSE_20_HELA |
— | AMIT_EGF_RESPONSE_40_HELA |
— | AMIT_EGF_RESPONSE_60_HELA |
— | AMIT_EGF_RESPONSE_120_HELA |
— | AMIT_EGF_RESPONSE_240_HELA |
— | AMIT_EGF_RESPONSE_480_HELA |
— | AMIT_EGF_RESPONSE_20_MCF10A |
— | AMIT_EGF_RESPONSE_40_MCF10A |
— | AMIT_EGF_RESPONSE_60_MCF10A |
— | AMIT_EGF_RESPONSE_120_MCF10A |
— | AMIT_EGF_RESPONSE_240_MCF10A |
— | AMIT_EGF_RESPONSE_480_MCF10A |
— | AMIT_EGF_PEAK 240 MIN |
— | AMIT_SERUM_RESPONSE_20_MCF10A |
— | AMIT_SERUM_RESPONSE_40_MCF10A |
— | AMIT_SERUM_RESPONSE_60_MCF10A |
— | AMIT_SERUM_RESPONSE_120_MCF10A |
— | AMIT_SERUM_RESPONSE_240_MCF10A |
— | AMIT_SERUM_RESPONSE_480_MCF10A |
— | MARKS_HDAC_TARGETS_UP |
— | MARKS_HDAC_TARGETS_DN |
— | MARKS_ACETYLATED_NON_HISTONE_PROTEINS |
— | MAHADEVAN_IMATINIB_RESISTANCE_UP |
— | MAHADEVAN_IMATINIB_RESISTANCE_DN |
— | MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH |
— | MAHADEVAN_RESPONSE_TO_MP470_DN |
— | MAHADEVAN_RESPONSE_TO_MP470_UP |
— | RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP |
— | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN |
— | KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION |
— | HUANG_DASATINIB_RESISTANCE_UP |
— | HUANG_DASATINIB_RESISTANCE_DN |
— | HUANG_TABLE_2_UP |
— | HUANG_TABLE_2_DN |
— | WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP |
— | WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN |
— | WEBER_METHYLATED_HCP_IN_SPERM_DN |
— | WEBER_METHYLATED_HCP_IN_SPERM_UP |
— | WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP |
— | WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN |
— | WEBER_METHYLATED_ICP_IN_FIBROBLAST |
— | WEBER_METHYLATED_ICP_IN_SPERM_UP |
— | WEBER_METHYLATED_ICP_IN_SPERM_DN |
— | WEBER_METHYLATED_LCP_IN_SPERM_UP |
— | WEBER_METHYLATED_LCP_IN_SPERM_DN |
— | SPIRA_SMOKERS_LUNG_CANCER_UP |
— | SPIRA_SMOKERS_LUNG_CANCER_DN |
— | SPIRA_TABLE_3S_UP |
— | SPIRA_TABLE_3S_DN |
— | RODRIGUES_DCC_TARGETS_UP |
— | RODRIGUES_DCC_TARGETS_DN |
— | RODRIGUES_NTN1_TARGETS_UP |
— | RODRIGUES_NTN1_TARGETS_DN |
— | RODRIGUES_NTN1_AND_DCC_TARGETS |
— | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_UP |
— | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN |
— | GREENMAN_KINASES_WITH_DRIVER_MUTATIONS |
— | CORRE_MULTIPLE_MYELOMA_UP |
— | CORRE_MULTIPLE_MYELOMA_DN |
— | MOOK_TABLE_1_UP |
— | MOOK_TABLE_1_DN |
— | MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN |
— | MATTHEWS_TABLE_1BS |
— | MATTHEWS_AP1_TARGETS |
— | QI_TABLE_1 |
— | QI_PLASMACYTOMA_UP |
— | QI_PLASMACYTOMA_DN |
— | WANG_GENES_IN_PAR1_CANDIDATE_REGION |
— | TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA |
— | ZINDY_FIG_3CB |
— | LAU_APOPTOSIS_CDKN2A_UP |
— | LAU_APOPTOSIS_CDKN2A_DN |
— | SANSOM_APC_TARGETS |
— | SANSOM_APC_MYC_TARGETS |
— | SANSOM_APC_TARGETS_REQUIRE_MYC |
— | SANSOM_SUPPLEMENTAL_TABLE_3A |
— | SANSOM_SUPPLEMENTAL_TABLE_3B |
— | SANSOM_WNT_PATHWAY_REQUIRE_MYC |
— | ONO_CD4+_T_CELLS_AML1>2.0_FOXP3>2.0 |
— | ONO_CD4+_T_CELLS_AML1>2.0_FOXP3<0.5 |
— | ONO_CD4+_T_CELLS_AML1<0.5_FOXP3>2.0 |
— | ONO_CD4+_T_CELLS_AML1<0.5_FOXP3<0.5 |
— | ONO_CD4+_T_CELLS_0.5<AML1<2.0_FOXP3>2.0 |
— | ONO_CD4+_T_CELLS_0.5<AML1<2.0_FOXP3<0.5 |
— | ONO_CD4+_T_CELLS_AML1>2.0_0.5<FOXP3<2.0 |
— | ONO_CD4+_T_CELLS_AML1<0.5_0.5<FOXP3<2.0 |
— | ONO_AML1_TARGETS_UP |
— | ONO_AML1_TARGETS_DN |
— | ONO_FOXP3_TARGETS_UP |
— | ONO_FOXP3_TARGETS_DN |
— | TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP |
— | TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN |
— | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP |
— | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN |
— | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP |
— | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN |
— | TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP |
— | TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN |
— | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP |
— | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN |
— | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP |
— | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN |
— | WANG_LSD1_TARGETS_UP |
— | WANG_LSD1_TARGETS_DN |
— | SCHAVOLT_TARGETS_OF_TP53_AND_TP63 |
— | CHASSOT_SKIN_WOUND |
— | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP |
— | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN |
— | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP |
— | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN |
— | RODRIGUES_THYROID_CARCINOMA_UP |
— | RODRIGUES_THYROID_CARCINOMA_DN |
— | KROEGER_TABLE_1S_2_UP |
— | KROEGER_TABLE_1S_2_DN |
— | KROEGER_TABLE_1S_3_UP |
— | KROEGER_TABLE_1S_3_DN |
— | KROEGER_TABLE_1S_1_UP |
— | KROEGER_TABLE_1S_1_DN |
— | CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP |
— | CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN |
— | HUPER_BREAST_BASAL_VS_LUMINAL_UP |
— | HUPER_BREAST_BASAL_VS_LUMINAL_DN |
— | MALONEY_RESPONSE_TO_17AAG_UP |
— | MALONEY_RESPONSE_TO_17AAG_DN |
— | BLUM_RESPONSE_TO_SALIRASIB_UP |
— | BLUM_RESPONSE_TO_SALIRASIB_DN |
— | CUI_GLUCOSE_DEPRIVATION |
— | WINTER_HYPOXIA_UP |
— | WINTER_HYPOXIA_DN |
— | WINTER_HYPOXIA_METAGENE |
— | WINTER_TABLE_2S_UP |
— | WINTER_TABLE_2S_DN |
— | ALONSO_METASTASIS_EMT_UP |
— | ALONSO_METASTASIS_EMT_DN |
— | ALONSO_METASTASIS_NEURAL_UP |
— | ALONSO_METASTASIS_NEURAL_DN |
— | ALONSO_METASTASIS_UP |
— | ALONSO_METASTASIS_DN |
— | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP |
— | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN |
— | HU_HSF1_TRANSCRIPTION_FACTOR_TARGETS |
— | WHITEHURST_PACLITAXEL_SENSITIVITY |
— | CHANDRAN_METASTASIS_TOP50_UP |
— | CHANDRAN_METASTASIS_TOP50_DN |
— | CHANDRAN_METASTASIS_UP |
— | CHANDRAN_METASTASIS_DN |
— | KIM_TABLE_1S_UP |
— | KIM_TABLE_1S_DN |
— | KIM_WT1_TARGETS_UP |
— | KIM_WT1_TARGETS_DN |
— | KIM_WT1_TARGETS_8HR_UP |
— | KIM_WT1_TARGETS_8HR_DN |
— | KIM_WT1_TARGETS_12HR_UP |
— | KIM_WT1_TARGETS_12HR_DN |
— | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA |
— | TANAKA_BAC |
— | WANG_TUMOR_INVASIVENESS_UP |
— | WANG_TUMOR_INVASIVENESS_DN |
— | JIANG_TIP30_TARGETS_UP |
— | JIANG_TIP30_TARGETS_DN |
— | GRESHOCK_CANCER_COPY_NUMBER_UP |
— | GRESHOCK_CANCER_COPY_NUMBER_DN |
— | WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC |
— | TSAI_RESPONSE_TO_RADIATION_THERAPY |
— | MIKI_COEXPRESSED_WITH_CYP19A1 |
— | NGO_MALIGNANT_GLIOMA_1P_LOH |
— | STEGMEIER_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS |
— | STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS |
— | WELCH_TABLE_1S_UP |
— | WELCH_TABLE_1S_DN |
— | DIERICK_DROSOPHILA_SEROTONIN_FUNCTION_GENES |
— | DIERICK_SEROTONIN_FUNCTION_GENES |
— | LEE_TARGETS_OF_PTCH1_AND_SUFU_UP |
— | LEE_TARGETS_OF_PTCH1_AND_SUFU_DN |
— | WANG_LMO4_TARGETS_UP |
— | WANG_LMO4_TARGETS_DN |
— | WANG_CLIM2_TARGETS_UP |
— | WANG_CLIM2_TARGETS_DN |
— | MARKEY_RB1_CHRONIC_LOF_UP |
— | MARKEY_RB1_CHRONIC_LOF_DN |
— | MARKEY_RB1_ACUTE_LOF_UP |
— | MARKEY_RB1_ACUTE_LOF_DN |
— | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER |
— | VARKI_SIALIC_ACID_BIOLOGY_HUMANS_VERSUS_OTHER_HOMINIDS |
— | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP |
— | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN |
— | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP |
— | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN |
— | THEODOROU_MAMMARY_TUMORIGENESIS |
— | HUI_MAPK14_TARGETS_UP |
— | HUI_MAPK14_TARGETS_DN |
— | SENESE_HDAC1_TARGETS_UP |
— | SENESE_HDAC1_TARGETS_DN |
— | SENESE_HDAC1_AND_HDAC2_TARGETS_UP |
— | SENESE_HDAC1_AND_HDAC2_TARGETS_DN |
— | SENESE_HDAC2_TARGETS_UP |
— | SENESE_HDAC2_TARGETS_DN |
— | SENESE_HDAC3_TARGETS_UP |
— | SENESE_HDAC3_TARGETS_DN |
— | DAIRKEE_TERT_TARGETS_UP |
— | DAIRKEE_TERT_TARGETS_DN |
— | BEIER_TABLE_1_UP |
— | BEIER_TABLE_1_DN |
— | BEIER_GLIOMA_STEM_CELL_UP |
— | BEIER_GLIOMA_STEM_CELL_DN |
— | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP |
— | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN |
— | STEMMER_TABLE_1_UP |
— | STEMMER_TABLE_1_DN |
— | STEMMER_TABLE_2_UP |
— | STEMMER_TABLE_2_DN |
— | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP |
— | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN |
— | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP |
— | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN |
— | BOYLAN_MULTIPLE_MYELOMA_D_UP |
— | BOYLAN_MULTIPLE_MYELOMA_D_DN |
— | BOYLAN_MULTIPLE_MYELOMA_C_D_UP |
— | BOYLAN_MULTIPLE_MYELOMA_C_D_DN |
— | BOYLAN_MULTIPLE_MYELOMA_C_UP |
— | BOYLAN_MULTIPLE_MYELOMA_C_DN |
— | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP |
— | BOYLAN_MULTIPLE_MYELOMA_PCA1_DN |
— | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP |
— | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN |
— | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS |
— | HELLEBREKERS_TABLE_5S |
— | REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS |
— | GU_PDEF_TARGETS_UP |
— | GU_PDEF_TARGETS_DN |
— | PARENT_MTOR_SIGNALING_UP |
— | PARENT_MTOR_SIGNALING_DN |
— | TOOKER_TABLE_1S_UP |
— | TOOKER_TABLE_1S_DN |
— | TOOKER_GEMCITABINE_RESISTANCE_UP |
— | TOOKER_GEMCITABINE_RESISTANCE_DN |
— | TOOKER_RESPONSE_TO_BEXAROTENE_UP |
— | TOOKER_RESPONSE_TO_BEXAROTENE_DN |
— | AIGNER_ZEB1_TARGETS |
— | WOOD_EBV_EBNA1_TARGETS_UP |
— | WOOD_EBV_EBNA1_TARGETS_DN |
— | WANG_HCP_PROSTATE_CANCER |
— | MCBRYAN_FIG_1D_UP |
— | MCBRYAN_FIG_1D_DN |
— | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP |
— | MCBRYAN_PUBERTAL_BREAST_3_4WK_DN |
— | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP |
— | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN |
— | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP |
— | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN |
— | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP |
— | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN |
— | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP |
— | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN |
— | MCBRYAN_TERMINAL_END_BUD_UP |
— | MCBRYAN_TERMINAL_END_BUD_DN |
— | MCBRYAN_FIG_1C |
— | MCBRYAN_FIG_5B |
— | MCBRYAN_TABLE_2S |
— | JU_AGING_TERC_TARGETS_UP |
— | JU_AGING_TERC_TARGETS_DN |
— | TURJANSKI_MAPK1_AND_MAPK2_TARGETS |
— | TURJANSKI_MAPK8_AND_MAPK9_TARGETS |
— | TURJANSKI_MAPK7_TARGETS |
— | TURJANSKI_MAPK11_TARGETS |
— | TURJANSKI_MAPK14_TARGETS |
— | TURJANSKI_MAPK12_TARGETS |
— | TURJANSKI_MAPK13_TARGETS |
— | OXFORD_RALA_TARGETS_UP |
— | OXFORD_RALA_TARGETS_DN |
— | OXFORD_RALB_TARGETS_DN |
— | OXFORD_RALB_TARGETS_UP |
— | OXFORD_RALA_AND_RALB_TARGETS_UP |
— | OXFORD_RALA_AND_RALB_TARGETS_DN |
— | OXFORD_RALA_OR_RALB_TARGETS_UP |
— | OXFORD_RALA_OR_RALB_TARGETS_DN |
— | SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP |
— | SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN |
— | PYEON_HPV_POSITIVE_TUMORS_UP |
— | PYEON_HPV_POSITIVE_TUMORS_DN |
— | PYEON_TABLE_4_UP |
— | PYEON_TABLE_4_DN |
— | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP |
— | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN |
— | MASER_ONCOGENE_TABLE_6S |
— | MASER_TUMOR_SUPPRESSOR_TABLE_6S |
— | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP |
— | EBAUER_TABLE_1S |
— | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN |
— | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION |
— | DARWICHE_SKIN_TUMOR_PROMOTER_UP |
— | DARWICHE_SKIN_TUMOR_PROMOTER_DN |
— | DARWICHE_PAPILLOMA_RISK_LOW_UP |
— | DARWICHE_PAPILLOMA_RISK_LOW_DN |
— | DARWICHE_PAPILLOMA_RISK_HIGH_UP |
— | DARWICHE_PAPILLOMA_RISK_HIGH_DN |
— | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP |
— | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN |
— | DARWICHE_PAPILLOMA_PROGRESSION_RISK |
— | DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP |
— | DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN |
— | EASTON_SNPS_ASSOCIATED_WITH_BREAST_CANCER |
— | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP |
— | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN |
— | LASTOWSKA_COAMPLIFIED_WITH_MYCN |
— | LASTOWSKA_TABLE_3 |
— | HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3 |
— | TANG_SENESCENCE_TP53_TARGETS_UP |
— | TANG_SENESCENCE_TP53_TARGETS_DN |
— | CHINTAPALLI_DROSOPHILA TISSUES |
— | CHINTAPALLI_DROSOPHILA MELANOGASTER |
— | FOSTER_INFLAMMATORY_RESPONSE_LPS_UP |
— | FOSTER_INFLAMMATORY_RESPONSE_LPS_DN |
— | DEN_INTERACT_WITH_LCA5 |
— | YANAGISAWA_LUNG_CANCER_RECURRENCE |
— | PEREZ_TP53_TARGETS |
— | PEREZ_TP63_TARGETS |
— | PEREZ_TP53_AND_TP63_TARGETS |
— | TESAR_ALK_TARGETS_HUMAN_ES_4D_UP |
— | TESAR_ALK_TARGETS_HUMAN_ES_4D_DN |
— | TESAR_ALK_TARGETS_HUMAN_ES_5D_UP |
— | TESAR_ALK_TARGETS_HUMAN_ES_5D_DN |
— | TESAR_ALK_TARGETS_EPISC_3D_UP |
— | TESAR_ALK_TARGETS_EPISC_3D_DN |
— | TESAR_ALK_TARGETS_EPISC_4D_UP |
— | TESAR_ALK_TARGETS_EPISC_4D_DN |
— | TESAR_ALK_TARGETS_MOUSE_ES_3D_UP |
— | TESAR_ALK_TARGETS_MOUSE_ES_3D_DN |
— | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP |
— | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN |
— | TESAR_ALK_TARGETS_MOUSE_ES_D4_UP |
— | TESAR_ALK_TARGETS_MOUSE_ES_D4_DN |
— | TESAR_JAK_TARGETS_MOUSE_ES_D3_UP |
— | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN |
— | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP |
— | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN |
— | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP |
— | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN |
— | MULLIGHAN_MLL_SIGNATURE_1_UP |
— | MULLIGHAN_MLL_SIGNATURE_1_DN |
— | MULLIGHAN_MLL_SIGNATURE_2_UP |
— | MULLIGHAN_MLL_SIGNATURE_2_DN |
— | MULLIGHAN_NPM1_SIGNATURE_3_UP |
— | MULLIGHAN_NPM1_SIGNATURE_3_DN |
— | SUZUKI_AMPLIFIED_IN_ORAL_CANCER |
— | MIKKELSEN_TABLE_4S_NPC_UP |
— | MIKKELSEN_TABLE_4S_NPC_DN |
— | MIKKELSEN_TABLE_4S_MEF_UP |
— | MIKKELSEN_TABLE_4S_MEF_DN |
— | MIKKELSEN_ES_HCP_WITH_H3K27ME3 |
— | MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED |
— | MIKKELSEN_ES_ICP_WITH_H3K27ME3 |
— | MIKKELSEN_ES_ICP_WITH_H3K4ME3 |
— | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MIKKELSEN_ES_LCP_WITH_H3K27ME3 |
— | MIKKELSEN_ES_LCP_WITH_H3K4ME3 |
— | MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 |
— | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 |
— | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 |
— | MIKKELSEN_NPC_WITH_LCP_H3K27ME3 |
— | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 |
— | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 |
— | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED |
— | MIKKELSEN_TABLE_4S_MEF_ICP_K27 |
— | SANDHU_SNP |
— | SANDHU_SNPS |
— | LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP |
— | LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN |
— | LIEN_BREAST_CARCINOMA_METAPLASTIC |
— | THUM_SYSTOLIC_HEART_FAILURE_UP |
— | THUM_SYSTOLIC_HEART_FAILURE_DN |
— | ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS |
— | ALCALA_APOPTOSIS |
— | DELYS_THYROID_CANCER_UP |
— | DELYS_THYROID_CANCER_DN |
— | DELYS_TABLE_4S |
— | DELYS_TABLE_2S_UP |
— | DELYS_TABLE_2S_DN |
— | DELYS_TABLE_3S_UP |
— | DELYS_TABLE_3S_DN |
— | DELYS_TABLE_5S |
— | KESHELAVA_MULTIPLE_DRUG_RESISTANCE |
— | MIGNOT_RLS |
— | OKAWA_NEUROBLASTOMA_1P36_31_DELETION |
— | JI_METASTASIS_REPRESSED_BY_STK11 |
— | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN |
— | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP |
— | JI_FIG_10S_UP |
— | JI_FIG_10S_DN |
— | JI_FIG_8S |
— | SEIKE_LUNG_CANCER_POOR_SURVIVAL |
— | BAKER_SAGA_COMPONENTS |
— | NAGY_SAGA_COMPONENTS_YEAST |
— | NAGY_ADA_COMPONENTS_YEAST |
— | NAGY_TFTC_COMPONENTS_HUMAN |
— | NAGY_STAGA_COMPONENTS_HUMAN |
— | NAGY_ATAC_COMPONENTS_HUMAN |
— | NAGY_SAGA_COMPONENTS_DROSOPHILA |
— | NAGY_PCAF_COMPONENTS_HUMAN |
— | NAGY_ATAC_COMPONENTS_DROSOPHILA |
— | LAFON_NUA3_COMPONENTS |
— | LAFON_SAS_COMPONENTS |
— | LAFON_NUA4_COMPONENTS |
— | MARTIN_INTERACT_WITH_HDAC |
— | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP |
— | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN |
— | WILLIAMS_ESR1_TARGETS_UP |
— | WILLIAMS_ESR1_TARGETS_DN |
— | WILLIAMS_TABLE_2_UP |
— | WILLIAMS_TABLE_2_DN |
— | WILLIAMS_ESR2_TARGETS_UP |
— | WILLIAMS_ESR2_TARGETS_DN |
— | BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION |
— | GROSS_HYPOXIA_VIA_HIF1A_ONLY |
— | GROSS_ELK3_TARGETS_UP |
— | GROSS_ELK3_TARGETS_DN |
— | GROSS_HYPOXIA_VIA_ELK3_UP |
— | GROSS_HYPOXIA_VIA_ELK3_DN |
— | GROSS_HIF1A_TARGETS_UP |
— | GROSS_HIF1A_TARGETS_DN |
— | GROSS_HYPOXIA_VIA_HIF1A_UP |
— | GROSS_HYPOXIA_VIA_HIF1A_DN |
— | GROSS_HYPOXIA_VIA_ELK3_ONLY_UP |
— | GROSS_HYPOXIA_VIA_ELK3_ONLY_DN |
— | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP |
— | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN |
— | COWLING_MYCN_TARGETS |
— | SCIBETTA_KDM5B_TARGETS_UP |
— | SCIBETTA_KDM5B_TARGETS_DN |
— | DURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP |
— | DURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN |
— | GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP |
— | GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN |
— | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP |
— | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN |
— | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP |
— | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN |
— | GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP |
— | GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN |
— | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP |
— | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN |
— | GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP |
— | GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN |
— | TANNO_HUMAN_ERYTHROBLAST_CULTURE_DAY_7_VS_DAY_14_UP |
— | TANNO_HUMAN_ERYTHROBLAST_CULTURE_DAY_7_VS_DAY_14_DN |
— | TANNO_TGFB_SUPERFAMILY |
— | RUNNE_GENDER_EFFECT_UP |
— | RUNNE_GENDER_EFFECT_DN |
— | FALVELLA_SMOKERS_WITH_LUNG_CANCER |
— | NUYTTEN_NIPP1_TARGETS_UP |
— | NUYTTEN_NIPP1_TARGETS_DN |
— | NUYTTEN_EZH2_TARGETS_UP |
— | NUYTTEN_EZH2_TARGETS_DN |
— | LIU_TABLE_3 |
— | GOZGIT_ESR1_TARGETS_UP |
— | GOZGIT_ESR1_TARGETS_DN |
— | ROY_WOUND_BLOOD_VESSEL_UP |
— | ROY_WOUND_BLOOD_VESSEL_DN |
— | MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP |
— | MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN |
— | WAGNER_APO2_SENSITIVITY |
— | GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS |
— | GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS |
— | DIXON_TABLE_1S |
— | DIXON_TABLE_2S |
— | DIXON_TABLE_3AS_NON_MHC |
— | DIXON_TABLE_3AS_MHC |
— | PALOMERO_GSI_SENSITIVITY_UP |
— | PALOMERO_GSI_SENSITIVITY_DN |
— | MONTERO_TABLE_3 |
— | MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP |
— | MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN |
— | INGRAM_SHH_TARGETS_UP |
— | INGRAM_SHH_TARGETS_DN |
— | GARY_CD5_TARGETS_UP |
— | GARY_CD5_TARGETS_DN |
— | OZEN_MIR125B1_TARGETS |
— | KAUFFMANN_MELANOMA_RELAPSE_UP |
— | KAUFFMANN_MELANOMA_RELAPSE_DN |
— | KAUFFMANN_DNA_REPAIR_GENES |
— | KAUFFMANN_DNA_REPLICATION_GENES |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP |
— | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_DN |
— | SOUCEK_MYC_TARGETS |
— | MANTOVANI_NFKB_TARGETS_UP |
— | MANTOVANI_NFKB_TARGETS_DN |
— | MANTOVANI_VIRAL_GPCR_SIGNALING_UP |
— | MANTOVANI_VIRAL_GPCR_SIGNALING_DN |
— | JIANG_CORE_DUPLICON_GENES |
— | PUJANA_BREAST_CANCER_LIT_INT_NETWORK |
— | PUJANA_XPRSS_INT_NETWORK |
— | PUJANA_BRCA1_PCC_NETWORK |
— | PUJANA_BRCA2_PCC_NETWORK |
— | PUJANA_ATM_PCC_NETWORK |
— | PUJANA_CHEK2_PCC_NETWORK |
— | PUJANA_TABLE_4S |
— | PUJANA_BCN_DIRECT_SUBNETWORK |
— | PUJANA_BRCA_CENTERED_NETWORK |
— | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP |
— | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN |
— | JEPSEN_SMRT_TARGETS |
— | RAY_ALZHEIMERS_DISEASE |
— | RICE_TABLE_1 |
— | RICE_TABLE_2 |
— | BAKER_TABLE_1 |
— | BAKER_HEMATOPOESIS_STAT1_TARGETS |
— | BAKER_HEMATOPOIESIS_STAT3_TARGETS |
— | BAKER_HEMATOPOESIS_STAT5_TARGETS |
— | SEKI_INFLAMMATORY_RESPONSE_LPS_UP |
— | SEKI_INFLAMMATORY_RESPONSE_LPS_DN |
— | YIN_ATF3_TARGETS |
— | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP |
— | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN |
— | HARADA_UPD_REGIONS_IN_PANCREATIC_CANCER |
— | HARADA_COPY_NUMBER_ANALYSIS_IN_PANCREATIC_CANCER_CELLS_UP |
— | HARADA_COPY_NUMBER_ANALYSIS_IN_PANCREATIC_CANCER_CELLS_DN |
— | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP |
— | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN |
— | GAZIN_EPIGENETIC_SILENCING_BY_KRAS |
— | PIONTEK_PKD1_TARGETS_UP |
— | PIONTEK_PKD1_TARGETS_DN |
— | FONTAINE_GENES_SPECIFIC_TO_EXPRESSION_OF_T_UM |
— | FONTAINE_TABLE_1S_FTA_UP |
— | FONTAINE_TABLE_1S_FTA_DN |
— | FONTAINE_TABLE_1S_FTA_ATY_UP |
— | FONTAINE_TABLE_1S_FTA_ATY_DN |
— | FONTAINE_TABLE_1S_FTA_ATY_FTA_UP |
— | FONTAINE_TABLE_1S_FTA_ATY_FTA_DN |
— | FONTAINE_TABLE_1S_FTA_ATY_PTC_UP |
— | FONTAINE_TABLE_1S_FTA_ATY_PTC_DN |
— | FONTAINE_TABLE_1S_PTC_UP |
— | FONTAINE_TABLE_1S_PTC_DN |
— | FONTAINE_TABLE_1S_FTA_PTC_UP |
— | FONTAINE_TABLE_1S_FTA_PTC_DN |
— | FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP |
— | FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN |
— | FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP |
— | FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN |
— | FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP |
— | FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN |
— | PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP |
— | PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN |
— | WANG_RECURRENT_LIVER_CANCER_UP |
— | WANG_RECURRENT_LIVER_CANCER_DN |
— | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP |
— | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN |
— | SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP |
— | SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN |
— | ZEITLINGER_SIGNAL_TRANSDUCTION_GENES_STALLED_POL2 |
— | ZEITLINGER_STALLED_POL2_AT_MUSCLE_GENES |
— | MUSE_EXPRESSION_LEVELS_CHANGED_BY_NELF-RNAI_UP |
— | MUSE_EXPRESSION_LEVELS_CHANGED_BY_NELF-RNAI_DN |
— | GALIE_TUMOR_ANGIOGENESIS |
— | GALIE_TUMOR_STEMNESS_GENES |
— | MARTINEZ_PROBABLE_TARGETS_OF_MIR_145 |
— | MARTINEZ_PROBABLE_TARGETS_OF_MIR_143 |
— | MARTINEZ_PROBABLE_TARGETS_OF_MIR_368 |
— | MARTINEZ_PROBABLE_TARGETS_OF_MIR_497 |
— | MARTINEZ_PROBABLE_TARGETS_OF_MIR_218 |
— | MARTINEZ_PROBABLE_TARGETS_OF_MIR_200C |
— | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP |
— | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN |
— | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP |
— | ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN |
— | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP |
— | ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN |
— | ZHOU_INFLAMMATORY_RESPONSE_LPS_UP |
— | ZHOU_INFLAMMATORY_RESPONSE_LPS_DN |
— | KHETCHOUMIAN_TRIM24_TARGETS_UP |
— | KHETCHOUMIAN_TRIM24_TARGETS_DN |
— | SCHWAB_TARGETS_OF_BMYB_S427G_UP |
— | SCHWAB_TARGETS_OF_BMYB_S427G_DN |
— | SCHWAB_TARGETS_OF_BMYB_I624M_UP |
— | SCHWAB_TARGETS_OF_BMYB_I624M_DN |
— | LEE_NEURAL_CREST_STEM_CELL_UP |
— | LEE_NEURAL_CREST_STEM_CELL_DN |
— | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP |
— | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN |
— | KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS |
— | KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD |
— | KUIJL_KINASES_CONTROLLING_INTRACELLULAR_SALMONELA_GROWTH_UP |
— | KUIJL_KINASES_CONTROLLING_INTRACELLULAR_SALMONELA_GROWTH_DN |
— | HUNSBERGER_EXERCISE_REGULATED_GENES |
— | PASQUALUCCI_TABLE_1S_UP |
— | PASQUALUCCI_TABLE_1S_DN |
— | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP |
— | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN |
— | PHILLIPS_TABLE_1 |
— | WILCOX_PRESPONSE_TO_ROGESTERONE_UP |
— | WILCOX_PRESPONSE_TO_ROGESTERONE_DN |
— | NAKAYAMA_FRA2_TARGETS |
— | GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 |
— | BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP |
— | BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN |
— | SABATES_COLORECTAL_ADENOMA_SIZE_UP |
— | SABATES_COLORECTAL_ADENOMA_SIZE_DN |
— | SABATES_COLORECTAL_ADENOMA_UP |
— | SABATES_COLORECTAL_ADENOMA_DN |
— | EHLERS_ANEUPLOIDY_UP |
— | EHLERS_ANEUPLOIDY_DN |
— | GUO_MIRNA_GENES_CORRELATED_WITH_ESOPHAGEAL_CANCER_SURVIVAL |
— | STEARMAN_TUMOR_FIELD_EFFECT_UP |
— | STEARMAN_TUMOR_FIELD_EFFECT_DN |
— | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP |
— | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN |
— | HELLER_TABLE_1S |
— | HELLER_TABLE_4S_AZA_DC |
— | HELLER_TABLE_3S |
— | HELLER_SILENCED_BY_METHYLATION_UP |
— | HELLER_SILENCED_BY_METHYLATION_DN |
— | HELLER_HDAC_TARGETS_UP |
— | HELLER_HDAC_TARGETS_DN |
— | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP |
— | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN |
— | CLAUS_PGR_POSITIVE_MENINGIOMA_UP |
— | CLAUS_PGR_POSITIVE_MENINGIOMA_DN |
— | TAVAZOIE_METASTASIS |
— | WILLER_SNP_ASSOCIATION_WITH_HDL |
— | WILLER_SNP_ASSOCIATION_WITH_LDL |
— | WILLER_SNP_ASSOCIATION_WITH_TRIGLYCERIDES |
— | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_LIPIDS_OR_LIPOPROTEINS |
— | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_LDL |
— | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_HDL |
— | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_TRIGLYCERIDES |
— | KATHIRESAN_EFFECTS_OF_LOCI_ON_MULTIPLE_LIPOPROTEIN_OR_LIPID_TRAITS |
— | KWAN_TRANSCRIPT_ISOFORM_CHANGES |
— | COURTOIS_SENESCENCE_TRIGGERS |
— | WONG_MITOCHONDRIA_GENE_MODULE |
— | WONG_PROTEASOME_GENE_MODULE |
— | AMUNDSON_TABLE_1S |
— | AMUNDSON_GAMMA_RADIATION_RESISTANCE |
— | AMUNDSON_GAMMA_RADIATION_RESPONSE |
— | AMUNDSON_TABLE_4S_D0 |
— | AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G |
— | AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G |
— | COATES_MACROPHAGE_M1_VS_M2_UP |
— | COATES_MACROPHAGE_M1_VS_M2_DN |
— | COATES_TABLE_3S_UP |
— | COATES_TABLE_3S_DN |
— | LOPEZ_MBD_TARGETS |
— | LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED |
— | LOPEZ_TABLE_3S |
— | WENDT_COHESIN_TARGETS_UP |
— | WENDT_COHESIN_TARGETS_DN |
— | ZHANG_TLX_TARGETS_36HR_UP |
— | ZHANG_TLX_TARGETS_36HR_DN |
— | ZHANG_TLX_TARGETS_60HR_UP |
— | ZHANG_TLX_TARGETS_60HR_DN |
— | ZHANG_TLX_TARGETS_DN |
— | ZHANG_TLX_TARGETS_UP |
— | LEE_METASTASIS_AND_RNA_PROCESSING_UP |
— | LEE_METASTASIS_AND_RNA_PROCESSING_DN |
— | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP |
— | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN |
— | LIN_MELANOMA_COPY_NUMBER_UP |
— | LIN_MELANOMA_COPY_NUMBER_DN |
— | MARTINEZ_RB1_TARGETS_UP |
— | MARTINEZ_RB1_TARGETS_DN |
— | MARTINEZ_TP53_TARGETS_UP |
— | MARTINEZ_TP53_TARGETS_DN |
— | MARTINEZ_RB1_AND_TP53_TARGETS_UP |
— | MARTINEZ_RB1_AND_TP53_TARGETS_DN |
— | FINETTI_BREAST_CANCER_KINOME_RED |
— | FINETTI_BREAST_CANCER_KINOME_GREEN |
— | FINETTI_BREAST_CANCERS_KINOME_BLUE |
— | FINETTI_BREAST_CANCERS_KINOME_GRAY |
— | FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL |
— | MASSARWEH_TAMOXIFEN_RESISTANCE_UP |
— | MASSARWEH_TAMOXIFEN_RESISTANCE_DN |
— | MASSARWEH_RESPONSE_TO_ESTRADIOL |
— | LAGUINGE_TABLE_1 |
— | WALLACE_TABLE_3_UP |
— | WALLACE_TABLE_3_DN |
— | WALLACE_PROSTATE_CANCER_UP |
— | WALLACE_PROSTATE_CANCER_DN |
— | WALLACE_PROSTATE_CANCER_RACE_UP |
— | WALLACE_PROSTATE_CANCER_RACE_DN |
— | BARREIRO_GENES_WITH_STRONGEST_SIGNATURES_FOR_POSITIVE_NATURAL_SELECTION |
— | JONES_TCOF1_TARGETS |
— | ZHENG_IL22_SIGNALING_UP |
— | ZHENG_IL22_SIGNALING_DN |
— | AUJLA_IL22_AND_IL17A_SIGNALING |
— | ROPERO_HDAC2_TARGETS |
— | COLINA_TARGETS_OF_4EBP1_AND_4EBP2 |
— | HAN_PROTEINS_UNIQUE_TO_AP |
— | HAN_PROTEINS_UNIQUE_TO_CAP |
— | HAN_PROTEINS_UNIQUE_TO_CP |
— | STROMNES_TABLE_2S_BRAIN_GROUP_1 |
— | STROMNES_TABLE_2S_CORD_UP |
— | STROMNES_TABLE_2S_CORD_DN |
— | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP |
— | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN |
— | OUILLETTE_CLL_13Q14_DELETION_UP |
— | OUILLETTE_CLL_13Q14_DELETION_DN |
— | YOKOE_CANCER_TESTIS_ANTIGENS |
— | MARZEC_IL2_SIGNALING_UP |
— | MARZEC_IL2_SIGNALING_DN |
— | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP |
— | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN |
— | IWANAGA_CARCINOGENESIS_BY_KRAS_UP |
— | IWANAGA_CARCINOGENESIS_BY_KRAS_DN |
— | BRUNEAU_SEPTATION_ATRIAL |
— | BRUNEAU_SEPTATION_VENTRICULAR |
— | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS |
— | MELLMAN_TUT1_TARGETS_UP |
— | MELLMAN_TUT1_TARGETS_DN |
— | HUNT_ASSOCIATION_FOR_CELIAC_DISEASE |
— | HUNT_CIS_EFFECTS_OF_CELIAC_ASSOCIATED_SNPS_ON_GENE_EXPRESSION_UP |
— | HUNT_CIS_EFFECTS_OF_CELIAC_ASSOCIATED_SNPS_ON_GENE_EXPRESSION_DN |
— | CAMPS_COLON_CANCER_COPY_NUMBER_UP |
— | CAMPS_COLON_CANCER_COPY_NUMBER_DN |
— | RIZKI_TUMOR_INVASIVENESS_3D_UP |
— | RIZKI_TUMOR_INVASIVENESS_3D_DN |
— | RIZKI_TUMOR_INVASIVENESS_2D_UP |
— | RIZKI_TUMOR_INVASIVENESS_2D_DN |
— | YAMASHITA_FIG_1C_UP |
— | YAMASHITA_FIG_1C_DN |
— | YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP |
— | YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN |
— | FUJII_YBX1_TARGETS_UP |
— | FUJII_YBX1_TARGETS_DN |
— | GOUYER_TUMOR_INVASIVENESS |
— | GOUYER_TATI_TARGETS_UP |
— | GOUYER_TATI_TARGETS_DN |
— | LIU_LIVER_CANCER |
— | LIU_BREAST_CANCER |
— | LIU_NASOPHARYNGEAL_CARCINOMA |
— | LIU_COMMON_CANCER_GENES |
— | HAN_FIG_5A_UP |
— | HAN_FIG_5A_DN |
— | HAN_SATB1_TARGETS_UP |
— | HAN_SATB1_TARGETS_DN |
— | OSADA_ASCL1_TARGETS_UP |
— | OSADA_ASCL1_TARGETS_DN |
— | CHENG_IMPRINTED_BY_ESTRADIOL |
— | DE_YY1_TARGETS_UP |
— | DE_YY1_TARGETS_DN |
— | BIERIE_INFLAMMATORY_RESPONSE_TGFB1 |
— | MCCABE_BOUND_BY_HOXC6 |
— | MCCABE_HOXC6_TARGETS_UP |
— | MCCABE_HOXC6_TARGETS_DN |
— | MCCABE_HOXC6_TARGETS_CANCER_UP |
— | MCCABE_HOXC6_TARGETS_CANCER_DN |
— | POS_RESPONSE_TO_HISTAMINE_UP |
— | POS_RESPONSE_TO_HISTAMINE_DN |
— | POS_HISTAMINE_RESPONSE_NETWORK |
— | CHEN_METABOLIC_SYNDROM_NETWORK |
— | CHEN_LIVER_METABOLISM_QTL_CIS |
— | ZEGGINI_T2D_ASSOCIATED_SNPS |
— | TOMLINSON_SNPS_ASSOCIATED_WITH_COLORECTAL_CANCER_SUSCEPTABILITY |
— | LU_POSSIBLE_TARGET_GENES_OF_MIR_21 |
— | DAIRKEE_CANCER_PRONE_RESPONSE_E2 |
— | DAIRKEE_CANCER_PRONE_RESPONSE_BPA |
— | DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 |
— | YAMASHITA_SILENCED_BY_METHYLATION |
— | YAMASHITA_METHYLATED_IN_PROSTATE_CANCER |
— | OUYANG_PROSTATE_CANCER_PROGRESSION_UP |
— | OUYANG_PROSTATE_CANCER_PROGRESSION_DN |
— | OUYANG_PROSTATE_CANCER_MARKERS |
— | RIGGI_EWING_SARCOMA_PROGENITOR_UP |
— | RIGGI_EWING_SARCOMA_PROGENITOR_DN |
— | RIGGI_SUPPL_DATA_1_DBDM_UP |
— | RIGGI_SUPPL_DATA_1_DBDM_DN |
— | RIGGI_SUPPL_DATA_2A |
— | RIGGI_FIG_3C |
— | GAUTSCHI_SRC_SIGNALING |
— | VICENT_METASTASIS_UP |
— | VICENT_METASTASIS_DN |
— | AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 |
— | HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP |
— | HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN |
— | ENGELMANN_CANCER_PROGENITORS_UP |
— | ENGELMANN_CANCER_PROGENITORS_DN |
— | WORSCHECH_TUMOR_REJECTION_UP |
— | WORSCHECH_TUMOR_REJECTION_DN |
— | WORSCHECH_TABLE_3 |
— | WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP |
— | WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN |
— | WOO_LIVER_CANCER_RECURRENCE_UP |
— | WOO_LIVER_CANCER_RECURRENCE_DN |
— | LETTRE_HEIGHT_ASSOCIATED_VARIANTS |
— | GUDBJARTSSON_SNPS_WITH_STRONGEST_HEIGHT_ASSOCIATION |
— | GUDBJARTSSON_SNP_ASSOCIATION_WITH_HEIGHT_BETWEEN_10-5_AND_10-7 |
— | GUDBJARTSSON_GENES_NEAR_LOCI_SHOWING_SUGGESTIVE_ASSOCIATION_WITH_HEIGHT |
— | WEEDON_SNPS_ASSOCIATED_WITH_HEIGHT_VARIATION |
— | LOCKWOOD_TABLE_2S |
— | LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER |
— | WONG_EMBRYONIC_STEM_CELL_CORE |
— | WONG_ADULT_TISSUE_STEM_MODULE |
— | UNGER_CHROMOSOMAL_CHANGES_IN_PAPILLARY_THYROID_CARCINOMAS |
— | UNGER_ALTERATIONS_IN_RET_PTC_POSITIVE_AND_NEGATIVE_TUMORS_UP |
— | UNGER_ALTERATIONS_IN_RET_PTC_POSITIVE_AND_NEGATIVE_TUMORS_DN |
— | TING_SILENCED_BY_DICER |
— | BOYERINAS_ONCOFETAL_TARGETS_OF_LET7 |
— | MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP |
— | MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN |
— | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP |
— | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN |
— | ACEVEDO_LIVER_CANCER_UP |
— | ACEVEDO_LIVER_CANCER_DN |
— | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
— | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN |
— | ACEVEDO_TABLE_23S_UP |
— | ACEVEDO_TABLE_23S_DN |
— | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP |
— | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN |
— | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP |
— | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN |
— | ACEVEDO_METHYLATED_IN_LIVER_CANCER_UP |
— | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN |
— | HOQUE_METHYLATED_IN_CANCER |
— | NADELLA_PRKAR1A_TARGETS_UP |
— | NADELLA_PRKAR1A_TARGETS_DN |
— | SAGIV_CD24_TARGETS_UP |
— | SAGIV_CD24_TARGETS_DN |
— | BLEWITT_GENES_IN_MOMMED1_LINKED_INTERVAL |
— | FREDERICK_PRKCI_TARGETS |
— | FRANKE_SNPS_ASSOCIATED_WITH_ULCERATIVE_COLITIS_OR_CROHN'S |
— | FISHER_SNPS_ASSOCIATED_WITH_ULCERATIVE_COLITIS |
— | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_3_UP |
— | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_3_DN |
— | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_2_UP |
— | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_2_DN |
— | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_2_V_3_UP |
— | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_2_V_3_DN |
— | FINAK_BREAST_CANCER_SDPP_SIGNATURE |
— | RAHMAN_TP53_TARGETS_PHOSPHORYLATED |
— | BENPORATH_ES_1 |
— | BENPORATH_ES_2 |
— | BENPORATH_NANOG_TARGETS |
— | BENPORATH_OCT4_TARGETS |
— | BENPORATH_SOX2_TARGETS |
— | BENPORATH_NOS_TARGETS |
— | BENPORATH_NOS_TARGETS_TRANSCRIPTION_FACTORS |
— | BENPORATH_SUZ12_TARGETS |
— | BENPORATH_EED_TARGETS |
— | BENPORATH_ES_WITH_H3K27ME3 |
— | BENPORATH_PRC2_TARGETS |
— | BENPORATH_MYC_TARGETS_WITH_EBOX |
— | BENPORATH_MYC_MAX_TARGETS |
— | BENPORATH_PROLIFERATION_BY_GO |
— | BENPORATH_CYCLING_GENES |
— | BENPORATH_PROLIFERATION |
— | BENPORATH_ES_TRANSCRIPTION_REGULATORS |
— | BENPORATH_ES_CORE_NINE |
— | BENPORATH_ES_CORE_NINE_CORRELATED |
— | PETRETTO_CARDIAC_HYPERTROPHY |
— | PETRETTO_BLOOD_PRESSURE_UP |
— | PETRETTO_BLOOD_PRESSURE_DN |
— | PETRETTO_HEART_MASS_QTL_CIS_UP |
— | PETRETTO_HEART_MASS_QTL_CIS_DN |
— | PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP |
— | PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN |
— | BEHMOARAS_TABLE_1S_UP |
— | BEHMOARAS_TABLE_1S_DN |
— | SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP |
— | SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN |
— | SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP |
— | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN |
— | SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP |
— | SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN |
— | SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP |
— | SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN |
— | SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP |
— | SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN |
— | SMID_BREAST_CANCER_LUMINAL_B_UP |
— | SMID_BREAST_CANCER_LUMINAL_B_DN |
— | SMID_BREAST_CANCER_LUMINAL_A_UP |
— | SMID_BREAST_CANCER_LUMINAL_A_DN |
— | SMID_BREAST_CANCER_ERBB2_UP |
— | SMID_BREAST_CANCER_ERBB2_DN |
— | SMID_BREAST_CANCER_NORMAL_LIKE_UP |
— | SMID_BREAST_CANCER_NORMAL_LIKE_DN |
— | SMID_BREAST_CANCER_BASAL_UP |
— | SMID_BREAST_CANCER_BASAL_DN |
— | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP |
— | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN |
— | KUMAMOTO_TABLE_1S |
— | ITO_PTTG1_TARGETS_UP |
— | ITO_PTTG1_TARGETS_DN |
— | LE_SKI_TARGETS_UP |
— | LE_SKI_TARGETS_DN |
— | MILI_PSEUDOPODIA |
— | MILI_PSEUDOPODIA_CHEMOTAXIS_UP |
— | MILI_PSEUDOPODIA_CHEMOTAXIS_DN |
— | MILI_PSEUDOPODIA_HAPTOTAXIS_UP |
— | MILI_PSEUDOPODIA_HAPTOTAXIS_DN |
— | CHAMBERS_SNPS_ASSOCIATED_WITH_INSULIN_RESISTANCE |
— | MUELLER_X_LINKED_COPY_NUMBER_UP |
— | MUELLER_X_LINKED_COPY_NUMBER_DN |
— | CAFFAREL_RESPONSE_TO_THC_UP |
— | CAFFAREL_RESPONSE_TO_THC_DN |
— | CAFFAREL_RESPONSE_TO_THC_8HR_5_UP |
— | CAFFAREL_RESPONSE_TO_THC_8HR_5_DN |
— | CAFFAREL_RESPONSE_TO_THC_8HR_3_UP |
— | CAFFAREL_RESPONSE_TO_THC_8HR_3_DN |
— | CAFFAREL_RESPONSE_TO_THC_24HR_3_UP |
— | CAFFAREL_RESPONSE_TO_THC_24HR_3_DN |
— | CAFFAREL_RESPONSE_TO_THC_24HR_5_UP |
— | CAFFAREL_RESPONSE_TO_THC_24HR_5_DN |
— | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP |
— | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN |
— | STARK_HYPPOCAMPUS_22Q11_DELETION_UP |
— | STARK_HYPPOCAMPUS_22Q11_DELETION_DN |
— | STARK_BRAIN_22Q11_DELETION |
— | STARK_TABLE_3S |
— | ZON_HSC_DEVELOPMENTAL_REGULATORS_AND_SELF-RENEWAL_FACTORS |
— | MEHRA_FIG_1AS |
— | KURLAND_TABLE_1 |
— | ONDER_CDH1_TARGETS_2_UP |
— | ONDER_CDH1_TARGETS_2_DN |
— | ONDER_CDH1_TARGETS_1_UP |
— | ONDER_CDH1_TARGETS_1_DN |
— | ONDER_CDH1_TARGETS_3_UP |
— | ONDER_CDH1_TARGETS_3_DN |
— | ONDER_CDH1_SIGNALING_VIA_CTNNB1 |
— | ZEILSTRA_CD44_TARGETS_UP |
— | ZEILSTRA_CD44_TARGETS_DN |
— | PUCA_TABLE_1S |
— | LOEPER_IKZF1_TARGETS |
— | CONNEROTTE_TABLE_2 |
— | GUDBJARTSSON_PIGMENTATION_VARIANTS_ASSOCIATED_WITH_CM_OR_SKIN_CANCERS |
— | SULEM_ASSOCIATION_WITH_PIGMENTATION_CHARACTERISTICS |
— | SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_TO_EYE_COLOR |
— | SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_TO_HAIR_COLOR |
— | SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_WITH_SKIN_SENSITIVITY_TO_SUN |
— | KONDO_TABLE_1 |
— | KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME1 |
— | KONDO_TABLE_1S |
— | KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3 |
— | KONDO_PROSTATE_CANCER_WITH_H3K27ME3 |
— | KONDO_COLON_CANCER_HCP_WITH_H3K27ME1 |
— | KONDO_COLON_CANCER_HCP_WITH_H3K27ME3 |
— | KONDO_EZH2_TARGETS |
— | SAKAMOTO_SNPS_ASSOCIATED_WITH_GASTRIC_CANCER |
— | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP |
— | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN |
— | BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP |
— | BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN |
— | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP |
— | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN |
— | LIAO_HAVE_SOX4_BINDING_SITES |
— | LIAO_METASTASIS |
— | WEI_MIR34A_TARGETS |
— | WEI_MYCN_TARGETS_WITH_E_BOX |
— | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP |
— | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN |
— | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP |
— | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN |
— | DUBOIS_ULCERATIVE_COLITIS_ASSOCIATED_REGIONS |
— | MIKKELSEN_PLURIPOTENT_STATE_UP |
— | MIKKELSEN_PLURIPOTENT_STATE_DN |
— | MIKKELSEN_DEDIFFERENTIATED_STATE_UP |
— | MIKKELSEN_DEDIFFERENTIATED_STATE_DN |
— | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY |
— | MIKKELSEN_TABLE_2S_ES_ICP_BIV |
— | MIKKELSEN_TABLE_2S_ES_LCP_BIV |
— | MIKKELSEN_TABLE_2S_MCV81_HCP_K27 |
— | MIKKELSEN_TABLE_2S_ES_ICP_K27 |
— | MIKKELSEN_TABLE_2S_ES_LCP_K27 |
— | MIKKELSEN_TABLE_2S_ES_ICP_K4 |
— | MIKKELSEN_TABLE_2S_ES_LCP_K4 |
— | MIKKELSEN_TABLE_2S_ES_HCP_NONE |
— | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 |
— | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 |
— | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 |
— | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 |
— | MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 |
— | MIKKELSEN_MEF_LCP_WITH_H3K27ME3 |
— | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 |
— | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 |
— | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED |
— | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 |
— | MIKKELSEN_IPS_ICP_WITH_H3K27ME3 |
— | MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MIKKELSEN_IPS_LCP_WITH_H3K27ME3 |
— | MIKKELSEN_IPS_LCP_WITH_H3K4ME3 |
— | XU_TABLE_3_UP |
— | XU_TABLE_3_DN |
— | XU_TABLE_2S_UP |
— | XU_TABLE_2S_DN |
— | XU_TABLE_4S_UP |
— | XU_TABLE_4S_DN |
— | CERVERA_FIG_4C_UP |
— | CERVERA_FIG_4C_DN |
— | CERVERA_SDHB_TARGETS_2 |
— | CERVERA_SDHB_TARGETS_1_UP |
— | CERVERA_SDHB_TARGETS_1_DN |
— | ROZANOV_MMP14_TARGETS_SUBSET |
— | ROZANOV_MMP14_CORRELATED |
— | ROZANOV_MMP14_TARGETS_UP |
— | ROZANOV_MMP14_TARGETS_DN |
— | KARP_FIG_2B |
— | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C |
— | LEE_LIVER_CANCER |
— | LEE_LIVER_CANCER_TOP50 |
— | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP |
— | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN |
— | MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP |
— | MISHRA_UP_IN_NAIVE_MESENCHYMAL_STEM_CELLS |
— | MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN |
— | SANGIORGI_COPY_NUMBER_POLYMORPHISMS_UP |
— | SANGIORGI_COPY_NUMBER_POLYMORPHISMS_DN |
— | ZHANG_GATA6_TARGETS_UP |
— | ZHANG_GATA6_TARGETS_DN |
— | HASEGAWA_TUMORIGENESIS_BY_RET_C634R |
— | SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP |
— | SUH_COEXPRESSED_WITH_ID1_AND_ID2_DN |
— | SCHOEN_NFKB_SIGNALING |
— | ZHANG_BREAST_CANCER_PROGENITORS_UP |
— | ZHANG_BREAST_CANCER_PROGENITORS_DN |
— | MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP |
— | MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN |
— | WOTTON_RUNX_TARGETS_UP |
— | WOTTON_RUNX_TARGETS_DN |
— | KERKEL_SEQUENCE_DEPENDENCE_OF_ASM_AT_SNP_TAGGED_LOCI |
— | SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM |
— | SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE |
— | SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE |
— | SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE |
— | SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL |
— | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP |
— | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN |
— | FUJIWARA_PARK2_IN_LIVER_CANCER_UP |
— | FUJIWARA_PARK2_IN_LIVER_CANCER_DN |
— | PHAROAH_ASSOCIATIONS_WITH_PIGMENTATION_CM_AND_BCC |
— | ALLEN_POLYMORPHISMS_SHOWING_SUMMARY_ORS |
— | BARRETT_CD_RISK_LOCI |
— | BARRETT_CROHN'S_RISK_LOCI_WITH_CORRELATED_NONSYNONYMOUS_SNP |
— | BARRETT_CIS-EQTL_EFFECTS_FOR_CD_ASSOCIATED_SNPS |
— | GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP |
— | GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN |
— | HUANG_FOXA2_TARGETS_UP |
— | HUANG_FOXA2_TARGETS_DN |
— | MITSIADES_RESPONSE_TO_APLIDIN_UP |
— | MITSIADES_RESPONSE_TO_APLIDIN_DN |
— | MAGDA_TABLE_2S_5002 |
— | MAGDA_TABLE_2S_5002_ZN_UP |
— | MAGDA_TABLE_2S_5002_ZN_DN |
— | MAGDA_FC_5002_VS_CONTROL_UP |
— | MAGDA_FC_5002_VS_CONTROL_DN |
— | MAGDA_FC_5003_VS_CONTROL_UP |
— | MAGDA_FC_5003_VS_CONTROL_DN |
— | ZENG_RESPONSE_TO_ID8_SUPERNATENT_VERSUS_CONTROL_UP |
— | ZENG_RESPONSE_TO_ID8_SUPERNATENT_VERSUS_CONTROL_DN |
— | ZENG_RESPONSE_TO_ID8_TUMOR_VERSUS_CONTROL_UP |
— | ZENG_RESPONSE_TO_ID8_TUMOR_VERSUS_CONTROL_DN |
— | ZENG_RESPONSE_TO_ID8_IRRADIATED_TUMOR_VERSUS_CONTROL_UP |
— | ZENG_RESPONSE_TO_ID8_IRRADIATED_TUMOR_VERSUS_CONTROL_DN |
— | SCHMIDT_BASAL |
— | SCHMIDT_CELLULAR_IMMUNSYSTEM |
— | SCHMIDT_HUMORAL_IMMUNSYSTEM |
— | SCHMIDT_INTERFERON |
— | SCHMIDT_PROLIFERATION |
— | SCHMIDT_ESTROGEN_RECEPTOR |
— | SCHMIDT_CHR_17 |
— | SCHMIDT_STROMAL |
— | SCHMIDT_NORMAL_LIKE |
— | SCHMIDT_JUN-FOS |
— | SCHMIDT_TRANSCRIPTION |
— | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP |
— | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN |
— | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING |
— | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING |
— | MEISSNER_ES_ICP_WITH_H3K4ME3 |
— | MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MEISSNER_NPC_HCP_WITH_H3K27ME3 |
— | MEISSNER_NPC_ICP_WITH_H3K4ME3 |
— | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED |
— | MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED |
— | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 |
— | MEISSNER_BRAIN_ICP_WITH_H3K4ME3 |
— | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 |
— | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED |
— | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 |
— | MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 |
— | MEISSNER_NPC_HCP_WITH_H3K4ME2 |
— | MEISSNER_BRAIN_HCP_WITH_H3K4ME2 |
— | GALI_TABLE_1S |
— | GALI_TP53_TARGETS_APOPTOTIC_UP |
— | GALI_TP53_TARGETS_APOPTOTIC_DN |
— | MOSERLE_IFNA_RESPONSE |
— | MOSERLE_TABLE_4S |
— | MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER |
— | MCGARVEY_TABLE_2S |
— | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP |
— | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN |
— | GAURNIER_PSMD4_TARGETS |
— | MCGOWAN_RSP6_TARGETS_UP |
— | MCGOWAN_RSP6_TARGETS_DN |
— | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD C |
— | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD D |
— | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD F |
— | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD G |
— | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD H |
— | SHEDDEN_SUPPL. DATA 1: METHOD J |
— | SHEDDEN_SUPPL. DATA 1: METHOD K |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 35 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 69 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 40 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 41 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 74 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 79 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 19 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 86 |
— | SHEDDEN_SUPPL. DATA 1: METAGENE 31 |
— | SHEDDEN_GENES_USED_TO_CLASSIFY_METHOD_B_RISK |
— | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 |
— | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 |
— | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 |
— | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 |
— | BOCHKIS_MODEL_FOR_HEPATIC_BILE_ACID_HOMEOSTASIS_BY_FOXA2 |
— | BOCHKIS_FOXA2_TARGETS |
— | TONG_INTERACT_WITH_PTTG1 |
— | BAEK_PROTEINS_DERIVED_FROM_MESSAGES_WITH_7-8MER_39-UTR_SITE_UP |
— | BAEK_PROTEINS_DERIVED_FROM_MESSAGES_WITH_7-8MER_39-UTR_SITE_DN |
— | LANDEMAINE_LUNG_METASTASIS |
— | LANDEMAINE_TABLE_1S |
— | AMBS_TABLE_1S |
— | AMBS_TABLE_2S |
— | CHANG_POU5F1_TARGETS_UP |
— | CHANG_POU5F1_TARGETS_DN |
— | LIU_PROSTATE_CANCER_RELATED_GENES_UP |
— | LIU_PROSTATE_CANCER_RELATED_GENES_DN |
— | LIU_INFLAMMATION_RELATED_GENES_IN_PROSTATE_CANCER_UP |
— | LIU_INFLAMMATION_RELATED_GENES_IN_PROSTATE_CANCER_DN |
— | LIU_GENES_IN_NETWORK_2_AND_3_UP |
— | LIU_GENES_IN_NETWORK_2_AND_3_DN |
— | LIU_VAV3_TARGETS_AND_NF-KAPPA-B_SIGNALING |
— | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP |
— | LIU_VAV3_PROSTATE_CARCINOGENESIS_DN |
— | LIU_INFLAMMATION_RELATED_GENES_UP |
— | LIU_INFLAMMATION_RELATED_GENES_DN |
— | LIU_NETWORK_2_AND_3_UP |
— | LIU_NETWORK_2_AND_3_DN |
— | STONER_ESOPHAGEAL_CARCINOGENESIS_UP |
— | STONER_ESOPHAGEAL_CARCINOGENESIS_DN |
— | O'DONOVAN_SCHIZOPHRENIA_ASSOCIATION_LOCI |
— | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP |
— | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN |
— | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP |
— | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN |
— | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP |
— | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN |
— | RICKMAN_METASTASIS_UP |
— | RICKMAN_METASTASIS_DN |
— | RICKMAN_TABLE_3S |
— | RICKMAN_HEAD_AND_NECK_CANCER_A |
— | RICKMAN_HEAD_AND_NECK_CANCER_B |
— | RICKMAN_HEAD_AND_NECK_CANCER_C |
— | RICKMAN_HEAD_AND_NECK_CANCER_D |
— | RICKMAN_HEAD_AND_NECK_CANCER_E |
— | RICKMAN_HEAD_AND_NECK_CANCER_F |
— | RICKMAN_TABLE_9S |
— | KRISHNAN_FURIN_TARGETS_UP |
— | KRISHNAN_FURIN_TARGETS_DN |
— | DOUGLAS_TABLE_1BS_UP |
— | DOUGLAS_TABLE_1BS_DN |
— | DOUGLAS_BMI1_TARGETS_UP |
— | DOUGLAS_BMI1_TARGETS_DN |
— | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP |
— | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN |
— | KRIGE_AMINO_ACID_DEPRIVATION |
— | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP |
— | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN |
— | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP |
— | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN |
— | GHO_ATF5_TARGETS_UP |
— | GHO_ATF5_TARGETS_DN |
— | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP |
— | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN |
— | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP |
— | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN |
— | CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP |
— | CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN |
— | CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP |
— | CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN |
— | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP |
— | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN |
— | YASUDA_DIABETES_MELLITUS_ASSOCIATED_SNPS |
— | FRIDMAN_SENESCENCE_UP |
— | FRIDMAN_SENESCENCE_DN |
— | FRIDMAN_IMMORTALIZATION_UP |
— | FRIDMAN_IMMORTALIZATION_DN |
— | ISHIKAWA_STING_SIGNALING |
— | MUELLER_PLURINET |
— | HONMA_DOCETAXEL_RESISTANCE |
— | WU_CELL_MIGRATION |
— | YAUCH_SUPPLEMENTARY_FILE_1_UP |
— | YAUCH_SUPPLEMENTARY_FILE_1_DN |
— | YAUCH_HEDGEHOG_PARACRINE_SIGNALING_UP |
— | YAUCH_HEDGEHOG_PARACRINE_SIGNALING_DN |
— | ZHOU_PANCREATIC_EXOCRINE_PROGENITOR |
— | ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR |
— | ZHOU_PANCREATIC_BETA_CELL |
— | DURCHDEWALD_SKIN_CARCINOGENESIS_UP |
— | DURCHDEWALD_SKIN_CARCINOGENESIS_DN |
— | LI_CYTIDINE_ANALOGS_CYCTOTOXICITY |
— | LI_CYTIDINE_ANALOG_PATHWAY |
— | KIM_LRRC3B_TARGETS |
— | BERNARD_PPAPDC1B_TARGETS_UP |
— | BERNARD_PPAPDC1B_TARGETS_DN |
— | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE |
— | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM |
— | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST |
— | KUGATHASAN_INFLAMMATORY_BOWEL_DISEASE_ASSOCIATION |
— | TAGHAVI_NEOPLASTIC_TRANSFORMATION |
— | TCGA_ALTERATIONS_IDENTIFIED_BY_RAE_UP |
— | TCGA_ALTERATIONS_IDENTIFIED_BY_RAE_DN |
— | TCGA_GLIOBLASTOMA_COPY_NUMBER_UP |
— | TCGA_GLIOBLASTOMA_COPY_NUMBER_DN |
— | TCGA_GTS_DEFINED_REGIONS_OF_INFORMATIVE_CNAS_UP |
— | TCGA_GTS_DEFINED_REGIONS_OF_INFORMATIVE_CNAS_DN |
— | TCGA_GLIOBLASTOMA_MUTATED |
— | LOPES_METHYLATED_IN_COLON_CANCER_UP |
— | LOPES_METHYLATED_IN_COLON_CANCER_DN |
— | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP |
— | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN |
— | YANG_TABLE_3S_1 |
— | YANG_MUC2_TARGETS_DUODENUM_3MO_UP |
— | YANG_MUC2_TARGETS_DUODENUM_3MO_DN |
— | YANG_MUC2_TARGETS_DUODENUM_6MO_UP |
— | YANG_MUC2_TARGETS_DUODENUM_6MO_DN |
— | YANG_MUC2_TARGETS_COLON_3MO_UP |
— | YANG_MUC2_TARGETS_COLON_3MO_DN |
— | YANG_TABLE_3S_2_UP |
— | YANG_TABLE_3S_2_DN |
— | YANG_TABLE_3S_3_UP |
— | YANG_TABLE_3S_3_DN |
— | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP |
— | MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN |
— | MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP |
— | MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN |
— | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 |
— | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 |
— | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 |
— | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4 |
— | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN |
— | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP |
— | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN |
— | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 |
— | RAYCHAUDHURI_SNPS_ASSOCIATED_WITH_RHEUMATOID_ARTHRITIS |
— | KOPP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_ASSOCIATED_VARIANTS |
— | BARTON_RHEUMATOID_ARTHRITIS_ASSOCIATED_SNPS |
— | FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION |
— | FIRESTEIN_CTNNB1_PATHWAY |
— | FIRESTEIN_PROLIFERATION |
— | WILENSKY_RESPONSE_TO_DARAPLADIB |
— | LIN_NPAS4_TARGETS_UP |
— | LIN_NPAS4_TARGETS_DN |
— | MAZAN-MAMCZARZ_QIN_TABLE_2S_HUR_UP |
— | MAZAN-MAMCZARZ_QIN_TABLE_2S_HUR_DN |
— | MAZAN-MAMCZARZ_TABLE_2S_AUF1 |
— | MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP |
— | MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN |
— | JAKSCH_TABLE_1S_CACO2_UP |
— | JAKSCH_TABLE_1S_CACO2_DN |
— | JAKSCH_TABLE_1S_WM115_UP |
— | JAKSCH_TABLE_1S_WM115_DN |
— | SINGH_NFE2L2_TARGETS |
— | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP |
— | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN |
— | LIU_FN1_TARGETS |
— | CONRAD_STEM_CELL |
— | CONRAD_GERMLINE_STEM_CELL |
— | CADWELL_ATG16L1_TARGETS_UP |
— | CADWELL_ATG16L1_TARGETS_DN |
— | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP |
— | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN |
— | BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP |
— | BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN |
— | KATTAH_SURFACE_MARKERS_ASSOCIATED_WITH_ACTIVATED_OR_RESTING_T_CELLS |
— | KATTAH_SAM-IDENTIFIED_MARKERS |
— | CHIANG_COEXPRESSIONS_OF_UPSTREAM_EFFECTORS_AND_COX2 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTER_I-1 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTER_I-2 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_II_III_IV |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_I_II_III-1 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_I_II_III-2 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_II_IV |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTER_III-1 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTER_III-2 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTER_IV-1 |
— | MORI_EMU_MYC_LYMPHOMA_CLUSTER_IV_2 |
— | MORI_PRE_BI_LYMPHOCYTE_UP |
— | MORI_PRE_BI_LYMPHOCYTE_DN |
— | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP |
— | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN |
— | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP |
— | MORI_SMALL_PRE_BII_LYMPHOCYTE_DN |
— | MORI_IMMATURE_B_LYMPHOCYTE_UP |
— | MORI_IMMATURE_B_LYMPHOCYTE_DN |
— | MORI_MATURE_B_LYMPHOCYTE_UP |
— | MORI_MATURE_B_LYMPHOCYTE_DN |
— | MORI_PLASMA_CELL_UP |
— | MORI_PLASMA_CELL_DN |
— | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP |
— | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN |
— | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP |
— | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN |
— | HOSHIDA_LIVER_CANCER_SURVIVAL_UP |
— | HOSHIDA_LIVER_CANCER_SURVIVAL_DN |
— | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS |
— | BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 |
— | DING_HIGHLY_MUTATED_GENES_SHOW_COPY_NUMBER_VARIATIONS |
— | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY |
— | DING_LUNG_CANCER_MUTATED_FREQUENTLY |
— | DING_MUTATED_GENES_IN_LUNG_ADENOCARCINOMAS |
— | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER |
— | DING_COPY_NUMBER_AND_EXPRESSION_CORRELATION_IN_HIGHLY_MUTATED_GENES |
— | DING_MUTATION_AND_COPY_NUMBER_CHANGE_CORRELATION_IN_LUNG_ADENOCARCINOMAS_UP |
— | DING_MUTATION_AND_COPY_NUMBER_CHANGE_CORRELATION_IN_LUNG_ADENOCARCINOMAS_DN |
— | DING_MUTATION_AND_EXPRESSION_CORRELATION_IN_LUNG_ADENOCARCINOMAS_UP |
— | DING_MUTATION_AND_EXPRESSION_CORRELATION_IN_LUNG_ADENOCARCINOMAS_DN |
— | DING_LANG_CANCER_MUTATED |
— | DING_LUNG_CANCER_MUTATED_RECURRENTLY |
— | DING_LUNG_CANCER_BY_MUTATION_RATE |
— | ZHENG_GLIOBLASTOMA_PLASTICITY_UP |
— | ZHENG_GLIOBLASTOMA_PLASTICITY_DN |
— | STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP |
— | STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN |
— | STEIN_ESRRA_TARGETS_UP |
— | STEIN_ESRRA_TARGETS_DN |
— | STEIN_TABLE_2S_UP |
— | STEIN_TABLE_2S_DN |
— | STEIN_ESR1_TARGETS |
— | STEIN_ESRRA_TARGETS |
— | STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA |
— | RIGGINS_FIG_6A |
— | RIGGINS_TAMOXIFEN_RESISTANCE_UP |
— | RIGGINS_TAMOXIFEN_RESISTANCE_DN |
— | YEGNASUBRAMANIAN_PROSTATE_CANCER |
— | COOPER_TYPE_1_DIABETES_ASSOCIATED_SNPS |
— | COOPER_TYPE_1_DIABETES_ASSOCIATED_SNPS_EXCLUDING_KNOWN_LOCI |
— | KOYAMA_SEMA3B_TARGETS_UP |
— | KOYAMA_SEMA3B_TARGETS_DN |
— | MATZUK_OVULATION |
— | MATZUK_CUMULUS_EXPANSION |
— | MATZUK_FERTILIZATION |
— | MATZUK_MATERNAL_EFFECT |
— | MATZUK_IMPLANTATION_AND_UTERINE |
— | MATZUK_POST-IMPLANTATION_AND_POST-PARTUM |
— | MATZUK_STEROIDOGENESIS |
— | MATZUK_MEIOTIC_AND_DNA_REPAIR |
— | MATZUK_CENTRAL_FOR_FEMALE_FERTILITY |
— | MATZUK_EMBRYONIC_GERM_CELL |
— | MATZUK_EARLY_ANTRAL_FOLLICLE |
— | MATZUK_SECONDARY_FOLLICLE |
— | MATZUK_PRIMARY_FOLLICLE |
— | MATZUK_PRIMORDIAL_FOLLICLE |
— | MATZUK_LUTEAL_GENES |
— | MATZUK_PREOVULATORY_FOLLICLE |
— | MATZUK_MALE_REPRODUCTION_SERTOLI |
— | MATZUK_SPERMATOGONIA |
— | MATZUK_SPERMATOCYTE |
— | MATZUK_SPERMATID_DIFFERENTIATION |
— | MATZUK_SPERMATOZOA |
— | MATZUK_GENETIC_MODEL_OF_MALE_REPRODUCTIVE_DEFECTS_IN_MICE_OTHER |
— | MATZUK_MALE_REPRODUCTIVE_DISORDERS |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_1 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_2 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_3 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_4 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_6 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_8 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_9 |
— | SHIN_B_CELL_LYMPHOMA_CLUSTER_10 |
— | BAFNA_MUC4_TARGETS_UP |
— | BAFNA_MUC4_TARGETS_DN |
— | ABOLHASSANI_FIG_1C |
— | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP |
— | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN |
— | NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_5P15_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_7P22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_7P15_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_16P13_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_17P11_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_19P13_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_20P13_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_20P12_P11_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON |
— | NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON |
— | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER |
— | NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER |
— | HOULSTON_COLORECTAL_CANCER_ASSOCIATED_SNPS |
— | KAO_ADAPTIVE_YEAST_CLONE_GENOTYPE |
— | KAO_EXPRESSION_CHANGED_IN_ACTIVATED_GPA2_AND_RAS_UP |
— | KAO_EXPRESSION_CHANGED_IN_ACTIVATED_GPA2_AND_RAS_DN |
— | CHUNG_BLISTER_CYTOTOXICITY_UP |
— | CHUNG_BLISTER_CYTOTOXICITY_DN |
— | THUM_MIR-21_TARGETS_IN_HEART |
— | THUM_MIR21_TARGETS_HEART_DISEASE_UP |
— | THUM_MIR21_TARGETS_HEART_DISEASE_DN |
— | JEON_SMAD6_TARGETS_UP |
— | JEON_SMAD6_TARGETS_DN |
— | HERRERO_EXPRESSION_EFFECTS_OF_PM02734_UP |
— | HERRERO_EXPRESSION_EFFECTS_OF_PM02734_DN |
— | WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT |
— | SUNG_METASTASIS_STROMA_UP |
— | SUNG_METASTASIS_STROMA_DN |
— | CHEN_HYPOXIA_UP |
— | CHEN_HYPOXIA_DN |
— | CHEN_LACTIC_ACIDOSIS_RESPONSE_UP |
— | CHEN_LACTIC_ACIDOSIS_RESPONSE_DN |
— | CHEN_INVASIVENESS_GENE_SIGNATURE |
— | CHEN_WOUND_HEALING_SIGNATURE_CORRELATING_WITH_TUMORS |
— | CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR_PROGNOSIS_UP |
— | CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR_PROGNOSIS_DN |
— | CAIRO_HEPATOBLASTOMA_UP |
— | CAIRO_HEPATOBLASTOMA_DN |
— | CAIRO_HEPATOBLASTOMA_CLASSES_UP |
— | CAIRO_HEPATOBLASTOMA_CLASSES_DN |
— | CAIRO_LIVER_DEVELOPMENT_UP |
— | CAIRO_LIVER_DEVELOPMENT_DN |
— | CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL |
— | POTTIER_CORTICOSTEROID_SENSITIVITY |
— | HARRIS_BRAIN_CANCER_PROGENITORS |
— | GEORGES_CELL_CYCLE_MIR192_TARGETS |
— | GEORGES_TARGETS_OF_MIR192_AND_MIR215 |
— | HILLION_HMGA1_TARGETS |
— | HILLION_HMGA1B_TARGETS |
— | SHEN_SMARCA2_TARGETS_UP |
— | SHEN_SMARCA2_TARGETS_DN |
— | ENJUANES_SNPS_ASSOCIATED_WITH_RISK_OF_CLL |
— | LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT |
— | SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN |
— | SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP |
— | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN |
— | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP |
— | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP |
— | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN |
— | YAMASHITA_LIVER_CANCER_STEM_CELL_UP |
— | YAMASHITA_LIVER_CANCER_STEM_CELL_DN |
— | YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP |
— | YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN |
— | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 |
— | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 |
— | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 |